data_1aiy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aiy _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.202 0.525 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.431 ' HA ' HG11 ' F' ' 2' ' ' VAL . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.413 ' HA ' HG22 ' B' ' 12' ' ' VAL . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' H' ' 14' ' ' ALA . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.402 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . 0.496 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.449 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.482 ' O ' HG22 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.482 HG22 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . 0.52 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.52 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 23.4 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.403 ' HA ' HG11 ' D' ' 2' ' ' VAL . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.496 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.492 HG11 ' HA ' ' K' ' 9' ' ' SER . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.426 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' B' ' 17' ' ' LEU . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' B' ' 14' ' ' ALA . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.436 ' HA ' HG11 ' B' ' 2' ' ' VAL . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.492 ' HA ' HG11 ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 6' ' ' CYS . 95.4 mt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.058 0.456 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 33.9 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.505 ' HB2' ' CD1' ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.424 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.481 ' O ' HG21 ' B' ' 12' ' ' VAL . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.481 HG21 ' O ' ' B' ' 9' ' ' SER . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.56 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.56 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' N ' ' D' ' 3' ' ' ASN . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.476 ' HB2' HD13 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . 0.509 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.403 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.455 ' O ' HG21 ' D' ' 12' ' ' VAL . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.455 HG21 ' O ' ' D' ' 9' ' ' SER . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.583 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.424 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' THR . . . . . 0.405 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' E' ' 6' ' ' CYS . 90.1 mt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . 0.449 ' HB2' HG21 ' E' ' 2' ' ' ILE . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.456 HG22 ' N ' ' F' ' 3' ' ' ASN . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.456 ' N ' HG22 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.597 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.461 HG21 ' O ' ' F' ' 9' ' ' SER . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.582 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.582 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' G' ' 6' ' ' CYS . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . 0.469 ' HB2' HG21 ' G' ' 2' ' ' ILE . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' D' ' 5' ' ' HIS . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.461 HG22 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.461 ' N ' HG22 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.485 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.451 HG21 ' O ' ' H' ' 9' ' ' SER . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.586 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' I' ' 6' ' ' CYS . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 31.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . 0.46 ' HB2' HG21 ' I' ' 2' ' ' ILE . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.499 HG22 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.499 ' N ' HG22 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . 0.423 ' OE1' ' OH ' ' J' ' 26' ' ' TYR . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.601 ' CE1' HD22 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.478 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.408 HD11 HG23 ' I' ' 2' ' ' ILE . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.411 HG21 ' O ' ' J' ' 9' ' ' SER . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' OE1' ' J' ' 4' ' ' GLN . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' K' ' 6' ' ' CYS . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.5 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . 0.408 ' HB2' HG21 ' K' ' 2' ' ' ILE . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.406 ' CD1' ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.515 HG22 ' N ' ' L' ' 3' ' ' ASN . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.515 ' N ' HG22 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . 0.474 ' HB2' HG23 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.473 ' O ' HG21 ' L' ' 12' ' ' VAL . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.473 HG21 ' O ' ' L' ' 9' ' ' SER . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' J' ' 5' ' ' HIS . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.431 ' O ' HG12 ' A' ' 2' ' ' ILE . 16.1 tt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.444 ' HB3' HD22 ' H' ' 17' ' ' LEU . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' H' ' 14' ' ' ALA . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.421 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.41 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' D' ' 15' ' ' LEU . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' J' ' 17' ' ' LEU . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' D' ' 16' ' ' TYR . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.443 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' J' ' 2' ' ' VAL . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . 0.416 ' N ' HG23 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.457 ' HA ' HD13 ' K' ' 10' ' ' ILE . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' H' ' 15' ' ' LEU . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.445 ' HB3' HD22 ' B' ' 17' ' ' LEU . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' B' ' 14' ' ' ALA . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . 0.467 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.439 ' HA ' HD13 ' E' ' 10' ' ' ILE . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' J' ' 16' ' ' TYR . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 30' ' ' THR . . . . . 0.467 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . 0.453 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.444 ' O ' HG12 ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' H' ' 2' ' ' VAL . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.45 HD21 ' CE1' ' L' ' 16' ' ' TYR . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 30' ' ' THR . . . . . 0.453 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.139 0.495 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.444 HG22 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.452 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.452 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.451 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.512 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' C' ' 9' ' ' SER . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' C' ' 20' ' ' CYS . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.483 HG21 ' N ' ' D' ' 13' ' ' GLU . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.483 ' N ' HG21 ' D' ' 12' ' ' VAL . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . 0.45 ' O ' HG12 ' J' ' 2' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.463 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.428 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.441 HG22 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.551 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.449 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.427 HG22 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.502 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' H' ' 24' ' ' PHE . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.457 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' I' ' 9' ' ' SER . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.45 HG12 ' O ' ' E' ' 7' ' ' CYS . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.427 HG22 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.454 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.454 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . 0.456 ' O ' HG21 ' K' ' 2' ' ' ILE . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . 0.443 ' HB2' HG21 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.512 ' CG1' ' HA ' ' C' ' 9' ' ' SER . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.416 HG22 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.405 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.195 0.521 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.442 HD22 HD22 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . 0.408 ' O ' ' OXT' ' C' ' 21' ' ' ASN . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' J' ' 17' ' ' LEU . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.457 ' HB3' HD23 ' L' ' 17' ' ' LEU . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.497 HD22 HD22 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.405 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.41 ' HA ' HG23 ' H' ' 12' ' ' VAL . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' H' ' 9' ' ' SER . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.442 HD22 HD22 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.436 ' HB3' HD23 ' D' ' 17' ' ' LEU . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.487 ' HB3' HD23 ' F' ' 17' ' ' LEU . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.497 HD22 HD22 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . 0.532 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.046 0.451 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.478 ' O ' HG21 ' B' ' 2' ' ' VAL . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.512 ' ND1' HD21 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.519 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.458 HD21 HD21 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.46 ' O ' HG21 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.414 HD22 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.563 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.49 HD21 HD21 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.458 HG21 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . 0.51 ' NE2' HD11 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . 0.512 HD21 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.423 HD22 ' N ' ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.505 ' O ' HG21 ' H' ' 2' ' ' VAL . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . 0.612 ' CE1' ' CD1' ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.488 HD21 ' ND1' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.459 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.536 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.51 HD11 ' NE2' ' F' ' 5' ' ' HIS . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.536 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 30' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.447 ' O ' HG21 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.582 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.49 HD21 HD21 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 30' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.451 ' O ' HG21 ' L' ' 2' ' ' VAL . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . 0.488 ' ND1' HD21 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.412 ' N ' HD22 ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . 0.511 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 30' ' ' THR . . . . . 0.511 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.425 ' C ' HG13 ' F' ' 2' ' ' VAL . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' F' ' 5' ' ' HIS . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' B' ' 3' ' ' ASN . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.466 ' HA ' HG22 ' B' ' 12' ' ' VAL . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.602 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.52 HD12 ' CD2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CD2' HD12 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' D' ' 3' ' ' ASN . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' SER . . . . . 0.41 ' HA ' HG22 ' D' ' 12' ' ' VAL . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.1 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' J' ' 2' ' ' VAL . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' F' ' 3' ' ' ASN . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . 0.436 ' HB2' HD12 ' A' ' 10' ' ' ILE . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.472 ' HA ' HG22 ' F' ' 12' ' ' VAL . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.584 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' H' ' 3' ' ' ASN . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.426 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.496 ' HA ' HG22 ' H' ' 12' ' ' VAL . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.567 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' J' ' 3' ' ' ASN . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 9' ' ' SER . . . . . 0.475 ' HA ' HG22 ' J' ' 12' ' ' VAL . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . 0.589 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' L' ' 3' ' ' ASN . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.444 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 9' ' ' SER . . . . . 0.427 ' HA ' HG22 ' L' ' 12' ' ' VAL . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.586 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' N ' HG21 ' A' ' 10' ' ' ILE . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.429 ' O ' HG12 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' H' ' 17' ' ' LEU . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' H' ' 14' ' ' ALA . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' C' ' 9' ' ' SER . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . 0.455 ' N ' HG21 ' C' ' 10' ' ' ILE . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.433 HG21 HD13 ' D' ' 6' ' ' LEU . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.433 HD13 HG21 ' D' ' 2' ' ' VAL . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.412 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.455 HG21 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . 0.455 ' N ' HG21 ' E' ' 10' ' ' ILE . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.449 HG21 HD13 ' F' ' 6' ' ' LEU . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . 0.449 HD13 HG21 ' F' ' 2' ' ' VAL . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 9' ' ' SER . . . . . 0.473 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.442 HG21 HD13 ' H' ' 6' ' ' LEU . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.442 HD13 HG21 ' H' ' 2' ' ' VAL . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.47 ' HB3' HD23 ' B' ' 17' ' ' LEU . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . 0.408 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . 0.462 HG21 ' N ' ' I' ' 11' ' ' CYS . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . 0.462 ' N ' HG21 ' I' ' 10' ' ' ILE . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.45 HG21 HD13 ' J' ' 6' ' ' LEU . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . 0.45 HD13 HG21 ' J' ' 2' ' ' VAL . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' K' ' 9' ' ' SER . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . 0.469 ' N ' HG21 ' K' ' 10' ' ' ILE . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.421 HG22 HD13 ' L' ' 6' ' ' LEU . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . 0.421 HD13 HG22 ' L' ' 2' ' ' VAL . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.454 HD13 HG22 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.477 HG21 ' N ' ' B' ' 3' ' ' ASN . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.477 ' N ' HG21 ' B' ' 2' ' ' VAL . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.445 HG21 ' N ' ' C' ' 3' ' ' VAL . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.427 HD13 HG22 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.439 HG21 ' N ' ' D' ' 3' ' ' ASN . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . 0.439 ' N ' HG21 ' D' ' 2' ' ' VAL . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' THR . . . . . 0.449 HG21 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . 0.496 ' HB3' HG22 ' C' ' 3' ' ' VAL . 36.3 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' J' ' 5' ' ' HIS . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.488 HG21 ' N ' ' F' ' 3' ' ' ASN . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . 0.488 ' N ' HG21 ' F' ' 2' ' ' VAL . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . 0.445 ' HB2' HD12 ' A' ' 10' ' ' ILE . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' SER . . . . . 0.432 ' HA ' HG23 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' L' ' 14' ' ' ALA . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.513 HG21 ' N ' ' H' ' 3' ' ' ASN . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . 0.513 ' N ' HG21 ' H' ' 2' ' ' VAL . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 9' ' ' SER . . . . . 0.402 ' HA ' HG23 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' H' ' 12' ' ' VAL . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . 0.522 ' O ' ' HB2' ' H' ' 29' ' ' LYS . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 9' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.51 HG21 ' N ' ' J' ' 3' ' ' ASN . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . 0.51 ' N ' HG21 ' J' ' 2' ' ' VAL . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . 0.413 ' HB2' HD12 ' E' ' 10' ' ' ILE . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.404 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' L' ' 28' ' ' PRO . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.454 HG21 ' N ' ' L' ' 3' ' ' ASN . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . 0.454 ' N ' HG21 ' L' ' 2' ' ' VAL . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.409 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' L' ' 11' ' ' LEU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.421 ' N ' HG21 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' F' ' 17' ' ' LEU . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 3' ' ' VAL . 19.1 tt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.427 ' N ' HG21 ' A' ' 2' ' ' ILE . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' ILE . . . . . 0.401 HG21 ' N ' ' C' ' 3' ' ' VAL . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' VAL . . . . . 0.401 ' N ' HG21 ' C' ' 2' ' ' ILE . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LEU . . . . . 0.463 ' HG ' HG23 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' LEU . . . . . 0.48 ' CG ' ' HB3' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' ILE . . . . . 0.439 HG21 ' N ' ' E' ' 3' ' ' VAL . 17.9 tt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' VAL . . . . . 0.439 ' N ' HG21 ' E' ' 2' ' ' ILE . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 2' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' TYR . . . . . 0.553 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 2' ' ' ILE . . . . . 0.432 HG21 ' N ' ' G' ' 3' ' ' VAL . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 3' ' ' VAL . . . . . 0.432 ' N ' HG21 ' G' ' 2' ' ' ILE . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 2' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 6' ' ' LEU . . . . . 0.454 ' HG ' HG23 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 13' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 14' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 16' ' ' TYR . . . . . 0.553 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 2' ' ' ILE . . . . . 0.439 HG21 ' N ' ' I' ' 3' ' ' VAL . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 3' ' ' VAL . . . . . 0.439 ' N ' HG21 ' I' ' 2' ' ' ILE . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 4' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 5' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 30.4 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 2' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 6' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 11' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 13' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 14' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 26' ' ' TYR . . . . . 0.408 ' CD1' ' OH ' ' L' ' 16' ' ' TYR . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 4' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 5' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 2' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 6' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 16' ' ' TYR . . . . . 0.408 ' OH ' ' CD1' ' J' ' 26' ' ' TYR . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.62 -13.89 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -1.147 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.431 ' HA ' HG11 ' F' ' 2' ' ' VAL . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.444 ' O ' ' CG2' ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.413 ' HA ' HG22 ' B' ' 12' ' ' VAL . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' H' ' 14' ' ' ALA . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.428 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.402 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . 0.496 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.42 HD23 ' H3 ' ' H' ' 31' ' ' IPH . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.449 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.482 ' O ' HG22 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.482 HG22 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.14 100.54 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -168.74 154.67 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.86 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.351 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt -85.8 -11.51 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -1.084 . . . . 0.0 108.912 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . 0.461 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . 0.52 ' O ' HG22 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.52 HG22 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 23.4 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.461 ' SG ' ' O1 ' ' H' ' 31' ' ' IPH . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.403 ' HA ' HG11 ' D' ' 2' ' ' VAL . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.496 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.492 HG11 ' HA ' ' K' ' 9' ' ' SER . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.426 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.45 ' HB3' HD23 ' B' ' 17' ' ' LEU . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' B' ' 14' ' ' ALA . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.436 ' HA ' HG11 ' B' ' 2' ' ' VAL . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.492 ' HA ' HG11 ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.423 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.512 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.405 ' O1 ' ' HA ' ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' IPH . . . . . 0.461 ' O1 ' ' SG ' ' G' ' 6' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . 0.402 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 6' ' ' CYS . 95.4 mt -98.17 -17.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.138 . . . . 0.0 109.869 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 33.9 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' HB2' HG21 ' A' ' 2' ' ' ILE . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.505 ' HB2' ' CD1' ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.424 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.481 ' O ' HG21 ' B' ' 12' ' ' VAL . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.454 ' CD2' ' C6 ' ' B' ' 32' ' ' IPH . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.481 HG21 ' O ' ' B' ' 9' ' ' SER . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.56 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.56 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' N ' ' D' ' 3' ' ' ASN . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.476 ' HB2' HD13 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . 0.509 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.403 ' O ' HG12 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.455 ' O ' HG21 ' D' ' 12' ' ' VAL . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.507 ' CD2' ' C6 ' ' D' ' 32' ' ' IPH . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.455 HG21 ' O ' ' D' ' 9' ' ' SER . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.583 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.424 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' THR . . . . . 0.405 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.9 114.94 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -128.98 121.83 28.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 109.182 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.341 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.449 HG21 ' HB2' ' E' ' 6' ' ' CYS . 90.1 mt -99.91 -17.78 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -1.204 . . . . 0.0 109.371 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . 0.449 ' HB2' HG21 ' E' ' 2' ' ' ILE . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.456 HG22 ' N ' ' F' ' 3' ' ' ASN . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.456 ' N ' HG22 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.597 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.528 ' CD2' ' C6 ' ' F' ' 32' ' ' IPH . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.461 HG21 ' O ' ' F' ' 9' ' ' SER . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.582 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.582 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' G' ' 6' ' ' CYS . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.469 ' HB2' HG21 ' G' ' 2' ' ' ILE . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.509 HG12 ' HB3' ' D' ' 5' ' ' HIS . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.461 HG22 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.461 ' N ' HG22 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.485 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.488 ' CD2' ' C6 ' ' H' ' 33' ' ' IPH . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.451 HG21 ' O ' ' H' ' 9' ' ' SER . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.586 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' I' ' 6' ' ' CYS . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 31.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . 0.46 ' HB2' HG21 ' I' ' 2' ' ' ILE . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.499 HG22 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.499 ' N ' HG22 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . 0.423 ' OE1' ' OH ' ' J' ' 26' ' ' TYR . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.601 ' CE1' HD22 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.478 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.515 ' CD2' ' C6 ' ' J' ' 33' ' ' IPH . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.411 HG21 ' O ' ' J' ' 9' ' ' SER . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . 0.423 ' OH ' ' OE1' ' J' ' 4' ' ' GLN . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' K' ' 6' ' ' CYS . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.5 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.408 ' HB2' HG21 ' K' ' 2' ' ' ILE . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.406 ' CD1' ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.515 HG22 ' N ' ' L' ' 3' ' ' ASN . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.515 ' N ' HG22 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.474 ' HB2' HG23 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.473 ' O ' HG21 ' L' ' 12' ' ' VAL . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.49 ' CD2' ' C6 ' ' L' ' 31' ' ' IPH . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.473 HG21 ' O ' ' L' ' 9' ' ' SER . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.527 ' CB ' ' H3 ' ' L' ' 31' ' ' IPH . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.601 HD22 ' CE1' ' J' ' 5' ' ' HIS . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.467 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.507 ' C6 ' ' CD2' ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.528 ' C6 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 33' ' ' IPH . . . . . 0.488 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 33' ' ' IPH . . . . . 0.515 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . 0.527 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.426 ' HA3' ' OXT' ' B' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 ' O ' HG12 ' A' ' 2' ' ' ILE . 16.1 tt -133.34 18.43 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.6 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.428 HD22 ' C5 ' ' B' ' 32' ' ' IPH . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.444 ' HB3' HD22 ' H' ' 17' ' ' LEU . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.445 HD22 ' HB3' ' H' ' 14' ' ' ALA . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.426 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.455 ' HA3' ' OXT' ' D' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.421 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.41 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.451 HD22 ' C5 ' ' D' ' 32' ' ' IPH . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.458 ' HB3' HD22 ' J' ' 17' ' ' LEU . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' D' ' 16' ' ' TYR . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.82 107.98 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -157.9 69.87 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' THR . . . . . 0.455 ' OXT' ' HA3' ' C' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.336 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.443 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt -135.97 19.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.107 . . . . 0.0 109.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' J' ' 2' ' ' VAL . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . 0.416 ' N ' HG23 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' F' ' 16' ' ' TYR . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.402 ' HA ' ' O1 ' ' H' ' 31' ' ' IPH . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.457 ' HA ' HD13 ' K' ' 10' ' ' ILE . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.482 ' CD2' ' C6 ' ' H' ' 31' ' ' IPH . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.445 ' HB3' HD22 ' B' ' 17' ' ' LEU . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' B' ' 14' ' ' ALA . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . 0.467 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.439 ' HA ' HD13 ' E' ' 10' ' ' ILE . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.472 HD22 ' C5 ' ' J' ' 31' ' ' IPH . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' J' ' 16' ' ' TYR . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 30' ' ' THR . . . . . 0.467 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . 0.453 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.444 ' O ' HG12 ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' H' ' 2' ' ' VAL . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.462 HD22 ' C5 ' ' L' ' 31' ' ' IPH . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.45 HD21 ' CE1' ' L' ' 16' ' ' TYR . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 30' ' ' THR . . . . . 0.453 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.428 ' C5 ' HD22 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.451 ' C5 ' HD22 ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.407 ' C6 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 31' ' ' IPH . . . . . 0.482 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 31' ' ' IPH . . . . . 0.472 ' C5 ' HD22 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . 0.462 ' C5 ' HD22 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt 65.09 10.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 109.673 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.444 HG22 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.452 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.452 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.451 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.512 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' C' ' 9' ' ' SER . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.464 ' O ' ' C ' ' C' ' 20' ' ' CYS . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.403 HD23 ' H6 ' ' H' ' 31' ' ' IPH . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.483 HG21 ' N ' ' D' ' 13' ' ' GLU . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.483 ' N ' HG21 ' D' ' 12' ' ' VAL . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.79 -9.77 16.98 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -107.4 7.77 29.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.552 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt 63.29 12.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -1.204 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . 0.45 ' O ' HG12 ' J' ' 2' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.463 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.428 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.469 ' CD2' ' C6 ' ' F' ' 32' ' ' IPH . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.441 HG22 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.551 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.452 HD23 ' H6 ' ' L' ' 31' ' ' IPH . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.449 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.427 HG22 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.502 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' H' ' 24' ' ' PHE . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.457 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' I' ' 9' ' ' SER . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.45 HG12 ' O ' ' E' ' 7' ' ' CYS . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.514 HD23 ' H6 ' ' F' ' 32' ' ' IPH . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.427 HG22 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' J' ' 11' ' ' LEU . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.454 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.454 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.456 ' O ' HG21 ' K' ' 2' ' ' ILE . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.443 ' HB2' HG21 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.512 ' CG1' ' HA ' ' C' ' 9' ' ' SER . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.47 ' CD2' ' C6 ' ' L' ' 31' ' ' IPH . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.416 HG22 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.509 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.405 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.514 ' H6 ' HD23 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 31' ' ' IPH . . . . . 0.408 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . 0.47 ' C6 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.14 -29.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.679 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.442 HD22 HD22 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . 0.408 ' O ' ' OXT' ' C' ' 21' ' ' ASN . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.42 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.26 128.17 8.77 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.01 -69.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.402 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.427 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt -100.35 -28.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.415 ' CD2' ' C3 ' ' F' ' 32' ' ' IPH . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.457 ' HB3' HD23 ' L' ' 17' ' ' LEU . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.497 HD22 HD22 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.405 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.41 ' HA ' HG23 ' H' ' 12' ' ' VAL . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.482 ' CD2' ' C3 ' ' H' ' 32' ' ' IPH . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' H' ' 9' ' ' SER . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.442 HD22 HD22 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.445 ' CD2' ' C3 ' ' J' ' 32' ' ' IPH . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.436 ' HB3' HD23 ' D' ' 17' ' ' LEU . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.421 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.434 ' CD2' ' C3 ' ' L' ' 31' ' ' IPH . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.487 ' HB3' HD23 ' F' ' 17' ' ' LEU . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.497 HD22 HD22 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . 0.532 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.42 ' H5 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.415 ' C3 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 32' ' ' IPH . . . . . 0.482 ' C3 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.445 ' C3 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . 0.434 ' C3 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt -87.76 -25.17 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 109.811 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.478 ' O ' HG21 ' B' ' 2' ' ' VAL . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.512 ' ND1' HD21 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.466 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.519 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.458 HD21 HD21 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.494 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.494 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.46 ' O ' HG21 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.414 HD22 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.403 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.563 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.49 HD21 HD21 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.16 80.7 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' D' ' 30' ' ' THR . 2.9 tptp -141.96 -96.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' D' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 109.72 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mt -90.09 -25.87 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 109.245 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.458 HG21 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . 0.51 ' NE2' HD11 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . 0.512 HD21 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.423 HD22 ' N ' ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.459 ' CB ' ' H3 ' ' F' ' 32' ' ' IPH . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.612 ' CD1' ' CE1' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.505 ' O ' HG21 ' H' ' 2' ' ' VAL . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . 0.612 ' CE1' ' CD1' ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.488 HD21 ' ND1' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.459 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.474 ' CB ' ' H3 ' ' H' ' 32' ' ' IPH . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.536 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.51 HD11 ' NE2' ' F' ' 5' ' ' HIS . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.536 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 30' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.447 ' O ' HG21 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.477 ' CB ' ' H3 ' ' J' ' 32' ' ' IPH . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.582 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.49 HD21 HD21 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.582 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 30' ' ' THR . . . . . 0.466 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.451 ' O ' HG21 ' L' ' 2' ' ' VAL . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . 0.488 ' ND1' HD21 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.412 ' N ' HD22 ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.51 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . 0.511 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 30' ' ' THR . . . . . 0.511 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.466 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.403 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.459 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 32' ' ' IPH . . . . . 0.474 ' H3 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.477 ' H3 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt -103.72 -29.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.223 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.425 ' C ' HG13 ' F' ' 2' ' ' VAL . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' F' ' 5' ' ' HIS . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' B' ' 3' ' ' ASN . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.466 ' HA ' HG22 ' B' ' 12' ' ' VAL . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.602 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.52 HD12 ' CD2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.52 ' CD2' HD12 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' D' ' 3' ' ' ASN . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.49 ' O ' ' CG2' ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' SER . . . . . 0.41 ' HA ' HG22 ' D' ' 12' ' ' VAL . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.588 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . 0.492 HD12 ' CD2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.492 ' CD2' HD12 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.69 93.43 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -164.29 100.1 0.83 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.611 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.1 tt -109.82 -30.71 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.444 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' J' ' 2' ' ' VAL . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' F' ' 3' ' ' ASN . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . 0.436 ' HB2' HD12 ' A' ' 10' ' ' ILE . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.472 ' HA ' HG22 ' F' ' 12' ' ' VAL . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.584 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.404 ' HA ' ' H6 ' ' H' ' 32' ' ' IPH . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' H' ' 3' ' ' ASN . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.426 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.496 ' HA ' HG22 ' H' ' 12' ' ' VAL . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.567 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . 0.498 HD12 ' CD2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.498 ' CD2' HD12 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' J' ' 3' ' ' ASN . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 9' ' ' SER . . . . . 0.475 ' HA ' HG22 ' J' ' 12' ' ' VAL . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . 0.589 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' L' ' 3' ' ' ASN . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.444 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 9' ' ' SER . . . . . 0.427 ' HA ' HG22 ' L' ' 12' ' ' VAL . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.586 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . 0.449 HD12 ' CD2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.449 ' CD2' HD12 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 32' ' ' IPH . . . . . 0.404 ' H6 ' ' HA ' ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -100.91 -13.93 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -1.208 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' N ' HG21 ' A' ' 10' ' ' ILE . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.429 ' O ' HG12 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' H' ' 17' ' ' LEU . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' H' ' 14' ' ' ALA . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' C' ' 9' ' ' SER . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . 0.455 ' N ' HG21 ' C' ' 10' ' ' ILE . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.433 HG21 HD13 ' D' ' 6' ' ' LEU . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.433 HD13 HG21 ' D' ' 2' ' ' VAL . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.412 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.98 78.75 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -132.62 162.64 30.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.78 -13.77 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.524 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.455 HG21 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . 0.455 ' N ' HG21 ' E' ' 10' ' ' ILE . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.449 HG21 HD13 ' F' ' 6' ' ' LEU . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . 0.449 HD13 HG21 ' F' ' 2' ' ' VAL . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.415 ' CB ' ' H5 ' ' F' ' 32' ' ' IPH . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 9' ' ' SER . . . . . 0.473 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.442 HG21 HD13 ' H' ' 6' ' ' LEU . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.442 HD13 HG21 ' H' ' 2' ' ' VAL . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.47 ' HB3' HD23 ' B' ' 17' ' ' LEU . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . 0.408 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . 0.462 HG21 ' N ' ' I' ' 11' ' ' CYS . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . 0.462 ' N ' HG21 ' I' ' 10' ' ' ILE . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.45 HG21 HD13 ' J' ' 6' ' ' LEU . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.45 HD13 HG21 ' J' ' 2' ' ' VAL . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.469 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' K' ' 9' ' ' SER . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . 0.469 ' N ' HG21 ' K' ' 10' ' ' ILE . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.421 HG22 HD13 ' L' ' 6' ' ' LEU . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.421 HD13 HG22 ' L' ' 2' ' ' VAL . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.469 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . 0.428 ' O1 ' HG21 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.431 ' O1 ' HG21 ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.448 ' O1 ' HG21 ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 32' ' ' IPH . . . . . 0.424 ' H5 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 32' ' ' IPH . . . . . 0.426 ' H5 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.469 ' H5 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt -77.47 -18.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.41 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 HD13 HG22 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.477 HG21 ' N ' ' B' ' 3' ' ' ASN . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.477 ' N ' HG21 ' B' ' 2' ' ' VAL . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.445 HG21 ' N ' ' C' ' 3' ' ' VAL . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.427 HD13 HG22 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.439 HG21 ' N ' ' D' ' 3' ' ' ASN . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . 0.439 ' N ' HG21 ' D' ' 2' ' ' VAL . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.46 ' C ' ' CD1' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' THR . . . . . 0.449 HG21 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' D' ' 29' ' ' LYS . 36.3 Cg_endo -79.65 105.74 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' D' ' 28' ' ' PRO . 0.1 OUTLIER 159.78 147.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.264 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.68 -18.22 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -1.158 . . . . 0.0 109.21 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' J' ' 5' ' ' HIS . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.488 HG21 ' N ' ' F' ' 3' ' ' ASN . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . 0.488 ' N ' HG21 ' F' ' 2' ' ' VAL . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . 0.445 ' HB2' HD12 ' A' ' 10' ' ' ILE . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' SER . . . . . 0.432 ' HA ' HG23 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.432 HG23 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' L' ' 14' ' ' ALA . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.513 HG21 ' N ' ' H' ' 3' ' ' ASN . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . 0.513 ' N ' HG21 ' H' ' 2' ' ' VAL . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.421 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 9' ' ' SER . . . . . 0.402 ' HA ' HG23 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' H' ' 12' ' ' VAL . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . 0.522 ' O ' ' HB2' ' H' ' 29' ' ' LYS . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 9' ' ' SER . . . . . 0.4 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.51 HG21 ' N ' ' J' ' 3' ' ' ASN . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . 0.51 ' N ' HG21 ' J' ' 2' ' ' VAL . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . 0.413 ' HB2' HD12 ' E' ' 10' ' ' ILE . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.404 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' L' ' 28' ' ' PRO . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.454 HG21 ' N ' ' L' ' 3' ' ' ASN . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . 0.454 ' N ' HG21 ' L' ' 2' ' ' VAL . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.409 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' L' ' 11' ' ' LEU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.421 ' N ' HG21 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' F' ' 17' ' ' LEU . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 3' ' ' VAL . 19.1 tt -92.77 -18.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.542 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.427 ' N ' HG21 ' A' ' 2' ' ' ILE . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.441 HG23 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.401 HG21 ' N ' ' C' ' 3' ' ' VAL . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.401 ' N ' HG21 ' C' ' 2' ' ' ILE . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.463 HG23 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . 0.463 ' HG ' HG23 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.41 ' CD2' ' C2 ' ' D' ' 32' ' ' IPH . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . 0.48 ' CG ' ' HB3' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . 0.504 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' D' ' 29' ' ' LYS . 36.3 Cg_endo -77.81 -53.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' D' ' 28' ' ' PRO . 2.6 tttt 40.75 -159.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.496 -0.752 . . . . 0.0 109.525 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.166 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.439 HG21 ' N ' ' E' ' 3' ' ' VAL . 17.9 tt -91.31 -18.1 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.262 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.439 ' N ' HG21 ' E' ' 2' ' ' ILE . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.485 HG23 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . 0.485 ' HG ' HG23 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . 0.436 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.461 ' CD2' ' C2 ' ' F' ' 32' ' ' IPH . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . 0.553 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.432 HG21 ' N ' ' G' ' 3' ' ' VAL . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.432 ' N ' HG21 ' G' ' 2' ' ' ILE . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.454 HG23 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . 0.454 ' HG ' HG23 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.553 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.439 HG21 ' N ' ' I' ' 3' ' ' VAL . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . 0.439 ' N ' HG21 ' I' ' 2' ' ' ILE . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 30.4 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.473 HG23 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . 0.473 ' HG ' HG23 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' C2 ' ' J' ' 31' ' ' IPH . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . 0.408 ' CD1' ' OH ' ' L' ' 16' ' ' TYR . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.408 ' OH ' ' CD1' ' J' ' 26' ' ' TYR . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' IPH . . . . . 0.41 ' C2 ' ' CD2' ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 32' ' ' IPH . . . . . 0.461 ' C2 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 31' ' ' IPH . . . . . 0.429 ' C2 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 32' ' ' IPH . . . . . 0.4 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.202 0.525 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 3' ' ' VAL . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.483 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.664 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.511 ' HA ' HD21 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' H' ' 17' ' ' LEU . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.412 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 3' ' ' VAL . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' C' ' 3' ' ' VAL . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.459 HD12 HG12 ' L' ' 2' ' ' VAL . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' CYS . . . . . 0.406 ' N ' HG22 ' C' ' 10' ' ' ILE . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 5' ' ' HIS . . . . . 0.508 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.649 ' O ' HG12 ' E' ' 3' ' ' VAL . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 5' ' ' HIS . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.545 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.523 ' HB3' HG21 ' E' ' 3' ' ' VAL . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.661 ' O ' HG12 ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 5' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 22.9 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.508 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.632 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.632 HG23 ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' B' ' 17' ' ' LEU . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.645 ' O ' HG12 ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.538 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.538 HG23 ' O ' ' J' ' 8' ' ' GLY . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.666 HG12 ' O ' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.426 ' HA ' ' CG1' ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.472 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.621 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.621 HG23 ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.058 0.456 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 27.4 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' B' ' 6' ' ' LEU . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.55 ' HB2' HD12 ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.446 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' B' ' 2' ' ' VAL . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.474 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 13' ' ' GLU . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' D' ' 6' ' ' LEU . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' HIS . . . . . 0.53 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.532 ' HB2' HG21 ' D' ' 2' ' ' VAL . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' HIS . . . . . 0.458 ' ND1' HD22 ' L' ' 6' ' ' LEU . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.529 HG23 ' N ' ' D' ' 13' ' ' GLU . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.426 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 5' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' F' ' 6' ' ' LEU . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.552 ' HB2' HG21 ' F' ' 2' ' ' VAL . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.508 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.622 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 10' ' ' HIS . . . . . 0.406 ' ND1' HD22 ' J' ' 6' ' ' LEU . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.508 HG13 ' O ' ' F' ' 8' ' ' GLY . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 23' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' H' ' 28' ' ' PRO . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.439 HG22 ' O ' ' G' ' 2' ' ' ILE . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' D' ' 3' ' ' ASN . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.552 HG23 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' H' ' 2' ' ' VAL . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.412 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 9' ' ' SER . . . . . 0.506 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 10' ' ' HIS . . . . . 0.401 ' ND1' HD22 ' D' ' 6' ' ' LEU . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' H' ' 13' ' ' GLU . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.436 ' HD2' ' HA3' ' F' ' 23' ' ' GLY . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 4' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 28.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.525 HG23 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.525 ' N ' HG23 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 5' ' ' HIS . . . . . 0.574 ' CE1' HD23 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' J' ' 2' ' ' VAL . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.467 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 9' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 10' ' ' HIS . . . . . 0.403 ' ND1' HD22 ' B' ' 6' ' ' LEU . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.49 HG23 ' N ' ' J' ' 13' ' ' GLU . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 19' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' J' ' 22' ' ' ARG . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 4' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 5' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.8 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.441 HD11 ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.55 HG21 HD12 ' L' ' 6' ' ' LEU . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.524 ' N ' HG23 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.55 HD12 HG21 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.442 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' L' ' 13' ' ' GLU . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 2' ' ' ILE . 16.1 tt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.615 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.465 ' N ' HG23 ' B' ' 12' ' ' VAL . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.53 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.433 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.605 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' D' ' 15' ' ' LEU . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.602 HD13 ' O ' ' D' ' 17' ' ' LEU . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.453 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.44 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 11' ' ' CYS . . . . . 0.44 ' N ' HG22 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' F' ' 2' ' ' VAL . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.413 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.413 ' N ' HG23 ' F' ' 12' ' ' VAL . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.586 HD13 ' O ' ' F' ' 17' ' ' LEU . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.579 ' O ' HG13 ' H' ' 2' ' ' VAL . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' H' ' 15' ' ' LEU . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' H' ' 17' ' ' LEU . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 1' ' ' GLY . . . . . 0.463 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.455 ' O ' HG12 ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.648 ' O ' HG13 ' J' ' 2' ' ' VAL . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.447 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.447 ' N ' HG23 ' J' ' 12' ' ' VAL . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' J' ' 17' ' ' LEU . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 30' ' ' THR . . . . . 0.463 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 1' ' ' GLY . . . . . 0.446 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.453 HG12 ' O ' ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.639 ' O ' HG13 ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.417 HG23 ' N ' ' L' ' 13' ' ' GLU . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.417 ' N ' HG23 ' L' ' 12' ' ' VAL . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.629 ' O ' HD13 ' L' ' 17' ' ' LEU . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 30' ' ' THR . . . . . 0.446 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.139 0.495 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 2' ' ' ILE . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.45 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.462 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' B' ' 17' ' ' LEU . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' C' ' 2' ' ' ILE . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 HG12 ' L' ' 2' ' ' VAL . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' C' ' 2' ' ' ILE . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.501 ' O ' HG23 ' D' ' 2' ' ' VAL . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.548 HD23 ' N ' ' D' ' 11' ' ' LEU . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.497 HG13 ' O ' ' D' ' 8' ' ' GLY . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 6' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' E' ' 2' ' ' ILE . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.594 ' O ' HG23 ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.503 ' N ' HD23 ' F' ' 11' ' ' LEU . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.456 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 26' ' ' TYR . . . . . 0.413 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' G' ' 2' ' ' ILE . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.534 ' O ' HG23 ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.467 ' N ' HD23 ' H' ' 11' ' ' LEU . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.467 HG23 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.427 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' H' ' 17' ' ' LEU . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' F' ' 26' ' ' TYR . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' I' I ' 1' ' ' GLY . . . . . 0.567 ' O ' HG23 ' I' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.567 HG23 ' O ' ' I' ' 1' ' ' GLY . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 6' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' I' ' 2' ' ' ILE . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 2' ' ' VAL . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.536 HG23 ' O ' ' J' ' 2' ' ' VAL . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.406 ' N ' HD23 ' J' ' 6' ' ' LEU . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.428 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 10' ' ' HIS . . . . . 0.409 ' C ' HD23 ' J' ' 11' ' ' LEU . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.504 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.468 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.429 HD11 HD13 ' I' ' 2' ' ' ILE . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' J' ' 17' ' ' LEU . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 26' ' ' TYR . . . . . 0.406 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' K' ' 6' ' ' CYS . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 6' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.673 HG12 HD12 ' C' ' 10' ' ' ILE . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.437 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.494 HD23 ' N ' ' L' ' 11' ' ' LEU . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.501 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.559 HD11 HD13 ' K' ' 2' ' ' ILE . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' L' ' 17' ' ' LEU . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' J' ' 26' ' ' TYR . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.195 0.521 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' D' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' HIS . . . . . 0.453 ' CG ' HD22 ' L' ' 6' ' ' LEU . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' SG ' ' C' ' 20' ' ' CYS . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.41 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' CYS . . . . . 0.41 ' N ' HG22 ' E' ' 10' ' ' ILE . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 30' ' ' THR . . . . . 0.515 HG22 ' O ' ' H' ' 30' ' ' THR . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.433 HD11 HG23 ' B' ' 2' ' ' VAL . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' L' ' 16' ' ' TYR . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.674 ' CE2' HG21 ' L' ' 12' ' ' VAL . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' L' L ' 1' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.453 HD22 ' CG ' ' D' ' 10' ' ' HIS . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.674 HG21 ' CE2' ' J' ' 16' ' ' TYR . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 26' ' ' TYR . . . . . 0.547 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 30' ' ' THR . . . . . 0.427 HG22 ' O ' ' L' ' 30' ' ' THR . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 HD11 ' B' ' 15' ' ' LEU . 58.0 mt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.046 0.451 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.545 HG23 HG13 ' I' ' 10' ' ' ILE . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.591 ' ND1' HD22 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 11' ' ' LEU . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.67 HD11 HD13 ' A' ' 2' ' ' ILE . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.673 HD13 HD11 ' D' ' 15' ' ' LEU . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.413 HG13 HG23 ' L' ' 2' ' ' VAL . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.404 ' O ' HG22 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' L' ' 6' ' ' LEU . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.444 HD23 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.673 HD11 HD13 ' C' ' 2' ' ' ILE . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.703 HD13 HD11 ' F' ' 15' ' ' LEU . 51.1 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 6' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' SER . . . . . 0.409 ' O ' HD12 ' E' ' 16' ' ' LEU . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.409 HD12 ' O ' ' E' ' 12' ' ' SER . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.444 HG22 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 5' ' ' HIS . . . . . 0.689 ' NE2' HD13 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.591 HD22 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.413 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.48 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.703 HD11 HD13 ' E' ' 2' ' ' ILE . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.518 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.8 HD13 ' NE2' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' H' ' 15' ' ' LEU . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 5' ' ' HIS . . . . . 0.8 ' NE2' HD13 ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 9' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' G' ' 6' ' ' CYS . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' H' ' 12' ' ' VAL . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' G' ' 2' ' ' ILE . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 17' ' ' LEU . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 30' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.722 HD13 HD11 ' J' ' 15' ' ' LEU . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 6' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.545 HG13 HG23 ' B' ' 2' ' ' VAL . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 12' ' ' SER . . . . . 0.449 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 16' ' ' LEU . . . . . 0.449 HD12 ' O ' ' I' ' 12' ' ' SER . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.437 ' O ' HG22 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.41 ' N ' HD23 ' J' ' 11' ' ' LEU . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.42 ' H ' HG22 ' J' ' 12' ' ' VAL . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.722 HD11 HD13 ' I' ' 2' ' ' ILE . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.604 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 29' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 30' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' L' ' 15' ' ' LEU . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 12' ' ' SER . . . . . 0.401 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 16' ' ' LEU . . . . . 0.401 HD12 ' O ' ' K' ' 12' ' ' SER . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.413 HG23 HG13 ' C' ' 10' ' ' ILE . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 5' ' ' HIS . . . . . 0.44 ' CE1' HD13 ' J' ' 17' ' ' LEU . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.45 HD22 ' CG ' ' D' ' 10' ' ' HIS . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 10' ' ' HIS . . . . . 0.478 ' CG ' HD22 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.466 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' K' ' 2' ' ' ILE . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 30' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' VAL . 14.1 tt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 2' ' ' ILE . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 6' ' ' CYS . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 5' ' ' GLN . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.714 ' O ' HG11 ' F' ' 2' ' ' VAL . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.599 ' O ' HG13 ' B' ' 2' ' ' VAL . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.784 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.615 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.47 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' ALA . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' ILE . . . . . 0.413 HG23 HG23 ' C' ' 3' ' ' VAL . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.413 HG23 HG23 ' C' ' 2' ' ' ILE . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.589 ' O ' HG13 ' D' ' 2' ' ' VAL . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.785 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' D' ' 5' ' ' HIS . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.785 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.721 HD13 ' CE2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 14' ' ' ALA . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.721 ' CE2' HD13 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 2' ' ' ILE . . . . . 0.404 HG23 HG23 ' E' ' 3' ' ' VAL . 17.1 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.404 HG23 HG23 ' E' ' 2' ' ' ILE . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 13' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 7' ' ' CYS . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 3' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 5' ' ' HIS . . . . . 0.433 ' O ' ' OG ' ' F' ' 9' ' ' SER . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.739 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' F' ' 5' ' ' HIS . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.474 ' O ' HD12 ' F' ' 15' ' ' LEU . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.739 HG23 ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' L' ' 17' ' ' LEU . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' F' ' 24' ' ' PHE . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' F' ' 15' ' ' LEU . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' G' ' 3' ' ' VAL . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' G' ' 2' ' ' ILE . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.572 ' O ' HG13 ' H' ' 2' ' ' VAL . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.753 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.753 HG23 ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.576 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 15' ' ' LEU . . . . . 0.672 HD13 ' CE2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' H' ' 14' ' ' ALA . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' I' ' 3' ' ' VAL . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' I' ' 2' ' ' ILE . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 5' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 6' ' ' CYS . . . . . 0.448 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.573 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.748 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.748 HG23 ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.598 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.449 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.661 HD13 ' CE2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' J' ' 14' ' ' ALA . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.661 ' CE2' HD13 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' K' K ' 2' ' ' ILE . . . . . 0.447 HG23 HG23 ' K' ' 3' ' ' VAL . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.447 HG23 HG23 ' K' ' 2' ' ' ILE . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 6' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.606 ' O ' HG13 ' L' ' 2' ' ' VAL . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.75 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.464 ' O ' HD12 ' L' ' 15' ' ' LEU . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.75 HG23 ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.599 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.454 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' L' ' 14' ' ' ALA . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' B' ' 11' ' ' LEU . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' B' ' 8' ' ' GLY . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 8' ' ' GLY . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' C' ' 9' ' ' SER . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' C' ' 16' ' ' LEU . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' C' ' 11' ' ' CYS . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.676 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.608 ' HA2' HD12 ' D' ' 11' ' ' LEU . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.608 HD12 ' HA2' ' D' ' 8' ' ' GLY . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.478 HG22 ' O ' ' D' ' 8' ' ' GLY . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' D' ' 22' ' ' ARG . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' D' ' 19' ' ' CYS . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' E' ' 9' ' ' SER . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.652 ' O ' HG13 ' F' ' 2' ' ' VAL . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' F' ' 11' ' ' LEU . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' F' ' 8' ' ' GLY . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.469 HG22 ' O ' ' F' ' 8' ' ' GLY . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' F' ' 17' ' ' LEU . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 9' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.625 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' H' ' 11' ' ' LEU . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.695 HD12 ' HA2' ' H' ' 8' ' ' GLY . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.433 HG22 ' O ' ' H' ' 8' ' ' GLY . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' I' ' 9' ' ' SER . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 11' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 16' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' I' ' 11' ' ' CYS . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.661 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' J' ' 11' ' ' LEU . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' J' ' 8' ' ' GLY . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.415 HG22 ' O ' ' J' ' 8' ' ' GLY . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 17' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' J' ' 17' ' ' LEU . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' K' ' 9' ' ' SER . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 12' ' ' SER . . . . . 0.481 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 16' ' ' LEU . . . . . 0.481 HD12 ' O ' ' K' ' 12' ' ' SER . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.668 ' O ' HG13 ' L' ' 2' ' ' VAL . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' L' ' 11' ' ' LEU . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.665 HD12 ' HA2' ' L' ' 8' ' ' GLY . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.451 HG22 ' O ' ' L' ' 8' ' ' GLY . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' L' ' 17' ' ' LEU . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 HG23 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 16' ' ' LEU . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' J' ' 10' ' ' HIS . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.533 HD11 HG23 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' C' ' 16' ' ' LEU . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' D' ' 15' ' ' LEU . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 17' ' ' LEU . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.635 HG22 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 28' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.3 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 3' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 10' ' ' ILE . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 9' ' ' SER . . . . . 0.406 ' HA ' HG22 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' F' ' 15' ' ' LEU . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 16' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' F' ' 17' ' ' LEU . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 3' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' H' H ' 1' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' L' ' 10' ' ' HIS . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 9' ' ' SER . . . . . 0.4 ' HA ' HG22 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' H' ' 17' ' ' LEU . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' G' ' 3' ' ' VAL . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 9' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 10' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' B' ' 6' ' ' LEU . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' J' ' 12' ' ' VAL . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' J' ' 15' ' ' LEU . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 7' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 9' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 16' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' K' ' 16' ' ' LEU . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.533 HG23 HD11 ' C' ' 10' ' ' ILE . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.417 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 10' ' ' HIS . . . . . 0.552 ' CD2' HD13 ' H' ' 6' ' ' LEU . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.425 HG23 ' N ' ' L' ' 13' ' ' GLU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.425 ' N ' HG23 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' L' ' 15' ' ' LEU . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.569 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' O ' HG22 ' A' ' 10' ' ' ILE . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' B' ' 15' ' ' LEU . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.495 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 4' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 5' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.566 HD12 ' N ' ' C' ' 10' ' ' ILE . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' D' ' 15' ' ' LEU . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' LEU . . . . . 0.724 HD11 ' HB1' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' TYR . . . . . 0.495 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 4' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 5' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 15.5 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.589 ' N ' HD12 ' E' ' 10' ' ' ILE . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' CYS . . . . . 0.442 ' O ' HG22 ' E' ' 10' ' ' ILE . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 2' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 6' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 12' ' ' VAL . . . . . 0.441 HG23 ' N ' ' F' ' 13' ' ' GLU . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 15' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' F' ' 15' ' ' LEU . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 17' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' F' ' 17' ' ' LEU . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 26' ' ' TYR . . . . . 0.547 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 10' ' ' ILE . . . . . 0.619 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 11' ' ' CYS . . . . . 0.416 ' O ' HG22 ' G' ' 10' ' ' ILE . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 2' ' ' VAL . . . . . 0.408 HG22 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 6' ' ' LEU . . . . . 0.408 ' HG ' HG22 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 12' ' ' VAL . . . . . 0.445 HG23 ' N ' ' H' ' 13' ' ' GLU . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 13' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 14' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 16' ' ' TYR . . . . . 0.547 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' I' I ' 2' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' I' ' 6' ' ' CYS . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 4' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 18.9 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' I' ' 2' ' ' ILE . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 10' ' ' ILE . . . . . 0.594 ' H ' HD12 ' I' ' 10' ' ' ILE . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 11' ' ' CYS . . . . . 0.408 ' O ' HG22 ' I' ' 10' ' ' ILE . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 2' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 6' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 11' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 12' ' ' VAL . . . . . 0.44 HG23 ' N ' ' J' ' 13' ' ' GLU . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 13' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 14' ' ' ALA . . . . . 0.724 ' HB1' HD11 ' D' ' 17' ' ' LEU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 4' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 5' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 10' ' ' ILE . . . . . 0.622 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 11' ' ' CYS . . . . . 0.428 ' O ' HG22 ' K' ' 10' ' ' ILE . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 2' ' ' VAL . . . . . 0.417 HG22 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 6' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 12' ' ' VAL . . . . . 0.431 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' L' ' 15' ' ' LEU . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 17' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' L' ' 17' ' ' LEU . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.62 -13.89 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -1.147 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 3' ' ' VAL . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.483 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.664 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.511 ' HA ' HD21 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' H' ' 17' ' ' LEU . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.412 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 3' ' ' VAL . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' C' ' 3' ' ' VAL . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.459 HD12 HG12 ' L' ' 2' ' ' VAL . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' CYS . . . . . 0.406 ' N ' HG22 ' C' ' 10' ' ' ILE . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.508 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.417 HD21 ' H3 ' ' H' ' 31' ' ' IPH . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -77.14 100.54 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -168.74 154.67 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.86 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.351 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt -85.8 -11.51 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -1.084 . . . . 0.0 108.912 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.649 ' O ' HG12 ' E' ' 3' ' ' VAL . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' HIS . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.545 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.523 ' HB3' HG21 ' E' ' 3' ' ' VAL . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.661 ' O ' HG12 ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 5' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 22.9 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.508 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.632 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.632 HG23 ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' B' ' 17' ' ' LEU . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.645 ' O ' HG12 ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.538 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.538 HG23 ' O ' ' J' ' 8' ' ' GLY . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.666 HG12 ' O ' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.426 ' HA ' ' CG1' ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.472 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.621 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.621 HG23 ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.416 ' O1 ' ' HA ' ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 31' ' ' IPH . . . . . 0.417 ' H3 ' HD21 ' D' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 31' ' ' IPH . . . . . 0.402 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.4 mt -98.17 -17.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.138 . . . . 0.0 109.869 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 27.4 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' B' ' 6' ' ' LEU . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.55 ' HB2' HD12 ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.446 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' B' ' 2' ' ' VAL . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.474 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.503 HD23 ' C5 ' ' B' ' 32' ' ' IPH . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 13' ' ' GLU . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' D' ' 6' ' ' LEU . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.53 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.532 ' HB2' HG21 ' D' ' 2' ' ' VAL . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' HIS . . . . . 0.458 ' ND1' HD22 ' L' ' 6' ' ' LEU . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.554 HD23 ' C5 ' ' D' ' 32' ' ' IPH . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.529 HG23 ' N ' ' D' ' 13' ' ' GLU . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.426 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.9 114.94 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -128.98 121.83 28.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 109.182 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.341 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 90.1 mt -99.91 -17.78 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -1.204 . . . . 0.0 109.371 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 5' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' F' ' 6' ' ' LEU . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.552 ' HB2' HG21 ' F' ' 2' ' ' VAL . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.508 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.622 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 10' ' ' HIS . . . . . 0.406 ' ND1' HD22 ' J' ' 6' ' ' LEU . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.577 HD23 ' C5 ' ' F' ' 32' ' ' IPH . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.508 HG13 ' O ' ' F' ' 8' ' ' GLY . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' H' ' 28' ' ' PRO . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.439 HG22 ' O ' ' G' ' 2' ' ' ILE . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' D' ' 3' ' ' ASN . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.552 HG23 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' H' ' 2' ' ' VAL . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.412 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 9' ' ' SER . . . . . 0.506 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 10' ' ' HIS . . . . . 0.401 ' ND1' HD22 ' D' ' 6' ' ' LEU . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.562 HD23 ' C5 ' ' H' ' 33' ' ' IPH . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' H' ' 13' ' ' GLU . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.436 ' HD2' ' HA3' ' F' ' 23' ' ' GLY . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 4' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 28.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.525 HG23 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.525 ' N ' HG23 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 5' ' ' HIS . . . . . 0.574 ' CE1' HD23 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' J' ' 2' ' ' VAL . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.467 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 9' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.403 ' ND1' HD22 ' B' ' 6' ' ' LEU . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.586 HD23 ' C5 ' ' J' ' 33' ' ' IPH . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.49 HG23 ' N ' ' J' ' 13' ' ' GLU . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 19' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' J' ' 22' ' ' ARG . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 4' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 5' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.8 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.441 HD11 ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.55 HG21 HD12 ' L' ' 6' ' ' LEU . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.524 ' N ' HG23 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.55 HD12 HG21 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.442 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.532 HD23 ' C5 ' ' L' ' 31' ' ' IPH . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' L' ' 13' ' ' GLU . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.536 ' CB ' ' H3 ' ' L' ' 31' ' ' IPH . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.503 ' C5 ' HD23 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.554 ' C5 ' HD23 ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.577 ' C5 ' HD23 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 33' ' ' IPH . . . . . 0.562 ' C5 ' HD23 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 33' ' ' IPH . . . . . 0.586 ' C5 ' HD23 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 31' ' ' IPH . . . . . 0.536 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' HA3' ' OXT' ' B' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 2' ' ' ILE . 16.1 tt -133.34 18.43 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.6 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.615 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.409 HD23 ' C5 ' ' B' ' 32' ' ' IPH . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.465 ' N ' HG23 ' B' ' 12' ' ' VAL . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' H3 ' ' B' ' 32' ' ' IPH . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.53 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.42 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.447 ' HA3' ' OXT' ' D' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.433 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.605 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' D' ' 15' ' ' LEU . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.409 ' HB3' ' H3 ' ' D' ' 32' ' ' IPH . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.602 HD13 ' O ' ' D' ' 17' ' ' LEU . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.82 107.98 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -157.9 69.87 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.447 ' OXT' ' HA3' ' C' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.336 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.453 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt -135.97 19.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.107 . . . . 0.0 109.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.44 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' CYS . . . . . 0.44 ' N ' HG22 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' F' ' 2' ' ' VAL . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.413 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.413 ' N ' HG23 ' F' ' 12' ' ' VAL . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.586 HD13 ' O ' ' F' ' 17' ' ' LEU . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.409 ' HA ' ' O1 ' ' H' ' 31' ' ' IPH . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.579 ' O ' HG13 ' H' ' 2' ' ' VAL . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.482 ' CD2' ' C6 ' ' H' ' 31' ' ' IPH . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' H' ' 17' ' ' LEU . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 1' ' ' GLY . . . . . 0.463 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.455 ' O ' HG12 ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.648 ' O ' HG13 ' J' ' 2' ' ' VAL . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.465 ' CD2' ' C6 ' ' J' ' 31' ' ' IPH . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.447 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.447 ' N ' HG23 ' J' ' 12' ' ' VAL . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' J' ' 17' ' ' LEU . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 30' ' ' THR . . . . . 0.463 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 1' ' ' GLY . . . . . 0.446 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.453 HG12 ' O ' ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.639 ' O ' HG13 ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.434 HD23 ' C5 ' ' L' ' 31' ' ' IPH . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.417 HG23 ' N ' ' L' ' 13' ' ' GLU . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.417 ' N ' HG23 ' L' ' 12' ' ' VAL . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.416 ' HB3' ' H3 ' ' L' ' 31' ' ' IPH . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.629 ' O ' HD13 ' L' ' 17' ' ' LEU . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 30' ' ' THR . . . . . 0.446 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.453 ' H3 ' ' HB3' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.409 ' H3 ' ' HB3' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.407 ' C6 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 31' ' ' IPH . . . . . 0.482 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 31' ' ' IPH . . . . . 0.465 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 31' ' ' IPH . . . . . 0.434 ' C5 ' HD23 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt 65.09 10.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 109.673 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 2' ' ' ILE . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.45 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.462 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' B' ' 17' ' ' LEU . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' C' ' 2' ' ' ILE . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 HG12 ' L' ' 2' ' ' VAL . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' C' ' 2' ' ' ILE . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.501 ' O ' HG23 ' D' ' 2' ' ' VAL . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.548 HD23 ' N ' ' D' ' 11' ' ' LEU . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.497 HG13 ' O ' ' D' ' 8' ' ' GLY . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.79 -9.77 16.98 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -107.4 7.77 29.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.552 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.409 ' O ' HG23 ' E' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt 63.29 12.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -1.204 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 6' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' E' ' 2' ' ' ILE . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.594 ' O ' HG23 ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.503 ' N ' HD23 ' F' ' 11' ' ' LEU . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.456 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 26' ' ' TYR . . . . . 0.413 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' G' ' 2' ' ' ILE . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.534 ' O ' HG23 ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.467 ' N ' HD23 ' H' ' 11' ' ' LEU . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.467 HG23 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.427 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' H' ' 17' ' ' LEU . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' F' ' 26' ' ' TYR . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' I' I ' 1' ' ' GLY . . . . . 0.567 ' O ' HG23 ' I' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.567 HG23 ' O ' ' I' ' 1' ' ' GLY . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 6' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' I' ' 2' ' ' ILE . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 2' ' ' VAL . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.536 HG23 ' O ' ' J' ' 2' ' ' VAL . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.515 HD21 ' H6 ' ' F' ' 32' ' ' IPH . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.428 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.409 ' C ' HD23 ' J' ' 11' ' ' LEU . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.504 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.468 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.429 HD11 HD13 ' I' ' 2' ' ' ILE . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' J' ' 17' ' ' LEU . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 26' ' ' TYR . . . . . 0.406 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' K' ' 6' ' ' CYS . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 6' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.673 HG12 HD12 ' C' ' 10' ' ' ILE . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.437 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.494 HD23 ' N ' ' L' ' 11' ' ' LEU . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.501 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.559 HD11 HD13 ' K' ' 2' ' ' ILE . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' L' ' 17' ' ' LEU . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' J' ' 26' ' ' TYR . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.515 ' H6 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 31' ' ' IPH . . . . . 0.408 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' L' L ' 31' ' ' IPH . . . . . 0.47 ' C6 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.14 -29.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.679 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.585 HD23 ' C3 ' ' B' ' 32' ' ' IPH . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' D' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' HIS . . . . . 0.453 ' CG ' HD22 ' L' ' 6' ' ' LEU . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.568 HD23 ' C3 ' ' D' ' 32' ' ' IPH . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.425 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' SG ' ' C' ' 20' ' ' CYS . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.26 128.17 8.77 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.01 -69.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.402 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.47 HG22 ' O ' ' D' ' 30' ' ' THR . 9.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.427 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt -100.35 -28.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.41 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' CYS . . . . . 0.41 ' N ' HG22 ' E' ' 10' ' ' ILE . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.593 HD23 ' C3 ' ' F' ' 32' ' ' IPH . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.685 HD23 ' C3 ' ' H' ' 32' ' ' IPH . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 30' ' ' THR . . . . . 0.515 HG22 ' O ' ' H' ' 30' ' ' THR . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.433 HD11 HG23 ' B' ' 2' ' ' VAL . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.621 HD23 ' C3 ' ' J' ' 32' ' ' IPH . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' L' ' 16' ' ' TYR . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.674 ' CE2' HG21 ' L' ' 12' ' ' VAL . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.453 HD22 ' CG ' ' D' ' 10' ' ' HIS . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.638 HD23 ' C3 ' ' L' ' 31' ' ' IPH . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.674 HG21 ' CE2' ' J' ' 16' ' ' TYR . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 26' ' ' TYR . . . . . 0.547 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 30' ' ' THR . . . . . 0.427 HG22 ' O ' ' L' ' 30' ' ' THR . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.585 ' C3 ' HD23 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.568 ' C3 ' HD23 ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.593 ' C3 ' HD23 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 32' ' ' IPH . . . . . 0.685 ' C3 ' HD23 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.621 ' C3 ' HD23 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 31' ' ' IPH . . . . . 0.638 ' C3 ' HD23 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 HD11 ' B' ' 15' ' ' LEU . 58.0 mt -87.76 -25.17 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 109.811 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.545 HG23 HG13 ' I' ' 10' ' ' ILE . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.591 ' ND1' HD22 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 11' ' ' LEU . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.469 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.67 HD11 HD13 ' A' ' 2' ' ' ILE . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.673 HD13 HD11 ' D' ' 15' ' ' LEU . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.413 HG13 HG23 ' L' ' 2' ' ' VAL . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.404 ' O ' HG22 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' L' ' 6' ' ' LEU . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.444 HD23 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.673 HD11 HD13 ' C' ' 2' ' ' ILE . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.16 80.7 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' D' ' 30' ' ' THR . 2.9 tptp -141.96 -96.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' D' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 109.72 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.703 HD13 HD11 ' F' ' 15' ' ' LEU . 51.1 mt -90.09 -25.87 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 109.245 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 6' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' SER . . . . . 0.409 ' O ' HD12 ' E' ' 16' ' ' LEU . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.409 HD12 ' O ' ' E' ' 12' ' ' SER . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.444 HG22 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 5' ' ' HIS . . . . . 0.689 ' NE2' HD13 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.591 HD22 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.413 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.48 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.464 ' CB ' ' H3 ' ' F' ' 32' ' ' IPH . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.703 HD11 HD13 ' E' ' 2' ' ' ILE . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.518 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.8 HD13 ' NE2' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' H' ' 15' ' ' LEU . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 5' ' ' HIS . . . . . 0.8 ' NE2' HD13 ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 9' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' G' ' 6' ' ' CYS . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' H' ' 12' ' ' VAL . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.479 ' CB ' ' H3 ' ' H' ' 32' ' ' IPH . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' G' ' 2' ' ' ILE . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 17' ' ' LEU . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 30' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.722 HD13 HD11 ' J' ' 15' ' ' LEU . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 6' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.545 HG13 HG23 ' B' ' 2' ' ' VAL . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 12' ' ' SER . . . . . 0.449 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 16' ' ' LEU . . . . . 0.449 HD12 ' O ' ' I' ' 12' ' ' SER . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.437 ' O ' HG22 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.41 ' N ' HD23 ' J' ' 11' ' ' LEU . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.42 ' H ' HG22 ' J' ' 12' ' ' VAL . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.482 ' CB ' ' H3 ' ' J' ' 32' ' ' IPH . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.722 HD11 HD13 ' I' ' 2' ' ' ILE . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.604 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 29' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 30' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' L' ' 15' ' ' LEU . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 12' ' ' SER . . . . . 0.401 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 16' ' ' LEU . . . . . 0.401 HD12 ' O ' ' K' ' 12' ' ' SER . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.413 HG23 HG13 ' C' ' 10' ' ' ILE . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 5' ' ' HIS . . . . . 0.44 ' CE1' HD13 ' J' ' 17' ' ' LEU . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.45 HD22 ' CG ' ' D' ' 10' ' ' HIS . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.478 ' CG ' HD22 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.466 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' K' ' 2' ' ' ILE . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 30' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.469 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.408 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.464 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 32' ' ' IPH . . . . . 0.479 ' H3 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.482 ' H3 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' VAL . 14.1 tt -103.72 -29.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.223 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 2' ' ' ILE . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 6' ' ' CYS . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 5' ' ' GLN . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.714 ' O ' HG11 ' F' ' 2' ' ' VAL . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 HG23 ' C6 ' ' B' ' 32' ' ' IPH . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.599 ' O ' HG13 ' B' ' 2' ' ' VAL . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.784 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.615 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.47 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' ALA . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.413 HG23 HG23 ' C' ' 3' ' ' VAL . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.413 HG23 HG23 ' C' ' 2' ' ' ILE . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.649 HG23 ' C6 ' ' D' ' 32' ' ' IPH . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.589 ' O ' HG13 ' D' ' 2' ' ' VAL . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.785 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' D' ' 5' ' ' HIS . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.785 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.721 HD13 ' CE2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 14' ' ' ALA . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.721 ' CE2' HD13 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.69 93.43 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -164.29 100.1 0.83 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.611 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.404 HG23 HG23 ' E' ' 3' ' ' VAL . 17.1 tt -109.82 -30.71 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.404 HG23 HG23 ' E' ' 2' ' ' ILE . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.515 HG23 ' C6 ' ' F' ' 32' ' ' IPH . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 13' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 7' ' ' CYS . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 5' ' ' HIS . . . . . 0.433 ' O ' ' OG ' ' F' ' 9' ' ' SER . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.629 HD21 ' H5 ' ' B' ' 32' ' ' IPH . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.739 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' F' ' 5' ' ' HIS . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.474 ' O ' HD12 ' F' ' 15' ' ' LEU . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.739 HG23 ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' L' ' 17' ' ' LEU . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' F' ' 24' ' ' PHE . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' F' ' 15' ' ' LEU . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' G' ' 3' ' ' VAL . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' G' ' 2' ' ' ILE . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.562 HG23 ' C6 ' ' H' ' 32' ' ' IPH . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.572 ' O ' HG13 ' H' ' 2' ' ' VAL . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.753 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.753 HG23 ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.576 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.672 HD13 ' CE2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' H' ' 14' ' ' ALA . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' I' ' 3' ' ' VAL . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' I' ' 2' ' ' ILE . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 5' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 6' ' ' CYS . . . . . 0.448 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.59 HG23 ' C6 ' ' J' ' 32' ' ' IPH . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.573 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.748 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.748 HG23 ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.598 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.449 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.661 HD13 ' CE2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' J' ' 14' ' ' ALA . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.661 ' CE2' HD13 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.447 HG23 HG23 ' K' ' 3' ' ' VAL . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.447 HG23 HG23 ' K' ' 2' ' ' ILE . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 6' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.463 HG23 ' C6 ' ' L' ' 32' ' ' IPH . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.606 ' O ' HG13 ' L' ' 2' ' ' VAL . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.75 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.464 ' O ' HD12 ' L' ' 15' ' ' LEU . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.75 HG23 ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.599 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.454 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' L' ' 14' ' ' ALA . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.629 ' H5 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.649 ' C6 ' HG23 ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.515 ' C6 ' HG23 ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 32' ' ' IPH . . . . . 0.562 ' C6 ' HG23 ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.59 ' C6 ' HG23 ' I' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.463 ' C6 ' HG23 ' K' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -100.91 -13.93 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -1.208 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.47 HG23 ' O1 ' ' B' ' 32' ' ' IPH . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' B' ' 11' ' ' LEU . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.527 ' CD2' HD13 ' F' ' 6' ' ' LEU . 65.6 m-70 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' B' ' 8' ' ' GLY . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 8' ' ' GLY . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.479 HG23 ' O1 ' ' D' ' 32' ' ' IPH . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' C' ' 16' ' ' LEU . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' C' ' 11' ' ' CYS . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.676 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.608 ' HA2' HD12 ' D' ' 11' ' ' LEU . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.608 HD12 ' HA2' ' D' ' 8' ' ' GLY . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.478 HG22 ' O ' ' D' ' 8' ' ' GLY . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.4 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' D' ' 22' ' ' ARG . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' D' ' 19' ' ' CYS . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.98 78.75 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -132.62 162.64 30.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.78 -13.77 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.524 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.503 HG23 ' O1 ' ' F' ' 32' ' ' IPH . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.652 ' O ' HG13 ' F' ' 2' ' ' VAL . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' B' ' 10' ' ' HIS . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' F' ' 11' ' ' LEU . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' F' ' 8' ' ' GLY . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.469 HG22 ' O ' ' F' ' 8' ' ' GLY . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.42 ' CB ' ' H5 ' ' F' ' 32' ' ' IPH . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' F' ' 17' ' ' LEU . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 9' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.625 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' H' ' 11' ' ' LEU . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.695 HD12 ' HA2' ' H' ' 8' ' ' GLY . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.433 HG22 ' O ' ' H' ' 8' ' ' GLY . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' H5 ' ' H' ' 32' ' ' IPH . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.476 HG23 ' O1 ' ' J' ' 32' ' ' IPH . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 11' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 16' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' I' ' 11' ' ' CYS . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.661 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' J' ' 11' ' ' LEU . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' J' ' 8' ' ' GLY . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.415 HG22 ' O ' ' J' ' 8' ' ' GLY . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.43 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' J' ' 17' ' ' LEU . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.586 HG23 ' O1 ' ' L' ' 32' ' ' IPH . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 12' ' ' SER . . . . . 0.481 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 16' ' ' LEU . . . . . 0.481 HD12 ' O ' ' K' ' 12' ' ' SER . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.668 ' O ' HG13 ' L' ' 2' ' ' VAL . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' L' ' 11' ' ' LEU . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.665 HD12 ' HA2' ' L' ' 8' ' ' GLY . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.451 HG22 ' O ' ' L' ' 8' ' ' GLY . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.474 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' L' ' 17' ' ' LEU . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 32' ' ' IPH . . . . . 0.47 ' O1 ' HG23 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.479 ' O1 ' HG23 ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.503 ' O1 ' HG23 ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 32' ' ' IPH . . . . . 0.434 ' O1 ' HG23 ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 32' ' ' IPH . . . . . 0.476 ' O1 ' HG23 ' I' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.586 ' O1 ' HG23 ' K' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt -77.47 -18.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.41 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 HG23 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 16' ' ' LEU . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' J' ' 10' ' ' HIS . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.533 HD11 HG23 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' C' ' 16' ' ' LEU . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' D' ' 15' ' ' LEU . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 17' ' ' LEU . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.635 HG22 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.3 Cg_endo -79.65 105.74 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' D' ' 28' ' ' PRO . 0.1 OUTLIER 159.78 147.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.264 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.68 -18.22 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -1.158 . . . . 0.0 109.21 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 10' ' ' ILE . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 9' ' ' SER . . . . . 0.406 ' HA ' HG22 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' F' ' 15' ' ' LEU . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' F' ' 17' ' ' LEU . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 1' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' L' ' 10' ' ' HIS . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 9' ' ' SER . . . . . 0.4 ' HA ' HG22 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' H' ' 17' ' ' LEU . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' G' ' 3' ' ' VAL . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 9' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' B' ' 6' ' ' LEU . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' J' ' 12' ' ' VAL . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' J' ' 15' ' ' LEU . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 16' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' K' ' 16' ' ' LEU . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.533 HG23 HD11 ' C' ' 10' ' ' ILE . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.417 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.552 ' CD2' HD13 ' H' ' 6' ' ' LEU . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.425 HG23 ' N ' ' L' ' 13' ' ' GLU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.425 ' N ' HG23 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' L' ' 15' ' ' LEU . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' L' L ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -92.77 -18.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.542 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.569 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' O ' HG22 ' A' ' 10' ' ' ILE . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' B' ' 15' ' ' LEU . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.495 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.566 HD12 ' N ' ' C' ' 10' ' ' ILE . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.41 ' CD2' ' C2 ' ' D' ' 32' ' ' IPH . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' D' ' 15' ' ' LEU . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.724 HD11 ' HB1' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.495 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' D' ' 29' ' ' LYS . 36.3 Cg_endo -77.81 -53.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' D' ' 28' ' ' PRO . 2.6 tttt 40.75 -159.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.496 -0.752 . . . . 0.0 109.525 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.166 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.31 -18.1 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.262 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 5' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 15.5 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.589 ' N ' HD12 ' E' ' 10' ' ' ILE . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' CYS . . . . . 0.442 ' O ' HG22 ' E' ' 10' ' ' ILE . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.461 ' CD2' ' C2 ' ' F' ' 32' ' ' IPH . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.441 HG23 ' N ' ' F' ' 13' ' ' GLU . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' F' ' 15' ' ' LEU . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' F' ' 17' ' ' LEU . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 26' ' ' TYR . . . . . 0.547 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.619 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 11' ' ' CYS . . . . . 0.416 ' O ' HG22 ' G' ' 10' ' ' ILE . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.408 HG22 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.408 ' HG ' HG22 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.445 HG23 ' N ' ' H' ' 13' ' ' GLU . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.547 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' I' ' 6' ' ' CYS . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 4' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 18.9 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' I' ' 2' ' ' ILE . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.594 ' H ' HD12 ' I' ' 10' ' ' ILE . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 11' ' ' CYS . . . . . 0.408 ' O ' HG22 ' I' ' 10' ' ' ILE . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' C2 ' ' J' ' 31' ' ' IPH . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.44 HG23 ' N ' ' J' ' 13' ' ' GLU . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.724 ' HB1' HD11 ' D' ' 17' ' ' LEU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 4' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 5' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.622 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 11' ' ' CYS . . . . . 0.428 ' O ' HG22 ' K' ' 10' ' ' ILE . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.417 HG22 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.431 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' L' ' 15' ' ' LEU . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' L' ' 17' ' ' LEU . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 32' ' ' IPH . . . . . 0.41 ' C2 ' ' CD2' ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 32' ' ' IPH . . . . . 0.461 ' C2 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' J' J ' 31' ' ' IPH . . . . . 0.43 ' H5 ' HD11 ' D' ' 17' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 32' ' ' IPH . . . . . 0.4 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.202 0.525 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 3' ' ' VAL . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.483 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.664 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.511 ' HA ' HD21 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' H' ' 17' ' ' LEU . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.412 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 3' ' ' VAL . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' C' ' 3' ' ' VAL . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.459 HD12 HG12 ' L' ' 2' ' ' VAL . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . 0.406 ' N ' HG22 ' C' ' 10' ' ' ILE . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . 0.508 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.649 ' O ' HG12 ' E' ' 3' ' ' VAL . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.545 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.523 ' HB3' HG21 ' E' ' 3' ' ' VAL . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.661 ' O ' HG12 ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 23.4 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.508 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.632 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.632 HG23 ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' B' ' 17' ' ' LEU . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.645 ' O ' HG12 ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.538 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.538 HG23 ' O ' ' J' ' 8' ' ' GLY . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.666 HG12 ' O ' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.426 ' HA ' ' CG1' ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.472 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.621 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.621 HG23 ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.058 0.456 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 33.9 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' B' ' 6' ' ' LEU . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.55 ' HB2' HD12 ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.446 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' B' ' 2' ' ' VAL . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.474 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 13' ' ' GLU . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' D' ' 6' ' ' LEU . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . 0.53 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.532 ' HB2' HG21 ' D' ' 2' ' ' VAL . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . 0.458 ' ND1' HD22 ' L' ' 6' ' ' LEU . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.529 HG23 ' N ' ' D' ' 13' ' ' GLU . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.426 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' F' ' 6' ' ' LEU . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.552 ' HB2' HG21 ' F' ' 2' ' ' VAL . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.508 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.622 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . 0.406 ' ND1' HD22 ' J' ' 6' ' ' LEU . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.508 HG13 ' O ' ' F' ' 8' ' ' GLY . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' H' ' 28' ' ' PRO . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.439 HG22 ' O ' ' G' ' 2' ' ' ILE . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' D' ' 3' ' ' ASN . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.552 HG23 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' H' ' 2' ' ' VAL . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.412 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . 0.506 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . 0.401 ' ND1' HD22 ' D' ' 6' ' ' LEU . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' H' ' 13' ' ' GLU . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.436 ' HD2' ' HA3' ' F' ' 23' ' ' GLY . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 31.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.525 HG23 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.525 ' N ' HG23 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . 0.574 ' CE1' HD23 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' J' ' 2' ' ' VAL . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.467 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . 0.403 ' ND1' HD22 ' B' ' 6' ' ' LEU . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.49 HG23 ' N ' ' J' ' 13' ' ' GLU . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' J' ' 22' ' ' ARG . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.5 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.441 HD11 ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.55 HG21 HD12 ' L' ' 6' ' ' LEU . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.524 ' N ' HG23 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.55 HD12 HG21 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.442 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' L' ' 13' ' ' GLU . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.524 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 2' ' ' ILE . 16.1 tt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.332 0.587 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.615 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.465 ' N ' HG23 ' B' ' 12' ' ' VAL . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.53 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.433 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.605 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' D' ' 15' ' ' LEU . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.602 HD13 ' O ' ' D' ' 17' ' ' LEU . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.453 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.44 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . 0.44 ' N ' HG22 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' F' ' 2' ' ' VAL . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.413 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.413 ' N ' HG23 ' F' ' 12' ' ' VAL . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.586 HD13 ' O ' ' F' ' 17' ' ' LEU . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.579 ' O ' HG13 ' H' ' 2' ' ' VAL . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' H' ' 15' ' ' LEU . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' H' ' 17' ' ' LEU . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . 0.463 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.455 ' O ' HG12 ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.648 ' O ' HG13 ' J' ' 2' ' ' VAL . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.447 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.447 ' N ' HG23 ' J' ' 12' ' ' VAL . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' J' ' 17' ' ' LEU . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . 0.463 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . 0.446 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.453 HG12 ' O ' ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.639 ' O ' HG13 ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.417 HG23 ' N ' ' L' ' 13' ' ' GLU . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.417 ' N ' HG23 ' L' ' 12' ' ' VAL . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.629 ' O ' HD13 ' L' ' 17' ' ' LEU . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . 0.446 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.139 0.495 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 2' ' ' ILE . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.45 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.462 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' B' ' 17' ' ' LEU . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' C' ' 2' ' ' ILE . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 HG12 ' L' ' 2' ' ' VAL . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' C' ' 2' ' ' ILE . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.501 ' O ' HG23 ' D' ' 2' ' ' VAL . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.548 HD23 ' N ' ' D' ' 11' ' ' LEU . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.497 HG13 ' O ' ' D' ' 8' ' ' GLY . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' E' ' 2' ' ' ILE . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.594 ' O ' HG23 ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.503 ' N ' HD23 ' F' ' 11' ' ' LEU . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.456 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . 0.413 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' G' ' 2' ' ' ILE . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.534 ' O ' HG23 ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.467 ' N ' HD23 ' H' ' 11' ' ' LEU . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.467 HG23 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.427 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' H' ' 17' ' ' LEU . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' F' ' 26' ' ' TYR . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . 0.567 ' O ' HG23 ' I' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.567 HG23 ' O ' ' I' ' 1' ' ' GLY . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' I' ' 2' ' ' ILE . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 2' ' ' VAL . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.536 HG23 ' O ' ' J' ' 2' ' ' VAL . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.406 ' N ' HD23 ' J' ' 6' ' ' LEU . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.428 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . 0.409 ' C ' HD23 ' J' ' 11' ' ' LEU . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.504 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.468 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.429 HD11 HD13 ' I' ' 2' ' ' ILE . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' J' ' 17' ' ' LEU . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . 0.406 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' K' ' 6' ' ' CYS . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.673 HG12 HD12 ' C' ' 10' ' ' ILE . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.437 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.494 HD23 ' N ' ' L' ' 11' ' ' LEU . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.501 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.559 HD11 HD13 ' K' ' 2' ' ' ILE . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' L' ' 17' ' ' LEU . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' J' ' 26' ' ' TYR . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.195 0.521 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' D' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . 0.453 ' CG ' HD22 ' L' ' 6' ' ' LEU . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' SG ' ' C' ' 20' ' ' CYS . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.41 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . 0.41 ' N ' HG22 ' E' ' 10' ' ' ILE . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . 0.515 HG22 ' O ' ' H' ' 30' ' ' THR . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.433 HD11 HG23 ' B' ' 2' ' ' VAL . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' L' ' 16' ' ' TYR . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.674 ' CE2' HG21 ' L' ' 12' ' ' VAL . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.453 HD22 ' CG ' ' D' ' 10' ' ' HIS . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.674 HG21 ' CE2' ' J' ' 16' ' ' TYR . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . 0.547 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . 0.427 HG22 ' O ' ' L' ' 30' ' ' THR . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 HD11 ' B' ' 15' ' ' LEU . 58.0 mt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.046 0.451 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.545 HG23 HG13 ' I' ' 10' ' ' ILE . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.591 ' ND1' HD22 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 11' ' ' LEU . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.67 HD11 HD13 ' A' ' 2' ' ' ILE . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.673 HD13 HD11 ' D' ' 15' ' ' LEU . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.413 HG13 HG23 ' L' ' 2' ' ' VAL . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.404 ' O ' HG22 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' L' ' 6' ' ' LEU . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.444 HD23 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.673 HD11 HD13 ' C' ' 2' ' ' ILE . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.703 HD13 HD11 ' F' ' 15' ' ' LEU . 51.1 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . 0.409 ' O ' HD12 ' E' ' 16' ' ' LEU . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.409 HD12 ' O ' ' E' ' 12' ' ' SER . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.444 HG22 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . 0.689 ' NE2' HD13 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.591 HD22 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.413 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.48 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.703 HD11 HD13 ' E' ' 2' ' ' ILE . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.518 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.8 HD13 ' NE2' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' H' ' 15' ' ' LEU . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . 0.8 ' NE2' HD13 ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' G' ' 6' ' ' CYS . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' H' ' 12' ' ' VAL . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' G' ' 2' ' ' ILE . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 17' ' ' LEU . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.722 HD13 HD11 ' J' ' 15' ' ' LEU . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.545 HG13 HG23 ' B' ' 2' ' ' VAL . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . 0.449 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . 0.449 HD12 ' O ' ' I' ' 12' ' ' SER . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.437 ' O ' HG22 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.41 ' N ' HD23 ' J' ' 11' ' ' LEU . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.42 ' H ' HG22 ' J' ' 12' ' ' VAL . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.722 HD11 HD13 ' I' ' 2' ' ' ILE . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.604 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' L' ' 15' ' ' LEU . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . 0.401 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . 0.401 HD12 ' O ' ' K' ' 12' ' ' SER . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.413 HG23 HG13 ' C' ' 10' ' ' ILE . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . 0.44 ' CE1' HD13 ' J' ' 17' ' ' LEU . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.45 HD22 ' CG ' ' D' ' 10' ' ' HIS . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . 0.478 ' CG ' HD22 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.466 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' K' ' 2' ' ' ILE . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' VAL . 14.1 tt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 2' ' ' ILE . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 6' ' ' CYS . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 5' ' ' GLN . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.714 ' O ' HG11 ' F' ' 2' ' ' VAL . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.599 ' O ' HG13 ' B' ' 2' ' ' VAL . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.784 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.615 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.47 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' ALA . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . 0.413 HG23 HG23 ' C' ' 3' ' ' VAL . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.413 HG23 HG23 ' C' ' 2' ' ' ILE . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.589 ' O ' HG13 ' D' ' 2' ' ' VAL . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.785 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' D' ' 5' ' ' HIS . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.785 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.721 HD13 ' CE2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 14' ' ' ALA . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.721 ' CE2' HD13 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . 0.404 HG23 HG23 ' E' ' 3' ' ' VAL . 17.1 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.404 HG23 HG23 ' E' ' 2' ' ' ILE . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 7' ' ' CYS . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . 0.433 ' O ' ' OG ' ' F' ' 9' ' ' SER . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.739 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' F' ' 5' ' ' HIS . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.474 ' O ' HD12 ' F' ' 15' ' ' LEU . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.739 HG23 ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' L' ' 17' ' ' LEU . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' F' ' 24' ' ' PHE . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' F' ' 15' ' ' LEU . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' G' ' 3' ' ' VAL . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' G' ' 2' ' ' ILE . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.572 ' O ' HG13 ' H' ' 2' ' ' VAL . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.753 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.753 HG23 ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.576 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . 0.672 HD13 ' CE2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' H' ' 14' ' ' ALA . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' I' ' 3' ' ' VAL . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' I' ' 2' ' ' ILE . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . 0.448 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.573 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.748 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.748 HG23 ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.598 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.449 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.661 HD13 ' CE2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' J' ' 14' ' ' ALA . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.661 ' CE2' HD13 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . 0.447 HG23 HG23 ' K' ' 3' ' ' VAL . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.447 HG23 HG23 ' K' ' 2' ' ' ILE . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.606 ' O ' HG13 ' L' ' 2' ' ' VAL . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.75 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.464 ' O ' HD12 ' L' ' 15' ' ' LEU . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.75 HG23 ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.599 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.454 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' L' ' 14' ' ' ALA . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' SER . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' B' ' 11' ' ' LEU . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.527 ' CD2' HD13 ' F' ' 6' ' ' LEU . 65.6 m-70 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' B' ' 8' ' ' GLY . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 8' ' ' GLY . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' C' ' 9' ' ' SER . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' C' ' 16' ' ' LEU . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' C' ' 11' ' ' CYS . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.676 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.608 ' HA2' HD12 ' D' ' 11' ' ' LEU . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.608 HD12 ' HA2' ' D' ' 8' ' ' GLY . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.478 HG22 ' O ' ' D' ' 8' ' ' GLY . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' D' ' 22' ' ' ARG . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' D' ' 19' ' ' CYS . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' E' ' 9' ' ' SER . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.652 ' O ' HG13 ' F' ' 2' ' ' VAL . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' B' ' 10' ' ' HIS . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' F' ' 11' ' ' LEU . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' F' ' 8' ' ' GLY . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.469 HG22 ' O ' ' F' ' 8' ' ' GLY . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' F' ' 17' ' ' LEU . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.625 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' H' ' 11' ' ' LEU . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.695 HD12 ' HA2' ' H' ' 8' ' ' GLY . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.433 HG22 ' O ' ' H' ' 8' ' ' GLY . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' I' ' 9' ' ' SER . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' I' ' 11' ' ' CYS . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.661 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' J' ' 11' ' ' LEU . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' J' ' 8' ' ' GLY . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.415 HG22 ' O ' ' J' ' 8' ' ' GLY . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' J' ' 17' ' ' LEU . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' K' ' 9' ' ' SER . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . 0.481 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . 0.481 HD12 ' O ' ' K' ' 12' ' ' SER . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.668 ' O ' HG13 ' L' ' 2' ' ' VAL . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' L' ' 11' ' ' LEU . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.665 HD12 ' HA2' ' L' ' 8' ' ' GLY . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.451 HG22 ' O ' ' L' ' 8' ' ' GLY . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' L' ' 17' ' ' LEU . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 HG23 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 16' ' ' LEU . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' J' ' 10' ' ' HIS . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.533 HD11 HG23 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' C' ' 16' ' ' LEU . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' D' ' 15' ' ' LEU . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 17' ' ' LEU . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.635 HG22 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.3 Cg_endo . . . . . 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 10' ' ' ILE . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . 0.406 ' HA ' HG22 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' F' ' 15' ' ' LEU . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' F' ' 17' ' ' LEU . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' L' ' 10' ' ' HIS . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . 0.4 ' HA ' HG22 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' H' ' 17' ' ' LEU . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' G' ' 3' ' ' VAL . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' B' ' 6' ' ' LEU . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' J' ' 12' ' ' VAL . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' J' ' 15' ' ' LEU . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' K' ' 16' ' ' LEU . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.533 HG23 HD11 ' C' ' 10' ' ' ILE . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.417 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . 0.552 ' CD2' HD13 ' H' ' 6' ' ' LEU . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.425 HG23 ' N ' ' L' ' 13' ' ' GLU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.425 ' N ' HG23 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' L' ' 15' ' ' LEU . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.569 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' O ' HG22 ' A' ' 10' ' ' ILE . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' B' ' 15' ' ' LEU . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.495 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.566 HD12 ' N ' ' C' ' 10' ' ' ILE . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' D' ' 15' ' ' LEU . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' LEU . . . . . 0.724 HD11 ' HB1' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' TYR . . . . . 0.495 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 32.6 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.589 ' N ' HD12 ' E' ' 10' ' ' ILE . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' CYS . . . . . 0.442 ' O ' HG22 ' E' ' 10' ' ' ILE . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 2' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' VAL . . . . . 0.441 HG23 ' N ' ' F' ' 13' ' ' GLU . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' F' ' 15' ' ' LEU . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' F' ' 17' ' ' LEU . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' TYR . . . . . 0.547 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 10' ' ' ILE . . . . . 0.619 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 11' ' ' CYS . . . . . 0.416 ' O ' HG22 ' G' ' 10' ' ' ILE . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 2' ' ' VAL . . . . . 0.408 HG22 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 6' ' ' LEU . . . . . 0.408 ' HG ' HG22 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 12' ' ' VAL . . . . . 0.445 HG23 ' N ' ' H' ' 13' ' ' GLU . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 13' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 14' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 16' ' ' TYR . . . . . 0.547 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' I' I ' 2' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' I' ' 6' ' ' CYS . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 4' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 30.4 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' I' ' 2' ' ' ILE . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 10' ' ' ILE . . . . . 0.594 ' H ' HD12 ' I' ' 10' ' ' ILE . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 11' ' ' CYS . . . . . 0.408 ' O ' HG22 ' I' ' 10' ' ' ILE . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 2' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 6' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 11' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 12' ' ' VAL . . . . . 0.44 HG23 ' N ' ' J' ' 13' ' ' GLU . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 13' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 14' ' ' ALA . . . . . 0.724 ' HB1' HD11 ' D' ' 17' ' ' LEU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 4' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 5' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 10' ' ' ILE . . . . . 0.622 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 11' ' ' CYS . . . . . 0.428 ' O ' HG22 ' K' ' 10' ' ' ILE . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 2' ' ' VAL . . . . . 0.417 HG22 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 6' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 12' ' ' VAL . . . . . 0.431 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' L' ' 15' ' ' LEU . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 17' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' L' ' 17' ' ' LEU . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mt -81.62 -13.89 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -1.147 . . . . 0.0 109.666 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 3' ' ' VAL . 30.8 t -90.17 28.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.651 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -168.46 -50.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 109.649 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.73 -26.1 67.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.2 m -119.89 -12.81 9.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.308 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -18.24 42.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.141 -0.974 . . . . 0.0 109.076 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -108.61 6.44 25.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.371 -0.831 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 p -177.78 127.61 0.14 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.483 HG12 ' HB2' ' F' ' 5' ' ' HIS . 2.2 mp -51.79 152.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -122.85 -170.44 2.1 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.37 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 164.01 12.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.097 -1.002 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -32.36 73.75 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.468 -0.77 . . . . 0.0 109.496 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -63.34 -46.76 85.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.404 -0.81 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -65.61 -38.33 89.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.895 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.54 -25.79 64.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.49 -22.87 61.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 109.94 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -70.16 -16.14 63.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 0.0 109.867 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -93.12 0.44 57.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.18 155.13 39.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.147 -0.971 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.397 0.618 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 8.3 m -68.72 145.71 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -81.66 -33.61 31.2 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.325 -0.86 . . . . 0.0 109.199 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.13 -25.6 61.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 108.912 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.5 mt -96.41 -23.83 16.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 108.967 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 52.5 t -77.77 -26.74 50.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.307 -0.87 . . . . 0.0 109.626 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.664 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -87.17 -11.55 69.44 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 6.2 t -93.51 -18.89 21.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -85.3 -17.26 37.41 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 18.2 mt -91.65 -24.84 19.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.958 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 8' ' ' GLY . 3.3 t -64.57 -42.32 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 109.06 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -65.01 -33.57 76.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.174 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.511 ' HA ' HD21 ' H' ' 17' ' ' LEU . . . -94.02 17.72 11.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.94 -59.39 1.85 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.123 -0.986 . . . . 0.0 109.631 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.0 p90 -66.52 -27.6 67.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' H' ' 17' ' ' LEU . 31.5 tp -70.6 -30.69 67.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.47 -57.5 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.908 . . . . 0.0 109.471 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 95.6 m -53.02 -52.47 58.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.235 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.73 -117.34 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.52 -10.04 59.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.509 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -89.49 171.23 9.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.875 . . . . 0.0 109.572 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.6 -161.28 15.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 4.5 p90 -168.93 173.01 7.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.311 -1.111 . . . . 0.0 109.341 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -120.31 154.81 34.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.008 . . . . 0.0 109.611 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.412 ' O ' ' HA3' ' D' ' 23' ' ' GLY . 30.3 t80 -140.57 114.33 8.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.514 -0.741 . . . . 0.0 109.025 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.06 102.85 4.42 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.151 -0.968 . . . . 0.0 109.277 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' A' ' 3' ' ' VAL . 34.7 Cg_endo -77.24 99.22 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.323 2.015 . . . . 0.0 110.282 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -167.03 157.5 11.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.734 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.285 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 57.2 mt -81.66 -16.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -1.099 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.635 HG12 ' O ' ' C' ' 3' ' ' VAL . 25.1 t -87.2 25.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -166.48 -51.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 109.678 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -64.22 -27.49 69.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 54.3 m -118.58 -11.99 9.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 42.1 t -82.08 -16.18 50.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 109.27 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 23.7 p -112.34 7.54 19.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 18.1 p -177.13 128.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.459 HD12 HG12 ' L' ' 2' ' ' VAL . 2.3 mp -50.31 156.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.192 -0.943 . . . . 0.0 109.228 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . 0.406 ' N ' HG22 ' C' ' 10' ' ' ILE . 84.9 m -126.5 -170.92 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.935 . . . . 0.0 109.535 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.41 162.28 14.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.563 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.75 -29.33 70.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.317 -0.865 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -66.65 -44.77 81.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.85 -35.94 81.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.0 -23.11 60.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.203 -0.936 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.03 -22.06 59.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -69.69 -20.72 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.266 -0.897 . . . . 0.0 109.614 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -89.44 -0.1 57.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.751 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.34 157.86 30.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.05 -1.031 . . . . 0.0 109.239 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 5.9 m -68.42 148.79 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.142 -0.974 . . . . 0.0 109.164 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 1.5 m-20 164.09 -33.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.141 -0.974 . . . . 0.0 109.423 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -79.54 -36.81 37.82 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.323 -0.861 . . . . 0.0 109.059 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.508 ' CB ' HG12 ' G' ' 10' ' ' ILE . 45.4 t60 -68.75 -30.37 68.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.392 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.417 HD21 ' H3 ' ' H' ' 31' ' ' IPH . 6.8 mt -90.88 -26.35 19.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.457 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 13.8 t -75.98 -28.81 57.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.865 . . . . 0.0 109.644 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -84.68 -6.8 85.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -98.06 -18.41 18.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -1.142 . . . . 0.0 109.53 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -87.17 -13.47 43.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 19.0 mt -94.86 -22.31 18.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.178 -0.951 . . . . 0.0 109.532 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.7 t -67.01 -41.79 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.193 -0.942 . . . . 0.0 108.911 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -65.47 -35.98 82.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.378 -0.826 . . . . 0.0 109.155 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.14 17.92 8.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -108.42 -61.08 1.65 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.205 -0.934 . . . . 0.0 109.693 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 7.9 p90 -65.36 -27.34 68.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.542 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 31.9 tp -69.66 -32.6 71.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.57 -56.18 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.32 -0.862 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -55.34 -47.24 76.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.276 -0.89 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.73 -120.34 6.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.3 -11.23 60.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.184 -1.186 . . . . 0.0 109.946 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -89.16 171.23 9.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.765 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' B' ' 26' ' ' TYR . . . -114.64 -169.09 16.14 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 2.4 p90 -160.02 177.45 10.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -1.213 . . . . 0.0 109.16 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -122.9 150.05 43.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.113 -0.992 . . . . 0.0 109.384 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -136.13 112.45 9.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.84 102.18 5.35 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.0 Cg_endo -77.14 100.54 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.447 2.098 . . . . 0.0 110.38 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -168.74 154.67 6.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 109.86 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.351 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 59.4 mt -85.8 -11.51 11.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -1.084 . . . . 0.0 108.912 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.649 ' O ' HG12 ' E' ' 3' ' ' VAL . 39.9 t -92.27 28.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.408 -0.807 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -169.43 -47.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.965 . . . . 0.0 109.659 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -68.58 -26.38 65.36 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.173 -0.955 . . . . 0.0 109.311 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 52.7 m -118.34 -15.27 9.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.281 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 -17.6 51.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 23.6 p -109.84 5.35 22.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.597 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 13.6 p -174.92 128.06 0.3 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.398 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mp -51.86 152.54 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.256 -0.902 . . . . 0.0 109.056 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 84.7 m -121.61 -167.69 1.56 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.711 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.55 163.68 13.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.286 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.0 -32.25 73.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 0.0 109.037 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -63.69 -47.06 82.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.376 -0.827 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -64.23 -38.61 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 109.69 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.83 -20.01 62.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.76 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -77.43 -20.05 55.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.184 -0.947 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -72.06 -19.66 61.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 0.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -89.08 0.36 56.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.0 109.783 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.0 156.89 32.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.485 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.5 m -65.9 144.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.861 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 1.5 m-20 167.7 -34.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -79.37 -33.91 42.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.293 -0.879 . . . . 0.0 109.318 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . 41.2 t60 -71.29 -28.08 63.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.297 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -94.93 -23.34 17.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.305 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 52.1 t -77.38 -27.9 52.67 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.414 -0.804 . . . . 0.0 109.088 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.545 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -85.93 -9.21 77.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -95.61 -19.09 20.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.537 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -85.37 -16.69 39.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 16.7 mt -92.12 -21.43 20.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 8' ' ' GLY . 2.9 t -67.33 -41.99 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 108.971 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.34 -36.41 83.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 109.251 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.95 21.07 6.01 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.347 -0.845 . . . . 0.0 109.56 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mt -110.39 -60.85 1.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.292 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.23 -26.43 67.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.389 -0.819 . . . . 0.0 109.482 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 tp -71.9 -31.1 66.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.165 -0.96 . . . . 0.0 109.289 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.62 -52.33 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.233 -0.917 . . . . 0.0 108.939 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 19.8 m -56.41 -53.68 54.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.808 . . . . 0.0 109.301 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.15 -116.69 5.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.11 -17.0 61.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -1.127 . . . . 0.0 109.534 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -84.06 169.79 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.44 -168.87 16.22 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 2.1 p90 -157.69 -178.2 7.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 109.571 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -127.85 149.42 50.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.69 113.3 10.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.833 . . . . 0.0 109.553 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.1 100.19 4.96 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.447 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.523 ' HB3' HG21 ' E' ' 3' ' ' VAL . 34.2 Cg_endo -76.71 99.68 1.32 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.552 2.168 . . . . 0.0 110.18 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -168.5 149.66 4.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.619 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mt -82.01 -15.22 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.661 ' O ' HG12 ' G' ' 3' ' ' VAL . 39.4 t -88.04 27.39 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.289 -0.882 . . . . 0.0 109.686 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -167.21 -51.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' G' ' 5' ' ' GLN . 23.4 tt0 -66.33 -23.4 66.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.912 . . . . 0.0 109.112 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 -19.67 8.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -18.37 53.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.905 . . . . 0.0 109.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -106.64 0.48 24.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.718 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 38.2 p -173.34 129.32 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.538 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.508 HG12 ' CB ' ' D' ' 5' ' ' HIS . 1.8 mp -53.74 146.15 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.528 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 13.1 m -114.71 -163.75 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.372 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -113.12 165.81 12.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.18 -28.27 68.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -67.55 -46.11 73.7 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -64.95 -39.64 93.8 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.55 -19.95 63.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.938 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.61 -22.04 51.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.051 -1.031 . . . . 0.0 109.345 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -70.02 -16.47 63.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.37 -0.831 . . . . 0.0 109.501 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.53 1.13 56.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.299 -0.875 . . . . 0.0 109.824 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -68.22 158.24 33.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.092 -1.005 . . . . 0.0 109.545 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.555 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.0 m -67.25 147.01 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.003 . . . . 0.0 109.321 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 1.6 m-20 166.84 -31.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.658 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -81.91 -37.34 26.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.988 -1.07 . . . . 0.0 108.985 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -66.71 -30.48 70.72 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.294 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.9 -27.27 18.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 54.0 t -74.83 -26.45 59.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.423 -0.798 . . . . 0.0 109.675 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.632 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -87.25 -9.14 73.63 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 5.4 t -96.18 -18.02 20.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -1.201 . . . . 0.0 109.497 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -85.7 -16.29 39.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 16.8 mt -92.25 -26.28 18.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.906 . . . . 0.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.632 HG23 ' O ' ' H' ' 8' ' ' GLY . 3.2 t -63.59 -42.28 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.942 . . . . 0.0 109.307 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.55 -36.12 83.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.925 . . . . 0.0 109.574 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.27 14.83 13.33 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -104.07 -63.37 1.21 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.682 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.2 p90 -62.39 -26.83 68.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.788 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.971 HD23 HD23 ' B' ' 17' ' ' LEU . 35.8 tp -71.47 -33.14 69.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.202 -0.936 . . . . 0.0 109.589 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -54.66 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.424 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.46 -50.6 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.98 -119.25 6.45 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.8 -16.58 62.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.2 . . . . 0.0 109.486 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -83.49 169.84 15.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.855 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.58 -159.67 14.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 4.1 p90 -169.55 178.2 4.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.629 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -124.24 152.89 42.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -139.12 109.7 6.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 0.0 109.266 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.81 101.34 7.19 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' G' ' 3' ' ' VAL . 35.7 Cg_endo -76.68 96.02 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.468 2.112 . . . . 0.0 110.464 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -164.63 151.38 10.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.521 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.57 -15.17 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.115 . . . . 0.0 108.936 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.645 ' O ' HG12 ' I' ' 3' ' ' VAL . 34.0 t -87.99 28.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -168.14 -52.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -63.99 -26.32 68.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.868 . . . . 0.0 109.783 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 60.5 m -119.25 -15.72 9.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.189 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -13.37 58.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 68.7 p -112.88 2.49 15.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.396 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.0 p -173.52 126.27 0.4 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.849 . . . . 0.0 109.051 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -49.82 153.93 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.045 -1.034 . . . . 0.0 109.076 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.66 -173.1 2.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.222 -0.924 . . . . 0.0 109.567 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -105.59 165.25 11.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.45 -30.24 70.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -65.11 -46.4 81.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -65.05 -38.47 90.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.737 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 28.5 mt -71.01 -20.68 62.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.859 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -76.82 -20.74 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.395 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -71.09 -18.66 62.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -91.1 2.86 56.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.8 t -68.64 156.09 38.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.354 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.271 0.558 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 5.3 m -67.84 146.12 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 1.5 m-20 167.69 -32.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -80.45 -37.23 32.34 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.332 -0.855 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -67.61 -28.74 68.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.224 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.22 -23.7 17.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.377 -0.827 . . . . 0.0 109.222 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 52.4 t -78.4 -25.96 46.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.89 . . . . 0.0 109.407 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.538 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -87.66 -8.11 74.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -96.09 -20.75 18.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -84.47 -16.0 44.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.061 -1.025 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 16.1 mt -91.75 -23.77 19.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 109.744 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.538 HG23 ' O ' ' J' ' 8' ' ' GLY . 3.2 t -66.44 -40.67 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.106 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.74 -37.96 89.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 109.304 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.74 13.77 13.47 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mt -103.15 -63.09 1.2 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.663 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 8.7 p90 -63.6 -26.51 68.72 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.958 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 34.9 tp -71.36 -31.82 67.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.637 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.75 -49.14 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.406 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.87 -51.73 68.76 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.0 -116.34 5.55 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 -11.34 59.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.461 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.68 169.53 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.15 -165.08 15.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 2.4 p90 -162.74 -179.8 7.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -1.196 . . . . 0.0 109.696 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -125.77 150.74 47.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -136.14 115.6 12.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.66 100.62 4.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.525 ' HB3' HG21 ' I' ' 3' ' ' VAL . 35.2 Cg_endo -77.13 98.11 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.498 2.132 . . . . 0.0 110.473 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -165.72 153.73 10.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.593 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 54.0 mt -84.33 -15.64 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -1.183 . . . . 0.0 109.341 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.666 HG12 ' O ' ' K' ' 3' ' ' VAL . 41.5 t -88.46 25.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.355 -0.841 . . . . 0.0 109.507 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.11 -49.91 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.112 -0.993 . . . . 0.0 109.798 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -65.37 -27.65 68.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.281 -0.887 . . . . 0.0 109.304 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 55.9 m -117.22 -13.83 10.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -81.58 -15.66 54.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -112.96 8.52 18.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.426 ' HA ' ' CG1' ' H' ' 2' ' ' VAL . 43.7 p 179.82 126.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.416 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.472 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.7 mp -50.04 151.63 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.854 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 62.0 m -121.96 -172.27 2.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -107.69 167.34 10.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.094 -1.004 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.18 -31.51 72.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.285 -0.885 . . . . 0.0 109.474 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -64.0 -46.76 83.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.892 . . . . 0.0 109.888 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -65.83 -36.88 84.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 109.795 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 26.2 mt -70.78 -24.04 62.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.053 -1.029 . . . . 0.0 109.615 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -73.36 -21.7 60.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.655 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.95 -18.53 62.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.22 3.58 54.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.3 t -68.83 155.89 39.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.789 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.334 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 4.4 m -68.0 146.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.183 -0.948 . . . . 0.0 109.511 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 1.5 m-20 166.85 -32.24 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.137 -0.977 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -81.9 -33.96 30.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 109.089 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -70.91 -26.88 63.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.348 -0.845 . . . . 0.0 109.197 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.74 -23.26 17.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.369 -0.832 . . . . 0.0 109.062 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 22.3 t -78.42 -30.31 47.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.407 -0.808 . . . . 0.0 109.602 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.621 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -83.5 -8.67 84.57 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.9 t -95.58 -18.97 20.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -1.163 . . . . 0.0 109.543 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -86.22 -14.89 42.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 19.9 mt -93.94 -25.31 17.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.423 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.621 HG23 ' O ' ' L' ' 8' ' ' GLY . 3.1 t -64.1 -41.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 108.756 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.67 -39.1 93.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 109.312 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.74 21.77 4.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.432 -0.792 . . . . 0.0 109.779 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.45 -60.07 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 12.6 p90 -65.75 -28.47 69.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.416 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 28.9 tp -69.38 -35.14 75.52 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.301 -0.874 . . . . 0.0 109.426 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.72 -52.31 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -56.85 -52.44 65.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.03 -119.92 6.7 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.03 -14.31 62.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -1.167 . . . . 0.0 109.676 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -86.29 168.92 13.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.856 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.13 -167.45 16.08 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 2.2 p90 -160.84 -178.46 6.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -1.138 . . . . 0.0 109.788 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -126.52 149.4 49.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -134.24 112.38 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.87 . . . . 0.0 109.594 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 100.2 6.47 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' K' ' 3' ' ' VAL . 36.0 Cg_endo -77.75 94.98 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.499 2.133 . . . . 0.0 110.144 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -164.45 155.01 14.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.709 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.28 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.416 ' O1 ' ' HA ' ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' IPH . . . . . 0.417 ' H3 ' HD21 ' D' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . 0.402 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.4 mt -98.17 -17.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.138 . . . . 0.0 109.869 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.43 -63.36 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.197 -0.939 . . . . 0.0 109.411 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -90.22 66.53 6.63 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.373 -0.83 . . . . 0.0 109.845 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 33.9 tt0 174.13 -31.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 109.285 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -126.78 13.78 7.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.959 . . . . 0.0 109.845 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 47.9 t -105.8 -24.37 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.115 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.8 p -94.23 -13.22 26.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -165.69 159.66 16.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.915 . . . . 0.0 109.414 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mt -71.49 140.13 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.869 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.5 m -100.64 -165.0 1.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.3 -0.875 . . . . 0.0 109.841 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.04 162.38 13.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.413 -0.804 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -28.08 69.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -47.1 73.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.527 -0.733 . . . . 0.0 109.842 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.53 -25.47 63.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.841 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.57 -15.21 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.894 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -88.17 -8.98 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.639 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -82.03 -2.67 52.51 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.229 -0.919 . . . . 0.0 109.77 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -110.33 10.3 23.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -0.989 . . . . 0.0 109.563 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.73 147.39 25.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.392 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' B' ' 6' ' ' LEU . 34.6 m -65.71 -138.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.128 -0.983 . . . . 0.0 109.056 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.55 ' HB2' HD12 ' I' ' 10' ' ' ILE . 0.7 OUTLIER -138.79 -164.37 1.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.702 -1.249 . . . . 0.0 109.809 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.78 -12.85 60.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.417 -0.802 . . . . 0.0 109.542 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.446 ' HB3' HG12 ' I' ' 10' ' ' ILE . 56.7 t60 -60.91 -22.7 64.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.0 108.885 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' B' ' 2' ' ' VAL . 66.0 mt -118.39 -47.13 2.56 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.502 -0.749 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -59.5 -22.39 61.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.425 -0.797 . . . . 0.0 109.386 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.474 ' O ' HG13 ' B' ' 12' ' ' VAL . . . -91.4 -30.24 11.11 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -68.46 -19.96 64.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.134 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -80.2 -31.79 38.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.0 109.038 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.503 HD23 ' C5 ' ' B' ' 32' ' ' IPH . 17.1 mt -79.82 -38.44 32.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 13' ' ' GLU . 34.5 m -58.8 -43.56 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.007 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 4.5 pt-20 -63.67 -32.37 73.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.051 -1.031 . . . . 0.0 109.809 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -99.78 19.98 15.0 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.3 -50.37 3.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.2 p90 -71.36 -18.33 62.38 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.143 -0.973 . . . . 0.0 109.357 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 5.9 mt -79.41 -30.15 42.26 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.0 t -64.08 -67.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 109.698 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 94.9 m -69.09 -44.79 71.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.855 . . . . 0.0 109.683 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.22 -90.96 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -53.13 -65.36 0.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -1.133 . . . . 0.0 109.321 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -60.72 128.04 34.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 26' ' ' TYR . . . -73.88 -164.39 10.02 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 9.5 p90 -161.13 -165.54 1.37 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -1.129 . . . . 0.0 109.203 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' D' ' 25' ' ' PHE . 42.5 p90 -151.66 138.37 18.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.055 -1.028 . . . . 0.0 109.59 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 48.9 t80 -120.46 99.98 6.88 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.9 83.69 13.98 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.301 -0.875 . . . . 0.0 109.182 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.2 114.52 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.619 2.213 . . . . 0.0 110.37 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.376 -0.827 . . . . 0.0 109.377 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.429 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -100.22 -17.16 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -1.133 . . . . 0.0 109.409 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.32 -67.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.859 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.46 59.82 5.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.376 -0.827 . . . . 0.0 109.763 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -178.97 -32.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.13 9.24 9.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 109.73 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 43.1 t -102.77 -22.72 13.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 109.429 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' L' ' 1' ' ' PHE . 30.1 p -94.67 -12.82 26.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.577 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 12.0 t -168.96 160.34 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.365 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.2 140.6 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.897 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.86 -155.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.087 -1.008 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.31 160.36 21.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.38 -0.825 . . . . 0.0 109.428 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -25.58 67.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 109.737 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.44 -47.14 64.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 109.806 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -71.44 -23.6 61.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.123 -0.985 . . . . 0.0 109.679 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 44.8 mt -82.69 -15.33 52.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.934 . . . . 0.0 109.96 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.77 -8.0 55.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.992 -1.067 . . . . 0.0 109.57 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -82.6 -0.51 47.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.231 -0.918 . . . . 0.0 109.942 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -111.58 8.24 20.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.549 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.95 149.41 22.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.405 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.595 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' D' ' 6' ' ' LEU . 31.6 m -65.34 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' G' ' 10' ' ' ILE . 0.7 OUTLIER -139.09 -163.15 1.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.712 -1.243 . . . . 0.0 110.072 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -67.7 -13.53 62.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.53 ' HB3' HG12 ' G' ' 10' ' ' ILE . 57.9 t60 -59.84 -25.38 64.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.093 -1.004 . . . . 0.0 108.874 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.532 ' HB2' HG21 ' D' ' 2' ' ' VAL . 66.4 mt -115.04 -48.65 2.82 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t -58.71 -17.0 19.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.403 -0.811 . . . . 0.0 108.926 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -95.93 -31.14 7.49 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 12.8 p -68.93 -18.46 64.1 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.38 -1.07 . . . . 0.0 109.145 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . 0.458 ' ND1' HD22 ' L' ' 6' ' ' LEU . 8.3 m-70 -82.36 -29.91 30.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.256 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.554 HD23 ' C5 ' ' D' ' 32' ' ' IPH . 18.7 mt -81.87 -36.34 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 109.778 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.529 HG23 ' N ' ' D' ' 13' ' ' GLU . 34.3 m -60.99 -42.17 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 109.836 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 4.6 pt-20 -63.88 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.576 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -102.55 20.86 16.3 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.244 -0.91 . . . . 0.0 109.658 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 -50.4 3.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.139 -0.976 . . . . 0.0 109.393 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.594 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 15.3 p90 -71.69 -18.71 62.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.594 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 5.7 mt -79.33 -28.95 42.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.96 . . . . 0.0 109.595 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.09 -68.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.873 . . . . 0.0 109.606 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 68.9 m -68.31 -44.8 74.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.466 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.08 0.2 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.97 -64.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.133 -1.216 . . . . 0.0 109.308 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -61.5 129.48 41.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.23 -165.34 15.26 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' B' ' 26' ' ' TYR . 13.3 p90 -160.67 -173.64 4.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -1.2 . . . . 0.0 109.505 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' B' ' 25' ' ' PHE . 44.7 p90 -143.51 137.18 28.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.446 ' O ' ' HA3' ' B' ' 23' ' ' GLY . 56.4 t80 -119.49 95.45 4.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.381 -0.825 . . . . 0.0 109.0 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.426 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 0.9 OUTLIER -135.53 84.25 34.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 0.0 109.541 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.9 114.94 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.634 2.223 . . . . 0.0 110.723 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -128.98 121.83 28.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 109.182 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.341 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 90.1 mt -99.91 -17.78 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -1.204 . . . . 0.0 109.371 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' E' ' 7' ' ' CYS . 13.6 t -75.65 -66.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -0.895 . . . . 0.0 109.436 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 0.5 OUTLIER -85.94 62.86 7.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.296 -0.877 . . . . 0.0 110.021 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 33.8 tt0 177.11 -29.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.11 -0.994 . . . . 0.0 109.949 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 90.7 m -127.66 8.33 6.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.032 . . . . 0.0 109.996 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' E' ' 3' ' ' VAL . 0.1 OUTLIER -101.27 -22.85 14.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.983 . . . . 0.0 109.241 179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -93.83 -13.87 26.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.316 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -165.74 160.08 16.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' J' ' 3' ' ' ASN . 2.7 mp -71.76 140.37 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -0.974 . . . . 0.0 109.536 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 71.7 m -100.63 -160.69 0.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 109.335 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.95 161.9 15.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.261 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -30.53 71.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.009 -1.057 . . . . 0.0 109.442 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -46.37 85.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.818 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -72.42 -24.85 61.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.889 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.94 -16.06 54.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.777 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -87.47 -10.76 50.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.258 -0.901 . . . . 0.0 109.702 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.14 -3.41 45.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.256 -0.902 . . . . 0.0 110.069 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -109.37 10.88 25.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.993 . . . . 0.0 109.698 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -99.84 147.61 25.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 109.721 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.428 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' F' ' 2' ' ' VAL . 3.8 t80 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' F' ' 6' ' ' LEU . 24.1 m -63.21 -138.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.292 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' F' ' 2' ' ' VAL . 0.4 OUTLIER -136.12 -164.67 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.825 -1.172 . . . . 0.0 110.076 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -66.23 -15.1 62.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.44 -0.787 . . . . 0.0 109.522 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -59.62 -18.4 41.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.138 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.552 ' HB2' HG21 ' F' ' 2' ' ' VAL . 60.9 mt -121.48 -51.6 2.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 t -56.94 -18.85 14.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 108.947 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.508 ' O ' HG13 ' F' ' 12' ' ' VAL . . . -94.32 -30.67 8.51 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.622 ' HB2' ' CZ ' ' H' ' 16' ' ' TYR . 11.2 p -68.87 -18.59 64.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.219 -1.165 . . . . 0.0 108.864 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . 0.406 ' ND1' HD22 ' J' ' 6' ' ' LEU . 4.7 m-70 -81.47 -31.95 32.75 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.421 -0.799 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.577 HD23 ' C5 ' ' F' ' 32' ' ' IPH . 17.2 mt -79.67 -37.06 36.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.374 -0.829 . . . . 0.0 109.888 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.508 HG13 ' O ' ' F' ' 8' ' ' GLY . 31.6 m -60.87 -39.19 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.006 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 5.0 pt-20 -68.24 -28.64 67.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.011 -1.056 . . . . 0.0 109.554 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -101.78 15.43 28.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.181 -0.949 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.14 -52.28 2.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 11.6 p90 -69.43 -18.01 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 109.83 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 5.2 mt -79.58 -33.38 41.75 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.131 -0.981 . . . . 0.0 109.584 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.29 -70.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 109.916 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 82.5 m -64.77 -47.64 77.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 109.565 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.84 -86.96 0.37 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -58.49 -62.57 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -1.159 . . . . 0.0 109.257 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -61.92 134.44 56.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.075 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' H' ' 28' ' ' PRO . . . -77.35 -160.17 12.01 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -168.95 175.64 5.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -1.052 . . . . 0.0 109.084 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 22.5 p90 -132.87 148.88 52.3 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.095 -1.003 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.34 82.64 2.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 109.468 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 3.4 m -124.3 87.68 53.64 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.163 -0.961 . . . . 0.0 109.669 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 114.23 3.77 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.669 2.246 . . . . 0.0 110.519 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -128.06 122.01 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.439 HG22 ' O ' ' G' ' 2' ' ' ILE . 86.3 mt -101.25 -15.12 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -1.182 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 t -78.92 -62.45 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.304 -0.873 . . . . 0.0 109.734 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' GLN . 0.3 OUTLIER -90.24 61.54 5.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.357 -0.839 . . . . 0.0 109.884 -179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' G' ' 4' ' ' GLU . 30.2 tt0 178.91 -31.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.043 . . . . 0.0 109.709 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 96.5 m -123.97 6.64 8.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 0.0 109.684 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.61 -30.13 13.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.0 -1.062 . . . . 0.0 109.616 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 17.3 p -87.83 -15.24 37.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -164.37 161.6 21.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.609 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' D' ' 3' ' ' ASN . 2.7 mt -72.81 142.4 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.809 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m -102.75 -161.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 158.71 17.94 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -28.2 68.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.101 -1.0 . . . . 0.0 109.468 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -45.97 77.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 109.855 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -72.2 -24.5 61.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.648 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 mt -82.25 -15.28 53.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.176 -0.952 . . . . 0.0 109.815 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -87.63 -9.8 53.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.74 -1.33 46.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -111.71 13.67 21.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.029 -1.044 . . . . 0.0 109.506 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -104.33 147.42 27.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.386 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' H' ' 2' ' ' VAL . 2.9 t80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.24 0.543 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.552 HG23 ' N ' ' H' ' 3' ' ' ASN . 23.2 m -61.95 -138.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 109.671 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.552 ' N ' HG23 ' H' ' 2' ' ' VAL . 0.5 OUTLIER -137.77 -167.14 2.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.932 -1.105 . . . . 0.0 110.283 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.86 -14.34 52.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.756 . . . . 0.0 109.537 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -59.45 -21.12 59.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.043 -1.035 . . . . 0.0 108.9 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' H' ' 2' ' ' VAL . 59.5 mt -119.66 -51.17 2.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.085 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 t -55.78 -24.42 35.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 108.961 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.412 ' O ' HG13 ' H' ' 12' ' ' VAL . . . -87.93 -32.5 12.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . 0.506 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 7.2 p -66.59 -21.13 66.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.502 -0.999 . . . . 0.0 109.429 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . 0.401 ' ND1' HD22 ' D' ' 6' ' ' LEU . 6.5 m-70 -81.63 -25.95 35.22 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.211 -0.93 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.562 HD23 ' C5 ' ' H' ' 33' ' ' IPH . 17.5 mt -85.17 -34.29 22.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.438 HG23 ' N ' ' H' ' 13' ' ' GLU . 34.0 m -63.69 -38.33 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.134 -0.979 . . . . 0.0 109.862 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 2.9 pt-20 -68.03 -27.22 66.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.518 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -105.02 20.96 17.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.2 -0.938 . . . . 0.0 109.579 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.23 -50.52 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' F' ' 9' ' ' SER . 14.6 p90 -71.44 -16.54 62.38 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.432 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.595 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 5.9 mt -81.81 -29.79 32.5 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.272 -0.893 . . . . 0.0 109.718 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.9 -67.16 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.315 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -67.49 -49.56 62.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.0 109.638 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.55 -90.83 0.55 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -54.48 -64.41 0.84 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -1.129 . . . . 0.0 109.015 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 -60.32 132.77 54.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.334 -0.854 . . . . 0.0 109.169 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.63 -166.79 33.35 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -161.42 -179.36 7.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -1.149 . . . . 0.0 109.658 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 24.7 p90 -136.43 150.01 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.078 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -131.44 79.22 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 109.854 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.64 87.58 26.72 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.737 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.436 ' HD2' ' HA3' ' F' ' 23' ' ' GLY . 34.1 Cg_endo -77.21 111.35 3.18 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.529 2.152 . . . . 0.0 110.032 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -127.0 123.26 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.009 -0.995 . . . . 0.0 109.477 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -99.9 -15.33 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -1.209 . . . . 0.0 109.427 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.29 -64.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.4 OUTLIER -89.57 64.56 6.68 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.172 -0.955 . . . . 0.0 109.818 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 31.7 tt0 177.08 -32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.918 . . . . 0.0 109.482 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m -123.95 8.96 8.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.76 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 50.8 t -101.97 -23.31 14.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.136 -0.977 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -93.37 -13.6 27.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.039 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 11.9 t -166.91 160.93 14.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.415 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' B' ' 3' ' ' ASN . 2.7 mt -72.47 139.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.928 . . . . 0.0 109.892 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 72.8 m -98.61 -162.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.46 -0.775 . . . . 0.0 109.555 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.65 158.6 18.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -29.17 67.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -45.76 80.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -72.04 -25.64 61.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.982 . . . . 0.0 109.493 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 49.6 mt -81.33 -12.28 59.08 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.242 -0.911 . . . . 0.0 110.055 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -91.51 -9.82 42.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -81.07 -1.26 43.42 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -110.25 3.29 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.066 -1.021 . . . . 0.0 109.893 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.4 149.29 21.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.537 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.626 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.525 HG23 ' N ' ' J' ' 3' ' ' ASN . 32.6 m -65.36 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.263 -0.898 . . . . 0.0 108.993 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.525 ' N ' HG23 ' J' ' 2' ' ' VAL . 0.5 OUTLIER -139.01 -164.09 1.59 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.896 -1.127 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -67.32 -15.57 63.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.764 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . 0.574 ' CE1' HD23 ' L' ' 17' ' ' LEU . 52.6 t60 -58.23 -19.75 36.36 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.099 -1.0 . . . . 0.0 108.981 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.519 ' HB2' HG21 ' J' ' 2' ' ' VAL . 48.7 mt -119.9 -48.91 2.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 109.145 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 t -59.55 -18.62 42.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.401 -0.812 . . . . 0.0 109.191 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.467 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -92.48 -32.99 7.8 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' L' ' 16' ' ' TYR . 10.7 p -66.87 -18.82 65.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.569 -0.959 . . . . 0.0 109.489 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.403 ' ND1' HD22 ' B' ' 6' ' ' LEU . 9.6 m-70 -84.05 -27.3 28.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 109.407 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.586 HD23 ' C5 ' ' J' ' 33' ' ' IPH . 20.1 mt -84.18 -35.14 23.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.673 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.49 HG23 ' N ' ' J' ' 13' ' ' GLU . 33.7 m -62.71 -40.19 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 109.817 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 3.6 pt-20 -66.33 -27.05 67.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.697 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -106.29 19.91 19.78 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.32 -0.863 . . . . 0.0 109.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.15 -50.6 3.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.414 -0.804 . . . . 0.0 109.378 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.591 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.4 p90 -71.67 -20.65 61.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.621 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' J' ' 16' ' ' TYR . 5.2 mt -77.95 -28.12 49.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.864 . . . . 0.0 109.619 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.94 -64.8 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 109.783 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' J' ' 22' ' ' ARG . 80.4 m -70.46 -45.17 66.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.39 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.3 -88.31 0.25 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -56.35 -62.4 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -1.157 . . . . 0.0 109.475 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . 0.42 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 46.8 mtt180 -62.57 129.44 40.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.548 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.1 -163.73 9.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 16.9 p90 -165.87 178.22 6.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 110.039 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -134.35 148.57 50.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.379 -0.826 . . . . 0.0 109.386 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -130.66 82.26 2.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 109.528 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -122.93 88.59 50.67 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.787 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.61 111.93 3.08 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.669 2.246 . . . . 0.0 110.452 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 tptp -125.65 125.35 42.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.167 -0.958 . . . . 0.0 109.366 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.484 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 80.1 mt -97.57 -17.31 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' K' ' 7' ' ' CYS . 10.5 t -76.27 -69.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.4 OUTLIER -83.78 64.34 7.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 109.992 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.5 tt0 176.05 -31.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 109.637 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 97.2 m -126.34 10.64 7.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 110.041 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' K' ' 3' ' ' VAL . 0.1 OUTLIER -103.27 -24.02 13.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 109.354 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -92.21 -18.58 23.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.164 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 3.2 t -160.26 162.39 33.64 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.436 -0.79 . . . . 0.0 109.368 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.441 HD11 ' HB ' ' H' ' 2' ' ' VAL . 2.6 mt -72.97 142.64 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -0.974 . . . . 0.0 109.695 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 71.9 m -103.34 -165.45 1.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.21 157.59 18.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -29.13 66.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -48.67 72.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 109.783 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -68.67 -27.99 66.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.911 . . . . 0.0 109.602 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 50.7 mt -78.95 -15.07 58.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 110.191 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -89.84 -5.53 56.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.705 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -86.12 0.42 53.58 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -111.14 7.41 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 0.0 109.431 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.54 148.0 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.574 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.456 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' C' ' 8' ' ' THR . 4.7 t80 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.55 HG21 HD12 ' L' ' 6' ' ' LEU . 32.7 m -64.21 -134.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.057 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.524 ' N ' HG23 ' L' ' 2' ' ' VAL . 0.5 OUTLIER -139.68 -166.6 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.812 -1.18 . . . . 0.0 109.784 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -64.49 -16.16 62.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.769 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -57.47 -21.73 39.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.923 -1.11 . . . . 0.0 108.943 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.55 HD12 HG21 ' L' ' 2' ' ' VAL . 66.1 mt -118.65 -48.57 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.489 -0.757 . . . . 0.0 109.202 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.4 -17.38 29.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.442 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -94.39 -32.04 7.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 14.9 p -68.78 -18.9 64.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -1.157 . . . . 0.0 109.166 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -81.4 -28.57 34.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.888 . . . . 0.0 108.913 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.532 HD23 ' C5 ' ' L' ' 31' ' ' IPH . 23.9 mt -82.09 -38.11 25.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -0.764 . . . . 0.0 109.695 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.509 HG23 ' N ' ' L' ' 13' ' ' GLU . 34.4 m -60.54 -42.18 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.955 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 5.5 pt-20 -64.36 -29.65 70.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 0.0 109.733 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.536 ' CB ' ' H3 ' ' L' ' 31' ' ' IPH . . . -102.9 18.9 20.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.04 -51.32 2.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' L' ' 17' ' ' LEU . 12.3 p90 -70.79 -17.9 62.76 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 109.512 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' L' ' 16' ' ' TYR . 6.9 mt -79.72 -32.17 41.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.193 -0.942 . . . . 0.0 109.493 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.4 -67.84 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.136 -0.978 . . . . 0.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 93.4 m -67.21 -48.66 67.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.186 -0.946 . . . . 0.0 109.606 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.98 -90.57 0.42 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -54.39 -63.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.163 . . . . 0.0 109.182 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 41.6 mtt180 -61.77 131.01 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.859 . . . . 0.0 109.262 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.47 -164.55 18.84 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.87 179.17 7.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.355 -1.085 . . . . 0.0 109.69 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -135.78 145.32 46.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.639 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -126.26 89.04 2.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -130.13 87.5 51.06 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.18 109.66 2.58 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.799 2.332 . . . . 0.0 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -123.01 127.73 49.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.264 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.511 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.503 ' C5 ' HD23 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.554 ' C5 ' HD23 ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.577 ' C5 ' HD23 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 33' ' ' IPH . . . . . 0.562 ' C5 ' HD23 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 33' ' ' IPH . . . . . 0.586 ' C5 ' HD23 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . 0.536 ' H3 ' ' CB ' ' L' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' HA3' ' OXT' ' B' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 2' ' ' ILE . 16.1 tt -133.34 18.43 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.6 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -98.48 -8.39 9.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -119.49 7.33 11.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.214 -0.929 . . . . 0.0 109.629 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -125.98 -36.36 2.37 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.234 -0.916 . . . . 0.0 109.801 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.05 24.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.156 -0.965 . . . . 0.0 109.792 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -90.68 -30.91 16.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.189 -0.944 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -82.03 -14.24 56.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.46 -0.775 . . . . 0.0 109.679 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.9 146.69 0.73 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 109.686 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -57.08 147.84 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 0.0 109.697 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.1 m -105.83 -170.68 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.956 . . . . 0.0 109.491 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -106.67 165.68 11.13 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.7 -11.46 58.37 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.156 -0.965 . . . . 0.0 109.225 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.27 -44.78 24.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.356 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -78.97 -36.5 41.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.984 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.0 mt -59.87 -31.66 69.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 109.798 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.84 -40.48 87.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 109.668 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -45.28 -37.94 5.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.825 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -94.47 61.3 2.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.074 -1.016 . . . . 0.0 109.614 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.7 t -160.04 137.22 9.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.699 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.305 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.285 0.564 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.615 ' O ' HG13 ' B' ' 2' ' ' VAL . 7.5 p -70.79 114.88 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -176.47 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -77.35 -28.39 53.0 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.338 -0.851 . . . . 0.0 109.388 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -74.55 -37.82 62.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.372 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.3 mt -81.94 -30.38 31.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.869 . . . . 0.0 109.058 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.402 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 12.6 t -72.49 -34.62 67.79 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.651 -0.655 . . . . 0.0 109.478 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.81 -26.59 53.26 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.2 p -72.29 -15.62 61.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -1.116 . . . . 0.0 109.551 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -90.98 -25.56 19.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.648 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.409 HD23 ' C5 ' ' B' ' 32' ' ' IPH . 32.9 mt -79.87 -50.55 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.549 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -47.37 -42.15 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.954 . . . . 0.0 109.286 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.465 ' N ' HG23 ' B' ' 12' ' ' VAL . 43.0 mt-10 -60.52 -50.02 75.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.607 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' H3 ' ' B' ' 32' ' ' IPH . . . -87.41 23.68 1.83 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.322 -0.861 . . . . 0.0 110.05 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.36 -52.5 2.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.951 . . . . 0.0 109.61 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' B' ' 16' ' ' TYR . 17.8 p90 -68.71 -20.43 64.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.136 -0.978 . . . . 0.0 109.542 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.53 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -73.82 -48.84 28.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.5 t -46.15 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.905 . . . . 0.0 109.626 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 42.8 m -58.11 -48.24 80.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.59 -115.27 3.98 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.66 -55.99 13.92 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.175 -1.191 . . . . 0.0 109.292 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -51.76 128.06 22.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.366 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -164.31 16.35 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -168.7 -176.95 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -1.098 . . . . 0.0 109.353 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' B' ' 25' ' ' PHE . 5.4 p90 -133.12 140.69 47.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.12 -0.988 . . . . 0.0 109.668 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -121.36 90.91 3.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.746 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.5 m -128.31 120.47 21.09 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 109.458 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -80.79 103.5 1.49 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.56 2.174 . . . . 0.0 110.803 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -152.22 72.68 1.01 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.805 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.42 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.645 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.447 ' HA3' ' OXT' ' D' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.433 ' O ' HG12 ' C' ' 2' ' ' ILE . 16.1 tt -133.19 18.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 109.282 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' C' ' 7' ' ' CYS . 31.4 m -99.24 -6.46 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.229 -0.92 . . . . 0.0 109.748 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -122.68 13.48 10.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.178 -0.952 . . . . 0.0 109.626 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -132.63 -32.84 1.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.696 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 78.0 m -111.68 -2.96 15.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' C' ' 3' ' ' VAL . 0.1 OUTLIER -88.57 -25.48 22.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.019 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 6.4 p -87.22 -16.26 35.8 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.2 143.88 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.577 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -52.35 152.27 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.161 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 95.7 m -111.44 -177.18 3.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.428 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -103.2 164.08 11.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.26 -16.15 63.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.684 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.0 -45.3 50.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -78.17 -37.0 46.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.71 -30.43 68.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.08 -38.73 82.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 109.598 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -47.76 -35.04 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 109.726 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -96.64 64.11 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.605 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -164.46 140.54 6.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.371 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.531 -179.794 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.605 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.1 p -70.32 112.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.222 -0.924 . . . . 0.0 109.815 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -174.27 -38.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 109.163 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -81.07 -25.73 36.85 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.305 -0.872 . . . . 0.0 109.099 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -76.56 -37.43 56.6 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.006 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.7 mt -81.89 -33.17 30.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 108.907 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 47.5 t -69.7 -32.49 71.13 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.745 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.92 -25.17 46.34 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -74.1 -13.99 60.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 0.0 109.277 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -91.55 -25.76 19.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.29 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' D' ' 15' ' ' LEU . 42.3 mt -79.4 -49.38 12.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.399 -0.813 . . . . 0.0 109.87 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -50.42 -39.57 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.249 -0.907 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.27 -46.06 88.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.409 ' HB3' ' H3 ' ' D' ' 32' ' ' IPH . . . -91.31 24.51 2.91 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.163 -0.96 . . . . 0.0 109.443 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' D' ' 11' ' ' LEU . 0.5 OUTLIER -111.47 -49.62 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.907 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 14.9 p90 -71.8 -17.62 62.15 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.082 -1.012 . . . . 0.0 109.191 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.602 HD13 ' O ' ' D' ' 17' ' ' LEU . 0.2 OUTLIER -78.11 -43.04 30.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.403 -0.811 . . . . 0.0 110.055 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -52.42 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.021 -1.049 . . . . 0.0 109.477 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 60.8 m -58.56 -46.9 85.9 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.44 -116.25 4.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -53.87 26.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.319 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -53.59 126.65 22.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.362 -0.836 . . . . 0.0 109.445 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.88 -166.96 18.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -165.0 -177.6 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' D' ' 25' ' ' PHE . 10.7 p90 -131.68 140.51 49.34 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.932 . . . . 0.0 109.455 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -124.0 94.37 4.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.1 m -131.28 119.08 17.45 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.82 107.98 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.34 2.027 . . . . 0.0 110.384 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -157.9 69.87 0.55 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.381 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.447 ' OXT' ' HA3' ' C' ' 1' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.336 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.453 ' O ' HG12 ' E' ' 2' ' ' ILE . 15.9 tt -135.97 19.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.317 -1.107 . . . . 0.0 109.397 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.76 -9.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.294 -0.879 . . . . 0.0 109.87 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -118.7 7.61 11.71 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.12 -0.987 . . . . 0.0 109.706 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -126.4 -35.84 2.34 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.12 -0.987 . . . . 0.0 109.805 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 22.2 m -107.12 -1.21 22.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.8 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 36.6 t -91.55 -27.88 17.91 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -0.927 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -83.41 -12.98 55.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.12 146.09 0.66 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.233 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.44 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.6 mp -54.16 155.63 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.094 -1.004 . . . . 0.0 109.279 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . 0.44 ' N ' HG22 ' E' ' 10' ' ' ILE . 0.1 OUTLIER -114.66 -177.12 3.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -0.798 . . . . 0.0 109.244 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 164.35 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 109.106 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.22 -14.9 62.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.46 -45.22 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.27 -0.894 . . . . 0.0 109.857 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -79.23 -35.97 40.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.008 -1.058 . . . . 0.0 109.979 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.05 -32.65 69.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -66.31 -38.91 88.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.912 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -47.3 -36.02 8.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.092 -1.005 . . . . 0.0 109.485 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -95.16 63.63 2.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 44.4 t -163.58 137.25 5.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.567 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.42 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.285 0.564 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.621 ' O ' HG13 ' F' ' 2' ' ' VAL . 8.9 p -71.74 113.5 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -175.39 -41.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -77.6 -27.59 51.33 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.21 -0.931 . . . . 0.0 108.999 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -73.99 -39.96 63.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.704 . . . . 0.0 109.253 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -81.92 -26.24 34.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -0.839 . . . . 0.0 109.15 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 17.4 t -75.86 -35.64 59.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.369 -0.832 . . . . 0.0 109.479 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.93 -25.43 55.89 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 2.6 p -71.48 -16.11 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -1.129 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -90.73 -28.87 18.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.53 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' F' ' 15' ' ' LEU . 41.1 mt -75.97 -51.17 12.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -0.904 . . . . 0.0 109.694 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.413 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.7 m -47.99 -39.84 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.623 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.413 ' N ' HG23 ' F' ' 12' ' ' VAL . 39.8 mt-10 -62.69 -50.8 69.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.629 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.92 24.49 1.49 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.327 -0.858 . . . . 0.0 109.848 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' F' ' 11' ' ' LEU . 0.5 OUTLIER -111.15 -51.18 2.88 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 13.4 p90 -69.56 -18.38 63.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 109.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.586 HD13 ' O ' ' F' ' 17' ' ' LEU . 0.2 OUTLIER -78.23 -42.48 31.14 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.31 -0.869 . . . . 0.0 109.779 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.78 -74.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 109.472 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 33.8 m -59.29 -48.1 82.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.407 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.63 -114.85 3.94 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -52.89 50.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -1.167 . . . . 0.0 109.486 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -54.47 125.14 18.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.49 -166.13 11.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -166.53 -178.96 4.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -1.083 . . . . 0.0 109.475 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' F' ' 25' ' ' PHE . 6.2 p90 -129.75 145.51 51.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.156 -0.965 . . . . 0.0 109.593 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -127.57 90.48 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 58.7 m -126.81 116.26 22.39 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.306 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 106.06 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.299 1.999 . . . . 0.0 110.081 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -156.63 70.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.613 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 tt -133.07 18.91 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.411 -1.052 . . . . 0.0 109.232 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 24.8 m -100.15 -4.55 9.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.364 -0.835 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -126.18 12.45 7.68 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.248 -0.907 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.06 -33.38 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.213 -0.929 . . . . 0.0 109.588 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -112.07 -2.75 14.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -87.91 -26.43 22.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 108.986 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 4.1 p -85.95 -15.12 42.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.429 -0.794 . . . . 0.0 109.433 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.99 142.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.409 ' HA ' ' O1 ' ' H' ' 31' ' ' IPH . 2.7 mp -51.26 151.6 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.0 109.55 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 96.9 m -111.91 -178.94 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.612 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -101.49 163.56 12.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 109.543 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -66.08 -13.66 60.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.571 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -45.93 31.03 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.258 -0.902 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -78.21 -37.32 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.714 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.54 -31.98 68.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.59 -39.14 84.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.026 . . . . 0.0 109.585 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -45.88 -36.49 5.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.283 -0.885 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -95.99 64.81 2.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.112 -0.992 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 53.0 t -163.89 136.47 5.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.225 -0.922 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.949 -1.025 . . . . 0.0 109.554 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.579 ' O ' HG13 ' H' ' 2' ' ' VAL . 8.9 p -70.99 115.74 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.589 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -177.78 -38.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.397 -0.814 . . . . 0.0 109.176 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -81.18 -26.76 35.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 109.02 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -74.08 -39.91 63.13 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 108.865 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.2 mt -80.91 -30.87 35.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.482 -0.761 . . . . 0.0 109.294 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.11 -34.32 68.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.36 -0.837 . . . . 0.0 109.338 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.27 -29.86 43.68 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 2.7 p -68.63 -15.42 63.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.298 -1.119 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -91.45 -29.03 17.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.947 . . . . 0.0 110.052 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.482 ' CD2' ' C6 ' ' H' ' 31' ' ' IPH . 26.6 mt -76.63 -47.98 20.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -0.972 . . . . 0.0 109.752 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.64 -38.94 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.77 -49.69 71.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.84 27.58 1.3 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.27 -0.894 . . . . 0.0 109.704 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' H' ' 11' ' ' LEU . 0.5 OUTLIER -113.55 -54.41 2.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.91 . . . . 0.0 108.943 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.543 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 10.1 p90 -67.66 -17.67 64.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' H' ' 17' ' ' LEU . 0.2 OUTLIER -78.45 -42.75 29.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.492 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -51.81 -74.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.361 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 46.5 m -58.31 -47.03 84.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.16 -118.08 4.55 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.55 -53.06 25.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.346 -1.09 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -53.71 128.52 29.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.78 -170.43 32.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -164.06 -179.05 5.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -1.117 . . . . 0.0 109.665 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' H' ' 25' ' ' PHE . 6.3 p90 -130.18 147.56 51.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 109.295 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -129.33 86.33 2.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.166 -0.959 . . . . 0.0 109.732 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 48.2 m -122.77 119.57 28.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.582 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.7 103.92 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.475 2.117 . . . . 0.0 110.288 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -153.81 75.81 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.288 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . 0.463 ' HA3' ' OXT' ' J' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.455 ' O ' HG12 ' I' ' 2' ' ' ILE . 16.0 tt -131.31 18.88 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.179 . . . . 0.0 109.822 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 29.5 m -99.07 -3.83 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.076 -1.015 . . . . 0.0 109.669 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -125.59 11.54 7.94 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -130.1 -33.07 1.77 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -111.25 -2.35 15.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -0.949 . . . . 0.0 109.279 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 38.9 t -88.52 -29.54 20.0 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.147 -0.97 . . . . 0.0 108.939 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -83.15 -11.97 57.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.862 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.1 142.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.62 149.7 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 96.5 m -109.99 177.45 4.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.383 -0.823 . . . . 0.0 109.201 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -97.05 169.16 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 tp -71.29 -11.32 60.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.525 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -44.72 27.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -77.92 -41.26 37.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 26.8 mt -54.32 -32.86 57.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -0.957 . . . . 0.0 109.831 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -66.05 -40.44 90.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.932 -1.105 . . . . 0.0 109.549 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.64 -38.08 6.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.633 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -94.64 64.37 2.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.974 . . . . 0.0 109.572 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -163.83 136.64 5.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.383 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.558 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.648 ' O ' HG13 ' J' ' 2' ' ' VAL . 9.4 p -71.69 113.06 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.208 -0.932 . . . . 0.0 109.615 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -175.29 -40.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -78.48 -27.36 46.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.21 -0.931 . . . . 0.0 109.081 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -73.78 -42.52 60.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -77.57 -33.62 53.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 33.5 t -69.21 -36.21 77.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.632 -0.668 . . . . 0.0 109.515 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.78 57.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 4.5 p -73.07 -15.13 61.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 109.32 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -90.69 -27.95 18.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.779 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.465 ' CD2' ' C6 ' ' J' ' 31' ' ' IPH . 25.8 mt -78.76 -49.98 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.447 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.6 m -47.38 -42.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.518 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.447 ' N ' HG23 ' J' ' 12' ' ' VAL . 49.3 mt-10 -61.22 -50.44 73.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 109.731 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.93 22.06 1.78 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -0.929 . . . . 0.0 109.968 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.01 -53.56 2.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.585 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.4 p90 -67.51 -16.2 64.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' J' ' 17' ' ' LEU . 0.2 OUTLIER -80.42 -43.39 21.06 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.297 -0.877 . . . . 0.0 109.871 -179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 69.4 t -50.64 -72.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.081 -1.012 . . . . 0.0 109.499 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 55.3 m -60.9 -48.64 80.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.39 -115.98 4.19 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.93 -52.11 45.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -1.154 . . . . 0.0 109.504 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -55.18 128.52 34.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.69 -164.11 18.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -169.22 179.83 3.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -1.076 . . . . 0.0 109.598 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' J' ' 25' ' ' PHE . 5.0 p90 -128.69 146.2 50.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.437 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -127.28 91.35 3.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 109.047 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 40.8 m -128.22 115.14 20.09 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.22 104.91 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.345 2.03 . . . . 0.0 110.391 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -155.01 73.41 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.87 . . . . 0.0 109.407 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . 0.463 ' OXT' ' HA3' ' I' ' 1' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.423 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . 0.446 ' HA3' ' OXT' ' L' ' 30' ' ' THR . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.453 HG12 ' O ' ' K' ' 2' ' ' ILE . 13.9 tt -135.06 21.26 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.245 -1.15 . . . . 0.0 109.416 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -101.72 -5.51 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.32 -0.862 . . . . 0.0 109.616 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -123.25 9.73 9.22 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.367 -0.833 . . . . 0.0 109.752 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -128.17 -33.92 2.14 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.229 -0.919 . . . . 0.0 109.653 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 92.9 m -110.57 0.42 17.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.503 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 30.9 t -89.84 -30.11 18.15 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 108.962 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.7 p -84.85 -10.69 56.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.578 -0.701 . . . . 0.0 109.705 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.29 140.28 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.056 -1.027 . . . . 0.0 109.898 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.72 147.99 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 109.306 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 85.4 m -108.63 179.64 4.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.159 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -101.22 164.68 11.67 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 tp -64.41 -17.22 63.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.395 -0.816 . . . . 0.0 109.729 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -73.27 -43.86 60.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.118 -0.989 . . . . 0.0 110.14 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -81.27 -33.94 32.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.952 -1.093 . . . . 0.0 109.798 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 18.6 mt -60.77 -32.95 72.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 109.456 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.31 -38.47 90.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.917 . . . . 0.0 109.646 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -48.36 -35.0 11.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -0.837 . . . . 0.0 109.98 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -97.47 63.97 1.81 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 53.2 t -162.85 137.31 6.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.099 -1.001 . . . . 0.0 109.451 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.256 0.551 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.639 ' O ' HG13 ' L' ' 2' ' ' VAL . 8.7 p -72.06 112.61 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -174.55 -40.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 109.062 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -79.32 -26.1 42.25 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -75.16 -40.46 59.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.142 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.4 mt -79.74 -31.04 41.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.423 -0.798 . . . . 0.0 109.143 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -71.28 -35.62 71.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.475 -0.765 . . . . 0.0 109.574 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.82 -25.69 55.47 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -73.06 -14.53 61.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -1.226 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -90.38 -30.15 17.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.501 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.434 HD23 ' C5 ' ' L' ' 31' ' ' IPH . 29.7 mt -75.86 -51.05 13.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.417 HG23 ' N ' ' L' ' 13' ' ' GLU . 15.9 m -47.45 -40.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.111 -0.993 . . . . 0.0 109.584 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.417 ' N ' HG23 ' L' ' 12' ' ' VAL . 52.7 mt-10 -63.37 -48.69 76.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.416 ' HB3' ' H3 ' ' L' ' 31' ' ' IPH . . . -88.0 22.02 2.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.227 -0.921 . . . . 0.0 109.727 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.6 -54.84 2.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.525 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.1 p90 -67.22 -17.86 64.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.753 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.629 ' O ' HD13 ' L' ' 17' ' ' LEU . 0.2 OUTLIER -77.75 -42.51 33.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.552 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 73.1 t -52.77 -75.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -57.03 -48.07 79.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.297 -0.877 . . . . 0.0 109.6 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -118.1 4.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.71 -55.18 12.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -1.177 . . . . 0.0 109.703 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.22 126.11 17.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.21 -167.03 11.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -166.32 179.38 5.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -1.218 . . . . 0.0 109.665 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' L' ' 25' ' ' PHE . 5.7 p90 -128.57 145.82 51.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.762 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -128.38 92.04 3.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 109.377 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 58.6 m -128.83 116.85 19.3 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.208 -0.932 . . . . 0.0 109.445 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.51 105.6 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.37 2.047 . . . . 0.0 110.206 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 45.6 tttt -156.52 72.05 0.73 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . 0.446 ' OXT' ' HA3' ' K' ' 1' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.453 ' H3 ' ' HB3' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.409 ' H3 ' ' HB3' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.407 ' C6 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 31' ' ' IPH . . . . . 0.482 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 31' ' ' IPH . . . . . 0.465 ' C6 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . 0.434 ' C5 ' HD23 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 19' ' ' TYR . 9.1 mt 65.09 10.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 109.673 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.54 -53.14 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.224 -0.922 . . . . 0.0 109.603 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.91 11.53 39.41 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -125.32 -32.54 2.93 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' A' ' 2' ' ' ILE . 88.0 m -101.19 -32.65 10.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 t -71.77 -24.23 61.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.566 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -80.99 -13.21 59.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.299 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.85 140.86 1.68 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.355 -0.84 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mp -48.52 115.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 0.0 109.01 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.46 167.45 14.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.068 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 169.61 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.792 . . . . 0.0 109.355 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -36.11 81.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.607 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -64.92 -40.42 95.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.634 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.07 -38.72 75.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.887 . . . . 0.0 109.379 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.6 mt -74.83 -18.8 60.39 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.489 -0.757 . . . . 0.0 109.73 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 109.199 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 19' ' ' TYR . 89.9 m-20 -51.68 -51.54 55.14 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' CYS . 44.4 m-85 -61.55 -111.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 19' ' ' TYR . 1.0 OUTLIER 40.62 -164.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.927 -1.108 . . . . 0.0 109.766 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.486 1.343 0 O-C-N 121.005 -1.059 . . . . 0.0 109.462 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.8 m -57.01 127.84 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.52 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -71.65 -31.97 67.42 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.471 -0.768 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.83 -52.06 41.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 108.948 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.54 -26.7 68.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.473 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 29.3 t -70.44 -39.38 74.37 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.472 -0.768 . . . . 0.0 109.729 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.87 -24.93 75.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -78.2 -13.19 59.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.523 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -91.39 -19.15 23.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.8 mt -93.43 -43.0 8.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.332 -0.855 . . . . 0.0 109.443 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.45 HG23 ' N ' ' B' ' 13' ' ' GLU . 15.9 m -48.77 -42.14 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 0.0 109.488 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 16.0 pt-20 -67.75 -37.67 82.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -94.48 24.8 4.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.315 -0.866 . . . . 0.0 109.796 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.19 -54.63 2.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.107 -0.996 . . . . 0.0 109.803 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.462 ' CE1' ' HG ' ' B' ' 17' ' ' LEU . 17.9 p90 -67.98 -17.08 64.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.627 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' B' ' 17' ' ' LEU . 7.2 mt -79.34 -33.13 43.3 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.116 -0.99 . . . . 0.0 109.274 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -75.44 -40.55 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -71.07 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.581 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.75 -132.21 10.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -89.22 34.37 0.8 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.13 -1.218 . . . . 0.0 109.465 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -108.81 -15.17 14.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.605 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.16 175.86 45.5 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -173.15 161.04 4.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -1.159 . . . . 0.0 109.652 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.98 161.32 19.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.163 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -141.26 101.46 4.02 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.12 -0.988 . . . . 0.0 109.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.75 107.15 40.79 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.45 -10.56 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.727 2.285 . . . . 0.0 110.388 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -108.63 10.21 27.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 109.455 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.515 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' C' ' 19' ' ' TYR . 8.9 mt 63.3 11.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.8 -53.01 6.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.05 14.16 32.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.324 -0.86 . . . . 0.0 109.702 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -128.58 -32.07 2.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' C' ' 2' ' ' ILE . 85.0 m -101.93 -31.44 10.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.269 -0.895 . . . . 0.0 109.074 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.62 -24.03 61.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.408 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 7.0 t -83.56 -13.67 53.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.85 . . . . 0.0 109.466 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.519 ' HA ' ' CG1' ' L' ' 2' ' ' VAL . 0.3 OUTLIER -169.77 134.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.673 HD12 HG12 ' L' ' 2' ' ' VAL . 1.7 mp -43.83 108.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.78 168.35 5.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.274 -0.891 . . . . 0.0 109.313 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.81 5.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.455 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -35.41 77.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.815 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -65.3 -39.25 92.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.99 . . . . 0.0 109.25 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.33 -37.49 71.73 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.374 -0.828 . . . . 0.0 109.652 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 37.0 mt -77.19 -14.24 59.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.271 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.542 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.46 -40.48 77.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.948 . . . . 0.0 109.47 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' C' ' 2' ' ' ILE . 47.4 m-85 -73.03 -42.61 62.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.376 -0.828 . . . . 0.0 109.829 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' C' ' 19' ' ' TYR . 1.0 OUTLIER -38.59 155.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.532 -0.73 . . . . 0.0 109.486 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.53 -179.728 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.501 ' O ' HG23 ' D' ' 2' ' ' VAL . 5.1 m -58.35 128.74 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.97 . . . . 0.0 109.368 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.91 -43.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.186 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -73.44 -32.01 64.13 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.333 -0.854 . . . . 0.0 109.022 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -66.97 -52.35 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.399 -0.813 . . . . 0.0 108.97 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 mt -66.48 -22.21 66.19 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 31.5 t -75.34 -36.0 61.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.404 -0.81 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.497 ' O ' HG13 ' D' ' 12' ' ' VAL . . . -74.74 -23.46 74.95 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -78.57 -15.59 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.76 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -88.02 -24.2 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 109.334 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.548 HD23 ' N ' ' D' ' 11' ' ' LEU . 2.6 mt -88.04 -44.92 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.497 HG13 ' O ' ' D' ' 8' ' ' GLY . 21.6 m -48.34 -42.69 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.773 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 15.9 pt-20 -67.8 -38.07 82.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.652 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -94.61 26.79 3.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.403 HD11 HD13 ' C' ' 2' ' ' ILE . 0.5 OUTLIER -117.32 -53.94 2.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.91 . . . . 0.0 109.621 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.587 ' CE1' ' HG ' ' D' ' 17' ' ' LEU . 14.9 p90 -67.46 -15.7 63.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -0.818 . . . . 0.0 109.379 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' D' ' 16' ' ' TYR . 7.0 mt -82.26 -32.72 29.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.926 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.73 -34.93 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.165 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -69.37 0.34 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.945 . . . . 0.0 109.384 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.37 -132.01 10.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -88.58 35.6 0.78 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.301 -1.117 . . . . 0.0 109.589 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -110.17 -19.74 12.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.561 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.06 172.63 46.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -169.48 160.16 8.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -1.104 . . . . 0.0 109.332 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -115.65 156.15 26.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.948 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -133.98 110.86 9.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.647 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.9 104.3 15.49 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.79 -9.77 16.98 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.483 2.122 . . . . 0.0 110.519 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -107.4 7.77 29.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.552 179.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.409 ' O ' HG23 ' E' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' E' ' 19' ' ' TYR . 8.4 mt 63.29 12.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -1.204 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 84.0 t -109.9 -53.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.46 8.77 44.27 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.409 -0.807 . . . . 0.0 109.719 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -123.3 -32.01 3.48 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.233 -0.917 . . . . 0.0 109.486 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' E' ' 2' ' ' ILE . 91.5 m -102.37 -32.68 9.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 8.0 t -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 0.0 109.42 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 5.3 t -84.0 -13.14 54.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.343 -0.848 . . . . 0.0 109.532 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.411 ' O ' ' C ' ' E' ' 10' ' ' ILE . 0.1 OUTLIER -173.35 135.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.16 -0.962 . . . . 0.0 109.635 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' E' ' 9' ' ' SER . 1.8 mp -42.36 111.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.514 -0.741 . . . . 0.0 109.636 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.06 166.1 16.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.008 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.86 170.95 7.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.22 83.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.478 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -62.88 -39.42 94.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.4 -0.813 . . . . 0.0 109.72 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.04 -34.65 66.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 35.8 mt -79.1 -14.28 59.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.149 -0.97 . . . . 0.0 109.611 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -83.32 -14.86 52.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -69.97 -42.6 72.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.006 . . . . 0.0 109.593 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' E' ' 2' ' ' ILE . 46.5 m-85 -69.92 -40.62 75.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 109.958 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . 0.43 ' C ' ' O ' ' E' ' 19' ' ' TYR . 1.1 m -41.13 154.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.485 -0.759 . . . . 0.0 109.712 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.584 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.594 ' O ' HG23 ' F' ' 2' ' ' VAL . 4.9 m -58.19 123.48 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.09 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -70.47 -32.02 69.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 109.119 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -67.16 -52.41 41.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 108.993 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 10.2 mt -65.87 -25.84 67.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 108.869 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 23.3 t -70.88 -37.98 73.04 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.473 -0.767 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.13 -26.16 71.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 28.7 t -75.22 -15.86 60.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -1.119 . . . . 0.0 109.648 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -88.69 -21.41 23.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.689 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.503 ' N ' HD23 ' F' ' 11' ' ' LEU . 3.2 mt -91.61 -44.23 9.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.636 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.456 HG23 ' N ' ' F' ' 13' ' ' GLU . 16.2 m -47.41 -41.87 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 16.3 pt-20 -68.45 -39.64 81.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -93.74 27.45 2.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.218 -0.926 . . . . 0.0 109.735 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.78 -54.68 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.561 ' CE1' ' HG ' ' F' ' 17' ' ' LEU . 17.9 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.433 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.561 ' HG ' ' CE1' ' F' ' 16' ' ' TYR . 7.5 mt -78.9 -35.13 44.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.177 -0.952 . . . . 0.0 109.697 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.97 -38.13 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -69.31 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.144 -0.973 . . . . 0.0 109.688 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.5 -132.9 11.31 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.18 35.14 0.69 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.12 -1.224 . . . . 0.0 109.799 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -109.51 -18.11 13.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.08 -1.012 . . . . 0.0 109.662 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.37 169.8 38.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -167.34 161.6 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -1.105 . . . . 0.0 109.667 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -115.53 162.97 16.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.176 -0.952 . . . . 0.0 109.35 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . 0.413 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 81.6 t80 -142.2 105.42 4.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.33 106.43 33.05 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.584 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -78.61 -9.38 15.97 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.314 2.009 . . . . 0.0 110.196 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -110.67 10.82 22.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.363 -0.836 . . . . 0.0 109.527 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.624 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' G' ' 19' ' ' TYR . 8.1 mt 64.38 13.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -1.166 . . . . 0.0 109.787 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' G' ' 7' ' ' CYS . 57.7 t -111.34 -52.57 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.094 -1.004 . . . . 0.0 109.465 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.4 13.6 34.54 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.269 -0.894 . . . . 0.0 109.522 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -127.28 -35.37 2.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 0.0 109.318 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' G' ' 2' ' ' ILE . 84.3 m -98.79 -32.92 11.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.882 . . . . 0.0 109.514 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' G' ' 3' ' ' VAL . 7.7 t -71.71 -26.29 62.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.4 t -79.03 -13.14 59.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.422 ' O ' ' C ' ' G' ' 10' ' ' ILE . 0.2 OUTLIER -172.32 138.41 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.463 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' G' ' 9' ' ' SER . 1.9 mp -44.61 115.33 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.0 169.4 13.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.744 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.18 169.97 8.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.329 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -36.83 84.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 109.62 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -63.62 -41.66 98.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.068 -1.02 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.76 -35.76 75.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.793 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.15 -13.87 59.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 0.0 110.165 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.77 -13.89 52.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.552 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.04 -41.25 74.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.906 . . . . 0.0 109.812 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' G' ' 2' ' ' ILE . 42.2 m-85 -72.58 -39.26 67.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 109.984 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' G' ' 19' ' ' TYR . 1.1 m -41.96 156.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 117.894 -1.05 . . . . 0.0 109.373 179.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.534 ' O ' HG23 ' H' ' 2' ' ' VAL . 5.0 m -56.27 127.07 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.794 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.42 -43.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.009 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.31 -30.27 66.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.318 -0.864 . . . . 0.0 108.987 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -70.15 -52.77 20.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.437 -0.789 . . . . 0.0 109.17 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mt -65.65 -21.85 66.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.315 -0.866 . . . . 0.0 108.897 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 39.3 t -74.05 -37.48 64.28 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.472 -0.767 . . . . 0.0 109.263 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.11 -26.57 70.46 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t -75.74 -13.85 60.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -1.13 . . . . 0.0 109.55 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -91.38 -19.83 22.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.69 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.467 ' N ' HD23 ' H' ' 11' ' ' LEU . 3.2 mt -93.54 -43.9 8.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.467 HG23 ' N ' ' H' ' 13' ' ' GLU . 16.2 m -47.42 -42.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 16.0 pt-20 -67.61 -39.21 84.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.772 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.53 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -94.93 29.09 2.49 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.115 -0.991 . . . . 0.0 109.751 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.427 HD11 HD13 ' G' ' 2' ' ' ILE . 0.5 OUTLIER -119.88 -54.0 2.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.425 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.511 ' CE1' ' HG ' ' H' ' 17' ' ' LEU . 12.9 p90 -67.9 -18.45 64.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.19 -0.944 . . . . 0.0 109.39 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' H' ' 17' ' ' LEU . 6.7 mt -78.78 -35.17 44.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.458 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.45 -41.57 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -70.69 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.94 -132.85 11.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -87.65 35.4 0.72 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.198 -1.177 . . . . 0.0 109.45 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -108.9 -20.58 13.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.09 162.61 28.84 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' F' ' 26' ' ' TYR . 4.2 p90 -160.46 160.94 32.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -115.18 159.62 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.462 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -138.42 108.33 6.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.859 . . . . 0.0 109.138 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.49 103.69 22.2 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.438 -0.789 . . . . 0.0 109.23 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.06 -7.41 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.426 2.084 . . . . 0.0 110.565 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -111.38 9.92 21.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.128 -0.983 . . . . 0.0 109.589 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.617 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . 0.567 ' O ' HG23 ' I' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' I' ' 19' ' ' TYR . 6.2 mt 56.69 16.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -1.104 . . . . 0.0 109.695 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.567 HG23 ' O ' ' I' ' 1' ' ' GLY . 98.3 t -113.83 -52.29 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.19 -0.944 . . . . 0.0 109.455 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.86 11.49 39.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.257 -0.902 . . . . 0.0 109.624 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -126.03 -32.58 2.76 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . 0.406 ' SG ' HG23 ' I' ' 2' ' ' ILE . 91.2 m -101.49 -31.55 10.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 t -72.55 -25.33 61.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.351 -0.843 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -79.86 -13.12 59.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.415 ' O ' ' C ' ' I' ' 10' ' ' ILE . 0.2 OUTLIER -172.25 137.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 109.329 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.419 HD12 HG12 ' B' ' 2' ' ' VAL . 1.7 mp -45.23 115.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.104 -0.998 . . . . 0.0 109.228 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.58 168.28 16.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.298 -0.876 . . . . 0.0 109.405 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.5 169.11 8.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -38.19 90.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.295 -0.878 . . . . 0.0 109.717 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -62.16 -40.42 95.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.99 . . . . 0.0 109.716 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -72.62 -30.99 64.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 33.3 mt -83.31 -10.49 58.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.024 -1.047 . . . . 0.0 109.585 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -86.2 -13.87 45.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -72.37 -34.79 68.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.789 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' I' ' 2' ' ' ILE . 50.0 m-85 -78.11 -39.04 42.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' I' ' 19' ' ' TYR . 2.0 t -40.37 155.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.566 -0.709 . . . . 0.0 109.425 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.553 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.536 HG23 ' O ' ' J' ' 2' ' ' VAL . 5.7 m -56.36 127.7 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 109.469 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 -43.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.041 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -72.21 -31.13 65.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.385 -0.822 . . . . 0.0 108.945 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.84 -51.76 37.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.422 -0.799 . . . . 0.0 109.12 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.515 HD21 ' H6 ' ' F' ' 32' ' ' IPH . 8.2 mt -65.57 -26.25 67.78 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 28.2 t -70.42 -38.4 74.59 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.482 -0.762 . . . . 0.0 109.501 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.428 ' O ' HG13 ' J' ' 12' ' ' VAL . . . -72.8 -25.53 73.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -78.76 -8.45 58.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -1.168 . . . . 0.0 109.335 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.409 ' C ' HD23 ' J' ' 11' ' ' LEU . 5.7 m-70 -95.62 -17.97 20.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.922 . . . . 0.0 109.211 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.504 HD23 ' N ' ' J' ' 11' ' ' LEU . 3.5 mt -95.43 -42.29 8.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.215 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.468 HG23 ' N ' ' J' ' 13' ' ' GLU . 16.2 m -49.19 -41.79 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 14.6 pt-20 -69.37 -38.45 78.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.24 -0.913 . . . . 0.0 109.517 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' J' ' 13' ' ' GLU . . . -94.42 26.64 3.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.144 -0.972 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.429 HD11 HD13 ' I' ' 2' ' ' ILE . 0.5 OUTLIER -116.23 -55.62 2.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.565 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CE1' ' HG ' ' J' ' 17' ' ' LEU . 15.6 p90 -67.0 -17.7 65.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' J' ' 17' ' ' LEU . 7.3 mt -79.21 -34.16 43.16 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.479 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 84.6 t -74.45 -39.34 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.282 -0.886 . . . . 0.0 109.393 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 m -66.41 -68.65 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 108.87 -131.99 10.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -88.2 34.05 0.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.28 -1.129 . . . . 0.0 109.896 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -109.7 -17.12 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 109.839 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.73 168.31 34.0 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -165.78 159.97 16.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.186 -1.185 . . . . 0.0 109.437 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -113.87 162.1 16.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . 0.406 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 77.5 t80 -140.11 107.0 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.482 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.68 104.35 24.03 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.133 -0.979 . . . . 0.0 109.706 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.78 -9.52 18.3 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.546 2.164 . . . . 0.0 110.58 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -109.84 8.43 24.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.468 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' K' ' 6' ' ' CYS . 3.8 mt -83.99 43.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 0.0 109.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.428 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 53.0 t -123.7 -50.87 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.227 -0.921 . . . . 0.0 109.876 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.11 8.94 43.55 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.246 -0.908 . . . . 0.0 110.31 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -123.99 -29.5 3.63 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.008 -1.057 . . . . 0.0 109.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' K' ' 2' ' ' ILE . 93.6 m -104.84 -30.19 10.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.532 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 8.9 t -73.45 -25.45 60.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.539 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.37 -11.4 59.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.409 ' O ' ' C ' ' K' ' 10' ' ' ILE . 0.6 OUTLIER -173.23 137.01 0.66 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.344 -0.847 . . . . 0.0 109.372 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' K' ' 9' ' ' SER . 2.0 mp -43.96 113.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.91 168.25 13.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 170.28 7.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 109.59 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.0 -38.62 88.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.137 -0.977 . . . . 0.0 109.669 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -61.61 -39.48 91.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -73.08 -35.25 66.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.67 -14.95 59.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.35 -13.5 54.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -71.42 -39.87 70.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.454 ' O ' ' C ' ' K' ' 20' ' ' CYS . 43.3 m-85 -73.3 -39.95 64.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.885 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . 0.454 ' C ' ' O ' ' K' ' 19' ' ' TYR . 1.1 m -40.59 155.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.417 -0.802 . . . . 0.0 109.593 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.569 -179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.299 0.571 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.673 HG12 HD12 ' C' ' 10' ' ' ILE . 5.7 m -58.85 128.83 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 109.644 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.5 -45.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.0 108.721 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -71.02 -31.54 68.06 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.064 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.32 -53.02 27.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.081 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -65.43 -25.6 67.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.448 -0.783 . . . . 0.0 109.109 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 38.7 t -70.76 -39.37 73.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.379 -0.825 . . . . 0.0 109.645 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.437 ' O ' HG13 ' L' ' 12' ' ' VAL . . . -71.62 -24.79 76.31 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -78.44 -11.93 59.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.276 -1.132 . . . . 0.0 109.56 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -91.99 -20.13 21.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.339 -0.851 . . . . 0.0 109.312 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.494 HD23 ' N ' ' L' ' 11' ' ' LEU . 2.4 mt -93.5 -42.92 8.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -0.819 . . . . 0.0 109.395 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.501 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.8 m -48.52 -44.96 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.167 -0.958 . . . . 0.0 109.115 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 15.4 pt-20 -65.01 -37.49 87.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.75 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -96.37 26.96 4.0 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.944 . . . . 0.0 109.876 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.559 HD11 HD13 ' K' ' 2' ' ' ILE . 0.5 OUTLIER -117.16 -55.57 2.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.962 . . . . 0.0 109.468 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 15.6 p90 -66.4 -17.6 64.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' L' ' 17' ' ' LEU . 7.0 mt -79.17 -33.06 44.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.624 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -75.83 -37.51 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -70.29 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.11 -128.34 8.35 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -93.43 31.66 1.48 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.269 -1.136 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -105.39 -18.3 14.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.22 169.63 40.07 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' J' ' 26' ' ' TYR . 5.3 p90 -165.11 157.82 16.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.272 -1.134 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -113.19 158.86 19.91 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.175 -0.953 . . . . 0.0 109.381 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -137.44 111.45 8.35 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.354 -0.841 . . . . 0.0 109.231 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 104.02 15.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 -10.58 18.87 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.462 2.108 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -109.15 11.71 25.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.051 -1.031 . . . . 0.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.359 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.515 ' H6 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 31' ' ' IPH . . . . . 0.408 ' C6 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . 0.47 ' C6 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.6 mt -98.14 -29.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.0 109.679 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.58 -22.58 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -117.37 49.48 1.2 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.341 -0.849 . . . . 0.0 109.653 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -166.09 -37.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 108.881 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 7.5 t -116.81 -34.0 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.576 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -34.81 11.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 108.885 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.4 p -75.24 -45.42 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 109.342 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 m -136.39 137.39 40.47 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.399 -0.813 . . . . 0.0 109.227 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.94 151.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -120.25 -171.22 2.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -108.15 169.82 8.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.25 86.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.399 -0.813 . . . . 0.0 109.32 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -57.4 -43.37 83.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.516 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.447 ' O ' ' CZ ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -74.54 -29.3 61.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.97 -24.98 61.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.859 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 12.04 30.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.943 . . . . 0.0 109.277 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -80.91 -21.18 40.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 110.313 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CZ ' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -118.92 -3.79 10.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.111 -0.993 . . . . 0.0 109.879 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -78.18 143.58 37.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.538 -179.807 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' B' ' 3' ' ' ASN . 6.0 p -83.13 140.79 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.791 . . . . 0.0 109.79 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' B' ' 2' ' ' VAL . 5.9 p30 167.24 -32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -84.77 -32.98 23.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.204 -0.935 . . . . 0.0 109.333 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -66.39 -29.61 69.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.34 -28.67 14.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.838 . . . . 0.0 109.155 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 25.7 t -65.26 -38.07 89.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.405 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.84 -25.31 62.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.6 t -72.73 -18.55 61.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.761 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -88.85 -25.33 22.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.571 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.585 HD23 ' C3 ' ' B' ' 32' ' ' IPH . 30.1 mt -79.66 -40.47 29.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 109.37 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.87 -31.93 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 109.629 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.46 -47.7 66.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.68 4.97 26.3 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.26 -59.23 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 109.752 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 12.7 p90 -66.48 -28.57 68.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' H' ' 17' ' ' LEU . 17.1 tp -66.3 -28.12 68.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.217 -0.927 . . . . 0.0 109.255 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.8 t -89.84 -29.81 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 0.0 109.69 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 16.4 m -119.45 43.44 2.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 109.163 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.85 -45.46 64.24 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.45 -62.79 1.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -1.199 . . . . 0.0 109.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.08 170.75 19.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -152.92 174.75 13.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.123 -1.222 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -128.33 150.2 50.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.361 -0.837 . . . . 0.0 109.313 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -126.66 100.4 6.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.053 -1.03 . . . . 0.0 109.607 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 14.0 m -141.88 100.21 6.03 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 125.13 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.537 2.158 . . . . 0.0 110.386 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.19 -65.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.541 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.52 -30.15 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.29 -1.123 . . . . 0.0 109.624 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 74.4 t -67.06 -23.88 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.932 . . . . 0.0 109.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.43 49.7 1.18 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -166.07 -36.92 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.124 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' C' ' 11' ' ' CYS . 10.9 t -117.83 -30.04 5.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.583 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.69 -36.03 56.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' L' ' 1' ' ' PHE . 81.5 p -73.54 -40.36 64.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 109.362 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -140.71 138.56 34.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.306 -0.871 . . . . 0.0 108.948 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mp -55.09 152.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.198 -0.939 . . . . 0.0 109.545 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . 0.521 ' N ' ' SG ' ' C' ' 6' ' ' CYS . 0.8 OUTLIER -119.8 -170.63 1.99 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -108.99 172.77 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.079 -1.013 . . . . 0.0 109.444 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -39.22 82.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -56.71 -43.59 80.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -29.33 62.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 0.0 109.694 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.93 -26.23 62.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.83 10.39 35.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 109.616 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -77.47 -25.16 50.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.885 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.2 -0.42 12.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.219 -0.926 . . . . 0.0 109.714 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' D' ' 24' ' ' PHE . 0.1 OUTLIER -79.28 135.09 36.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.027 . . . . 0.0 109.597 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . 0.408 ' OXT' ' O ' ' C' ' 20' ' ' CYS . 38.2 m-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' D' ' 3' ' ' ASN . 8.9 p -85.94 138.32 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.156 -0.965 . . . . 0.0 109.64 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' D' ' 2' ' ' VAL . 5.4 p30 169.47 -29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.302 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.1 -31.33 19.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -68.22 -30.0 68.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.99 -26.92 15.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.24 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -66.78 -41.61 87.38 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.344 -0.848 . . . . 0.0 109.177 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.73 -23.56 76.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -75.48 -16.47 60.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.147 . . . . 0.0 109.584 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . 0.453 ' CG ' HD22 ' L' ' 6' ' ' LEU . 11.5 m-70 -90.2 -25.67 20.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.568 HD23 ' C3 ' ' D' ' 32' ' ' IPH . 29.5 mt -79.46 -42.01 26.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -55.4 -33.9 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -68.43 -44.92 73.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.229 -0.92 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.425 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -85.88 7.3 24.61 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.61 -60.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.592 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 9.5 p90 -64.58 -28.46 69.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.554 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 21.3 tp -67.1 -26.89 66.93 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.58 -32.74 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 41.7 m -117.1 42.61 2.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.439 -0.788 . . . . 0.0 109.433 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.18 -49.18 63.14 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -60.52 -67.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -1.195 . . . . 0.0 109.559 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -88.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.37 177.97 27.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' SG ' ' C' ' 20' ' ' CYS . 20.2 p90 -159.17 174.09 15.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -1.152 . . . . 0.0 109.717 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -127.37 148.26 50.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.434 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -123.7 103.08 8.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 109.437 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 21.9 m -145.53 99.9 4.44 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.36 -0.838 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.26 128.17 8.77 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.331 2.021 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.01 -69.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.402 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.47 HG22 ' O ' ' D' ' 30' ' ' THR . 9.0 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.427 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mt -100.35 -28.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.19 -23.71 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.34 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 52.31 0.9 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.382 -0.824 . . . . 0.0 109.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -173.23 -36.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.66 -33.55 6.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 108.885 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.0 t -53.43 -41.56 66.19 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.429 -0.795 . . . . 0.0 109.581 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 32.0 p -67.58 -44.4 78.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.917 . . . . 0.0 109.709 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -140.28 139.24 35.47 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.0 -1.063 . . . . 0.0 109.724 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.41 HG22 ' N ' ' E' ' 11' ' ' CYS . 2.3 mp -55.77 153.9 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . 0.41 ' N ' HG22 ' E' ' 10' ' ' ILE . 4.8 m -123.92 -161.76 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 109.098 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -115.75 168.95 9.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.004 . . . . 0.0 109.668 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -37.58 87.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -57.91 -41.82 83.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . 0.444 ' O ' ' CZ ' ' E' ' 19' ' ' TYR . 0.0 OUTLIER -76.22 -28.67 57.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.126 -0.984 . . . . 0.0 109.693 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.23 -25.72 61.75 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.67 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.38 13.15 26.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.18 -23.44 35.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.204 -0.935 . . . . 0.0 109.942 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' E' ' 15' ' ' GLN . 0.0 OUTLIER -115.15 -5.83 12.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' F' ' 24' ' ' PHE . 0.1 OUTLIER -74.4 138.28 43.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.49 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.252 0.549 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' F' ' 3' ' ' ASN . 5.9 p -83.79 140.25 16.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.396 -0.815 . . . . 0.0 109.907 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' F' ' 2' ' ' VAL . 4.7 p30 167.95 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.356 -0.84 . . . . 0.0 109.296 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -84.56 -29.93 25.48 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.355 -0.841 . . . . 0.0 109.461 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -69.81 -31.13 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.101 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mt -93.31 -28.34 16.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.34 -0.85 . . . . 0.0 109.094 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 11.2 t -65.56 -41.17 93.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.339 -0.851 . . . . 0.0 109.609 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.62 -21.86 76.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 19.8 t -76.26 -14.91 60.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.617 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -92.19 -26.46 18.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.36 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.593 HD23 ' C3 ' ' F' ' 32' ' ' IPH . 34.5 mt -78.37 -40.11 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.275 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.44 -35.08 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 109.291 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.6 -47.22 73.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.96 6.71 20.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.214 -0.929 . . . . 0.0 109.702 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mt -91.0 -58.95 2.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.138 -0.976 . . . . 0.0 109.74 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 11.2 p90 -66.73 -27.04 67.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.099 -1.001 . . . . 0.0 109.511 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' L' ' 17' ' ' LEU . 20.2 tp -68.32 -27.65 66.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -88.02 -33.83 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.911 . . . . 0.0 109.472 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 31.6 m -116.64 41.51 2.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.46 -48.71 75.91 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -61.22 -69.92 0.21 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -1.158 . . . . 0.0 109.61 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.142 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.09 23.73 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' SG ' ' E' ' 20' ' ' CYS . 28.0 p90 -153.43 172.56 16.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -1.109 . . . . 0.0 109.641 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -127.14 147.67 50.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -122.88 104.22 9.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -0.937 . . . . 0.0 109.305 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -146.55 97.97 4.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.76 127.8 9.72 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.585 2.19 . . . . 0.0 110.655 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.26 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 108.906 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.353 179.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 40.3 mt -99.31 -27.51 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.222 -1.163 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.21 -25.64 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.214 -0.929 . . . . 0.0 109.075 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -115.71 55.08 0.79 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.326 -0.859 . . . . 0.0 109.784 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -174.06 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.4 -0.813 . . . . 0.0 108.872 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.46 -34.9 4.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.9 t -52.98 -38.33 62.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.362 -0.836 . . . . 0.0 109.719 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 34.8 p -70.42 -42.73 71.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.161 -0.962 . . . . 0.0 109.577 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -140.53 141.57 35.29 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -58.83 154.01 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.148 -0.97 . . . . 0.0 109.436 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 m -122.46 -163.5 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -115.11 167.24 10.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.472 -0.768 . . . . 0.0 109.333 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -38.25 90.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -56.48 -43.75 79.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 109.69 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -31.28 62.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.791 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.33 -26.75 64.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.713 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.1 13.53 24.94 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.192 -0.943 . . . . 0.0 109.719 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.12 -25.29 37.06 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.088 -1.008 . . . . 0.0 109.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -2.1 12.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.145 -0.972 . . . . 0.0 109.94 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' H' ' 23' ' ' GLY . 40.9 t -77.29 142.08 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.207 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.628 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' H' ' 3' ' ' ASN . 7.5 p -91.08 142.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.214 -0.929 . . . . 0.0 109.65 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' H' ' 2' ' ' VAL . 5.8 p30 166.56 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.333 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.26 -31.09 25.15 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.345 -0.847 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.31 -30.71 68.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.281 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -93.72 -30.25 14.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.451 -0.781 . . . . 0.0 109.286 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 7.7 t -64.42 -42.42 96.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.321 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.15 -25.94 73.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 6.7 t -73.7 -17.36 61.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -1.225 . . . . 0.0 109.781 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.01 -24.91 23.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 109.615 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.685 HD23 ' C3 ' ' H' ' 32' ' ' IPH . 21.3 mt -80.89 -40.48 24.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.68 -34.79 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 109.254 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.64 -48.0 73.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.245 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.9 8.47 17.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.756 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -92.14 -57.47 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.066 -1.021 . . . . 0.0 109.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 9.7 p90 -67.97 -25.52 65.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.627 HD23 HD23 ' B' ' 17' ' ' LEU . 18.2 tp -71.5 -20.25 62.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.242 -0.912 . . . . 0.0 109.941 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 75.7 t -96.79 -29.72 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 108.81 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 57.6 m -118.34 42.15 2.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.24 -48.75 57.12 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -61.26 -67.39 0.41 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -1.134 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -87.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.434 -0.791 . . . . 0.0 109.655 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.434 ' O ' ' SG ' ' G' ' 20' ' ' CYS . . . 154.24 176.1 26.2 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -157.94 172.36 18.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -1.173 . . . . 0.0 109.637 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.36 148.06 50.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -123.39 103.83 8.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.125 -0.984 . . . . 0.0 109.511 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 15.5 m -145.01 99.72 4.63 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.98 122.65 5.88 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.554 2.169 . . . . 0.0 110.675 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.57 -67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.775 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . 0.515 HG22 ' O ' ' H' ' 30' ' ' THR . 17.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.671 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 56.8 mt -102.29 -27.59 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -1.144 . . . . 0.0 108.934 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -68.67 -24.71 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.434 -0.791 . . . . 0.0 109.231 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.29 55.26 0.81 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.347 -0.846 . . . . 0.0 109.256 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -175.28 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 109.121 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.98 -35.82 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.183 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.0 t -51.89 -39.93 59.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -69.69 -40.22 76.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -144.6 136.67 26.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.968 . . . . 0.0 109.637 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.433 HD11 HG23 ' B' ' 2' ' ' VAL . 2.5 mp -54.71 152.91 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.42 -0.8 . . . . 0.0 109.544 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 5.9 m -123.3 -162.12 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.438 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 4.6 m -115.49 167.78 10.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.861 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -34.82 78.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -61.28 -41.43 96.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.486 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.35 60.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.541 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.58 -24.18 61.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.08 11.64 35.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.003 -1.061 . . . . 0.0 109.724 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -79.39 -25.03 42.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.3 -0.875 . . . . 0.0 109.856 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' I' ' 19' ' ' TYR . 0.0 OUTLIER -113.91 -7.17 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' J' ' 24' ' ' PHE . 0.1 OUTLIER -71.94 138.91 48.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 109.433 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.523 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' J' ' 3' ' ' ASN . 6.5 p -85.0 140.04 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.159 -0.963 . . . . 0.0 109.773 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' J' ' 2' ' ' VAL . 5.5 p30 167.77 -32.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -85.06 -28.2 25.83 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.216 -0.927 . . . . 0.0 109.375 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -72.06 -30.15 64.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 109.405 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.28 -27.55 16.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 11.4 t -66.64 -40.66 88.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.514 -0.741 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -23.53 74.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -75.65 -15.69 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -1.106 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -90.84 -23.79 20.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.621 HD23 ' C3 ' ' J' ' 32' ' ' IPH . 47.2 mt -80.75 -41.51 23.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.309 -0.87 . . . . 0.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' L' ' 16' ' ' TYR . 22.0 m -56.0 -36.09 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.847 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -66.09 -45.05 82.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.0 109.536 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.7 6.99 25.21 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.603 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.18 -60.2 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 0.0 109.504 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.674 ' CE2' HG21 ' L' ' 12' ' ' VAL . 9.4 p90 -64.9 -27.77 69.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 109.621 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 21.4 tp -68.56 -25.27 64.82 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.297 -0.877 . . . . 0.0 109.78 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.51 -30.3 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.4 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 28.9 m -119.51 41.0 3.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.179 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.67 -46.56 89.56 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.34 -65.83 0.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 0.0 109.583 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.08 -87.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 109.444 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.42 179.21 29.52 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' L' ' 26' ' ' TYR . 32.1 p90 -160.79 175.0 13.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -1.148 . . . . 0.0 109.265 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -131.52 141.56 49.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.978 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -117.28 106.7 13.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.529 -0.732 . . . . 0.0 109.229 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 24.8 m -149.53 97.76 3.49 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.269 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.33 128.75 10.66 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.501 2.134 . . . . 0.0 110.836 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.12 -68.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.845 . . . . 0.0 109.156 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.123 -0.942 . . . . 0.0 109.204 179.63 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.99 -30.49 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -1.111 . . . . 0.0 109.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 64.1 t -66.92 -24.71 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.63 53.01 0.86 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -172.58 -34.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -115.27 -34.81 4.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.18 -38.88 59.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 53.8 p -70.43 -47.39 60.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 44.8 m -136.34 139.38 42.52 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.944 . . . . 0.0 109.784 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -56.79 152.25 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.14 -166.28 1.43 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.99 170.54 8.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.028 . . . . 0.0 110.279 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.8 -35.58 80.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.464 -0.773 . . . . 0.0 109.047 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -60.15 -41.51 92.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.436 -0.79 . . . . 0.0 109.628 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -28.67 54.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.463 -0.773 . . . . 0.0 109.749 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 10.2 mt -71.83 -26.17 62.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.51 14.34 21.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 109.734 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -82.03 -24.66 35.23 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.1 -1.0 . . . . 0.0 109.68 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' K' ' 19' ' ' TYR . 0.0 OUTLIER -114.33 -5.78 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.555 -179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.31 135.45 42.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.518 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' C' ' 8' ' ' THR . 37.2 m-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.339 0.59 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' L' ' 3' ' ' ASN . 5.9 p -86.19 142.31 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 109.834 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' L' ' 2' ' ' VAL . 5.2 p30 165.38 -32.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.85 . . . . 0.0 109.101 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -84.01 -30.98 25.71 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.319 -0.863 . . . . 0.0 109.444 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.83 -30.17 67.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.125 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.453 HD22 ' CG ' ' D' ' 10' ' ' HIS . 2.3 mt -93.95 -28.97 15.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.356 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 20.1 t -65.37 -40.18 93.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.852 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.23 -22.96 72.39 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 1.4 t -75.07 -15.49 60.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.23 . . . . 0.0 109.627 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -90.32 -25.66 20.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.638 HD23 ' C3 ' ' L' ' 31' ' ' IPH . 29.5 mt -79.55 -40.7 28.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.663 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.674 HG21 ' CE2' ' J' ' 16' ' ' TYR . 16.2 m -57.3 -33.86 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 109.444 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -67.97 -45.85 73.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.867 . . . . 0.0 109.17 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.58 9.97 14.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.411 -0.805 . . . . 0.0 109.581 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.87 -59.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 109.51 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 9.8 p90 -65.66 -27.4 68.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.392 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.831 HD23 HD23 ' F' ' 17' ' ' LEU . 20.6 tp -68.29 -26.99 65.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.819 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 79.4 t -89.48 -32.28 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.253 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 38.9 m -117.77 41.24 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 0.0 109.762 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.87 77.77 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -60.23 -69.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -1.165 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.8 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 156.27 -178.64 32.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -164.42 167.64 19.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -1.219 . . . . 0.0 109.732 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.31 148.76 45.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . 0.547 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 28.8 t80 -125.55 90.46 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 109.938 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 21.3 m -132.23 102.96 14.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.68 130.86 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.506 2.137 . . . . 0.0 110.172 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.79 -66.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.344 -0.847 . . . . 0.0 108.883 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . 0.427 HG22 ' O ' ' L' ' 30' ' ' THR . 5.3 m . . . . . 0 C--N 1.303 -1.448 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.428 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.585 ' C3 ' HD23 ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.568 ' C3 ' HD23 ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.593 ' C3 ' HD23 ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 32' ' ' IPH . . . . . 0.685 ' C3 ' HD23 ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.621 ' C3 ' HD23 ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . 0.638 ' C3 ' HD23 ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 HD11 ' B' ' 15' ' ' LEU . 58.0 mt -87.76 -25.17 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -1.174 . . . . 0.0 109.811 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.5 t -72.89 -31.16 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.61 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.49 47.83 0.95 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.237 -0.914 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' SER . 13.3 tt0 -162.34 -37.93 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 9' ' ' SER . 1.3 m -99.67 -29.17 12.81 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.446 -0.783 . . . . 0.0 109.389 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.4 t -77.86 -30.56 50.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 108.927 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 p -91.01 -20.88 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.367 -0.833 . . . . 0.0 109.66 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -163.39 140.98 7.59 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.133 -0.979 . . . . 0.0 109.799 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.59 99.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.6 m -49.29 147.38 3.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.03 -1.044 . . . . 0.0 109.439 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -177.16 2.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.78 -30.92 59.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 0.0 109.709 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -72.94 -36.86 67.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.198 -0.938 . . . . 0.0 109.676 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -70.25 -26.87 64.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.787 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.56 -24.92 31.38 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.079 -1.013 . . . . 0.0 109.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -99.18 36.47 1.72 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 109.744 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.572 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 24.5 p-10 -114.1 -24.53 8.95 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.134 -0.979 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.572 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -127.36 52.7 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 t -111.85 153.52 26.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.175 -0.953 . . . . 0.0 109.87 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.47 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.545 HG23 HG13 ' I' ' 10' ' ' ILE . 12.1 p -70.99 -9.72 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' B' ' 7' ' ' CYS . 8.4 m-20 -56.89 -37.93 72.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.014 -1.054 . . . . 0.0 109.422 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -48.74 -35.97 15.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -86.46 -34.71 20.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.706 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -93.18 -68.52 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.991 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' B' ' 3' ' ' ASN . 11.7 t -46.27 -31.92 2.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.092 -1.005 . . . . 0.0 109.486 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.02 42.22 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -65.88 -12.04 51.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -1.115 . . . . 0.0 109.654 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.591 ' ND1' HD22 ' F' ' 6' ' ' LEU . 8.8 m-70 -88.38 -30.16 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 11' ' ' LEU . 7.7 mt -71.01 -47.97 55.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 109.831 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 m -55.99 -38.22 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.092 -1.005 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.02 -38.8 92.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.469 ' CB ' ' H3 ' ' B' ' 32' ' ' IPH . . . -94.72 18.47 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.195 -0.94 . . . . 0.0 109.866 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.67 HD11 HD13 ' A' ' 2' ' ' ILE . 1.3 mt -107.53 -52.69 2.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 15.4 p90 -69.06 -17.37 63.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' H' ' 17' ' ' LEU . 12.4 tp -81.54 -35.41 30.33 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.158 -0.964 . . . . 0.0 109.523 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -64.51 -72.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.846 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 -28.53 3.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.815 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.38 -138.34 16.97 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -53.89 -27.17 28.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -1.116 . . . . 0.0 109.533 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 134.94 56.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.82 -168.19 38.81 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 23.8 p90 -170.28 -178.06 2.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -1.071 . . . . 0.0 109.391 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -138.84 153.85 48.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.132 -0.98 . . . . 0.0 109.841 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -131.87 130.5 41.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.035 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 86.6 m -151.66 101.5 2.9 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.025 . . . . 0.0 109.493 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.85 83.87 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.568 2.179 . . . . 0.0 110.492 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' B' ' 30' ' ' THR . 2.3 tptp -142.85 -97.14 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.333 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.673 HD13 HD11 ' D' ' 15' ' ' LEU . 55.4 mt -89.58 -24.78 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.195 -1.179 . . . . 0.0 109.36 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.89 -33.22 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.218 -0.926 . . . . 0.0 109.278 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.48 40.8 1.62 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.511 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' C' ' 9' ' ' SER . 10.1 tt0 -155.0 -36.78 0.09 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.384 -0.822 . . . . 0.0 109.238 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -100.95 -26.11 13.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.542 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 19.3 t -81.15 -25.25 37.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.155 -0.966 . . . . 0.0 108.735 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.8 -19.12 19.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.462 -0.774 . . . . 0.0 109.57 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 5' ' ' GLN . 0.0 OUTLIER -165.06 137.76 4.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.413 HG13 HG23 ' L' ' 2' ' ' VAL . 2.7 mp -58.5 97.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.74 143.14 5.49 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.948 . . . . 0.0 109.389 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.04 -176.82 0.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.861 . . . . 0.0 109.653 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -34.27 62.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.752 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -37.05 76.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.851 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . 0.434 ' O ' ' OD1' ' C' ' 18' ' ' ASN . 73.8 mt-30 -70.48 -26.21 63.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.248 -0.908 . . . . 0.0 109.858 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 16.4 mt -83.9 -25.11 30.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.107 -0.995 . . . . 0.0 109.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -100.07 40.53 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.428 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.531 ' OD1' ' CD2' ' C' ' 19' ' ' TYR . 22.4 p-10 -119.3 -21.53 7.48 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.531 ' CD2' ' OD1' ' C' ' 18' ' ' ASN . 0.1 OUTLIER -131.57 54.32 1.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t -113.9 154.76 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 109.47 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.586 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.404 ' O ' HG22 ' D' ' 2' ' ' VAL . 13.8 p -74.76 -8.65 11.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.206 -0.934 . . . . 0.0 109.326 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' D' ' 7' ' ' CYS . 8.4 m-20 -57.82 -35.98 71.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.185 -0.947 . . . . 0.0 109.724 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -51.37 -33.59 30.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.083 -1.01 . . . . 0.0 109.329 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -89.38 -31.3 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.241 -0.912 . . . . 0.0 109.52 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.98 -69.04 0.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.64 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.422 ' N ' ' O ' ' D' ' 3' ' ' ASN . 13.8 t -48.38 -26.49 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.438 -0.789 . . . . 0.0 109.739 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.8 -40.85 20.67 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 44.4 t -68.63 -9.86 52.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -1.136 . . . . 0.0 109.534 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . 0.45 ' CG ' HD22 ' L' ' 6' ' ' LEU . 2.9 m-70 -89.02 -26.65 21.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.186 -0.946 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.444 HD23 ' N ' ' D' ' 11' ' ' LEU . 7.3 mt -75.88 -47.23 26.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.372 -0.83 . . . . 0.0 109.245 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.57 -39.09 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.693 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.38 -41.15 98.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.408 ' CB ' ' H3 ' ' D' ' 32' ' ' IPH . . . -93.19 18.25 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.239 -0.913 . . . . 0.0 110.136 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.673 HD11 HD13 ' C' ' 2' ' ' ILE . 1.2 mt -106.55 -54.7 2.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.491 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 16.3 p90 -66.95 -18.37 65.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.646 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' J' ' 17' ' ' LEU . 15.5 tp -81.08 -33.69 33.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.289 -0.882 . . . . 0.0 109.925 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.3 t -66.66 -72.09 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.647 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.35 -31.29 2.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.35 -135.49 13.21 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.03 -27.2 52.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -1.131 . . . . 0.0 109.376 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 134.05 55.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.81 -165.72 34.05 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 20.8 p90 -170.95 -175.63 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.257 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -141.13 150.4 42.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.541 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.27 128.41 44.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 108.924 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 29.5 m -146.77 102.09 3.93 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 0.0 109.594 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.16 80.7 2.92 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.453 2.102 . . . . 0.0 110.64 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' D' ' 30' ' ' THR . 2.9 tptp -141.96 -96.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.442 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . 0.483 ' N ' ' HG3' ' D' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.004 -1.06 . . . . 0.0 109.72 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.703 HD13 HD11 ' F' ' 15' ' ' LEU . 51.1 mt -90.09 -25.87 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -1.155 . . . . 0.0 109.245 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 27.8 t -71.5 -34.41 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.243 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -107.57 45.31 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.43 -0.794 . . . . 0.0 109.497 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' E' ' 9' ' ' SER . 12.7 tt0 -159.98 -37.25 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 108.959 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' E' ' 9' ' ' SER . 1.4 m -99.97 -27.59 13.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 109.182 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 16.6 t -79.13 -30.08 43.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.268 -0.895 . . . . 0.0 109.181 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 7.4 p -92.02 -21.6 20.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.592 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.425 ' O ' ' O ' ' E' ' 5' ' ' GLN . 0.0 OUTLIER -162.16 141.55 9.59 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.245 -0.909 . . . . 0.0 109.72 -179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -60.41 100.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.655 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 24.8 m -49.22 144.4 5.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.122 -0.986 . . . . 0.0 109.139 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . 0.409 ' O ' HD12 ' E' ' 16' ' ' LEU . 0.5 OUTLIER -72.13 -176.85 1.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.052 -1.03 . . . . 0.0 108.967 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.02 -34.32 61.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 0.0 109.773 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -37.54 77.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.637 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . 0.459 ' O ' ' OD1' ' E' ' 18' ' ' ASN . 73.0 mt-30 -69.6 -25.91 64.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.849 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.409 HD12 ' O ' ' E' ' 12' ' ' SER . 15.0 mt -84.5 -23.43 29.84 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -0.89 . . . . 0.0 110.216 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.49 36.33 2.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.119 -0.988 . . . . 0.0 109.671 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.495 ' OD1' ' CD2' ' E' ' 19' ' ' TYR . 21.5 p-10 -115.16 -19.79 10.69 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.146 -0.971 . . . . 0.0 109.747 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.495 ' CD2' ' OD1' ' E' ' 18' ' ' ASN . 0.1 OUTLIER -131.73 52.18 2.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.152 -0.968 . . . . 0.0 109.59 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 t -112.65 156.31 22.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.421 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.422 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.444 HG22 ' O ' ' F' ' 2' ' ' VAL . 11.3 p -70.57 -8.12 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' F' ' 7' ' ' CYS . 6.6 m-20 -57.97 -39.16 77.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -48.17 -33.22 8.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . 0.689 ' NE2' HD13 ' H' ' 17' ' ' LEU . 9.5 t60 -90.15 -30.16 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.591 HD22 ' ND1' ' B' ' 10' ' ' HIS . 15.5 mt -96.28 -67.71 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.363 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' F' ' 3' ' ' ASN . 16.1 t -47.06 -32.03 3.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.09 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.413 ' HB2' ' OH ' ' H' ' 16' ' ' TYR . 29.3 t -64.42 -11.09 29.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -1.154 . . . . 0.0 109.792 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -89.67 -27.35 20.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.48 ' N ' HD23 ' F' ' 11' ' ' LEU . 5.9 mt -75.12 -50.06 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.247 -0.908 . . . . 0.0 109.412 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.6 -38.68 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.371 -0.83 . . . . 0.0 109.512 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -63.73 -38.64 91.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.338 -0.851 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.464 ' CB ' ' H3 ' ' F' ' 32' ' ' IPH . . . -95.69 20.74 9.3 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.079 -1.013 . . . . 0.0 109.899 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.703 HD11 HD13 ' E' ' 2' ' ' ILE . 0.9 OUTLIER -108.7 -54.42 2.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 0.0 109.533 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.518 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 16.1 p90 -66.31 -21.82 66.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.451 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.8 HD13 ' NE2' ' H' ' 5' ' ' HIS . 16.2 tp -76.6 -37.13 56.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.769 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.16 -74.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.18 -0.95 . . . . 0.0 109.817 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -30.16 1.67 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 109.921 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.34 -136.55 14.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -54.66 -27.14 37.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -1.157 . . . . 0.0 109.415 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.2 133.68 55.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.172 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' F' ' 24' ' ' PHE . . . -77.56 -158.08 9.71 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 26.7 p90 179.22 177.34 0.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -1.159 . . . . 0.0 109.385 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -136.43 149.56 48.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -129.49 122.13 28.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.373 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 49.8 m -139.89 109.46 7.13 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.243 -0.911 . . . . 0.0 109.415 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -76.17 76.33 3.88 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.193 1.929 . . . . 0.0 109.742 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' F' ' 30' ' ' THR . 0.2 OUTLIER -157.9 152.7 25.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' F' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.09 -1.006 . . . . 0.0 109.606 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' H' ' 15' ' ' LEU . 59.7 mt -89.11 -24.23 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -1.18 . . . . 0.0 108.996 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.31 -32.88 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.81 44.21 1.16 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.326 -0.859 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' G' ' 9' ' ' SER . 12.4 tt0 -158.64 -39.32 0.06 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' G' ' 9' ' ' SER . 9.2 m -97.58 -28.75 13.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.502 -0.749 . . . . 0.0 109.126 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 t -78.98 -28.55 43.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.284 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.3 p -92.84 -19.75 21.39 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.346 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.433 ' O ' ' O ' ' G' ' 5' ' ' GLN . 0.8 OUTLIER -165.04 142.75 6.14 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.383 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.72 101.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.637 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 30.4 m -50.89 145.98 6.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.273 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 179.71 3.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.263 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -32.73 65.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 109.853 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.78 73.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -69.79 -24.26 63.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 0.0 109.761 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -85.84 -23.56 27.08 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.112 -0.993 . . . . 0.0 109.923 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -101.68 36.89 1.94 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 0.0 109.625 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . 0.602 ' OD1' ' CD2' ' G' ' 19' ' ' TYR . 24.0 p-10 -114.1 -22.05 10.22 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.602 ' CD2' ' OD1' ' G' ' 18' ' ' ASN . 0.2 OUTLIER -130.71 55.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 109.622 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 4.7 t -116.13 153.38 31.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.989 . . . . 0.0 109.85 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.384 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.14 -7.94 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.338 -0.851 . . . . 0.0 109.318 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' H' ' 7' ' ' CYS . 6.4 m-20 -58.03 -37.86 75.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.049 -1.032 . . . . 0.0 109.353 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -49.15 -34.14 13.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . 0.8 ' NE2' HD13 ' F' ' 17' ' ' LEU . 9.9 t60 -89.44 -31.34 17.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.342 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' L' ' 10' ' ' HIS . 16.9 mt -94.78 -68.62 0.79 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.3 -0.875 . . . . 0.0 109.332 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' H' ' 3' ' ' ASN . 20.4 t -45.47 -33.27 2.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.357 -0.84 . . . . 0.0 109.961 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.62 45.73 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' F' ' 16' ' ' TYR . 47.8 t -64.36 -11.2 30.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -1.107 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -90.39 -26.19 20.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' G' ' 6' ' ' CYS . 7.8 mt -76.85 -45.36 28.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.573 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.407 HG22 ' H ' ' H' ' 12' ' ' VAL . 6.8 m -57.51 -37.37 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -64.6 -36.45 84.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.709 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.479 ' CB ' ' H3 ' ' H' ' 32' ' ' IPH . . . -97.59 18.4 15.58 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 0.0 109.798 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' G' ' 2' ' ' ILE . 1.2 mt -106.51 -55.36 2.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 16.3 p90 -66.04 -20.06 66.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.697 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 17' ' ' LEU . 21.9 tp -78.65 -37.77 41.19 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.129 -0.982 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' H' ' 19' ' ' CYS . 99.0 t -62.2 -74.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.748 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' H' ' 18' ' ' VAL . 0.0 OUTLIER -44.46 -31.17 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 109.722 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.58 -138.84 16.06 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.5 -28.15 29.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.82 135.51 51.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.533 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.55 -160.13 22.26 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 25.4 p90 -177.16 -172.2 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.099 -1.236 . . . . 0.0 109.2 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.68 152.61 39.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.0 109.7 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -133.14 119.04 19.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.93 . . . . 0.0 109.793 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 92.8 m -139.13 104.4 7.29 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.15 81.54 2.69 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.553 2.169 . . . . 0.0 110.518 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' H' ' 30' ' ' THR . 1.5 tptp -141.46 -95.7 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . 0.482 ' N ' ' HG3' ' H' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 109.526 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.722 HD13 HD11 ' J' ' 15' ' ' LEU . 51.9 mt -86.97 -27.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.396 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.15 -34.77 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.071 -1.018 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -106.95 45.86 0.96 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.587 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' I' ' 9' ' ' SER . 11.0 tt0 -159.97 -37.61 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.392 -0.817 . . . . 0.0 109.126 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' I' ' 9' ' ' SER . 1.7 m -100.03 -28.92 12.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.174 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.8 t -78.49 -26.22 45.9 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.163 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 5.5 p -96.17 -20.51 18.55 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.314 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' I' ' 6' ' ' CYS . 0.0 OUTLIER -163.63 141.18 7.38 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.898 . . . . 0.0 109.619 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.545 HG13 HG23 ' B' ' 2' ' ' VAL . 2.7 mp -60.13 98.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 18.2 m -48.52 148.09 2.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 108.924 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . 0.449 ' O ' HD12 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -73.6 -174.98 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 0.0 109.498 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.99 -32.01 56.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -72.96 -35.73 67.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.63 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' I' ' 18' ' ' ASN . 75.8 mt-30 -70.61 -23.84 62.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.266 -0.896 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . 0.449 HD12 ' O ' ' I' ' 12' ' ' SER . 14.7 mt -87.11 -26.33 23.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.184 -0.947 . . . . 0.0 109.71 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.78 37.85 1.35 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . 0.528 ' OD1' ' CD2' ' I' ' 19' ' ' TYR . 21.5 p-10 -116.68 -21.34 9.14 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.269 -0.894 . . . . 0.0 109.488 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.528 ' CD2' ' OD1' ' I' ' 18' ' ' ASN . 0.1 OUTLIER -131.2 51.73 2.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.64 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.13 156.4 21.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.265 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.447 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.437 ' O ' HG22 ' J' ' 2' ' ' VAL . 14.4 p -70.18 -8.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.793 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' J' ' 7' ' ' CYS . 9.2 m-20 -59.18 -36.63 75.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.94 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -50.22 -32.76 17.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -0.988 . . . . 0.0 109.426 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -90.52 -30.88 17.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.947 . . . . 0.0 109.504 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 mt -95.48 -67.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.631 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' J' ' 3' ' ' ASN . 11.8 t -47.69 -31.56 4.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.58 -39.98 48.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -67.02 -13.47 61.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -1.216 . . . . 0.0 109.672 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -87.16 -29.23 21.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.133 -0.979 . . . . 0.0 109.792 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.41 ' N ' HD23 ' J' ' 11' ' ' LEU . 8.2 mt -72.8 -46.96 50.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.828 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.42 ' H ' HG22 ' J' ' 12' ' ' VAL . 5.3 m -56.37 -39.42 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -62.06 -38.45 88.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.686 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.482 ' CB ' ' H3 ' ' J' ' 32' ' ' IPH . . . -96.39 20.78 10.0 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.182 -0.949 . . . . 0.0 110.088 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.722 HD11 HD13 ' I' ' 2' ' ' ILE . 1.2 mt -109.39 -50.83 2.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.674 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.604 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 14.4 p90 -70.78 -18.93 62.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.492 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.669 HD23 HD23 ' D' ' 17' ' ' LEU . 15.7 tp -79.98 -34.2 38.83 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 0.0 109.454 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.17 -73.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 109.572 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.47 -31.25 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -134.98 12.85 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.24 -28.31 58.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.97 134.99 52.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.607 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.96 -162.14 18.36 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 27.3 p90 -178.09 179.53 0.82 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.344 -1.092 . . . . 0.0 109.151 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.1 157.03 47.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 0.0 110.277 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -137.01 123.76 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.627 -0.67 . . . . 0.0 109.297 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -144.26 103.37 4.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.381 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.0 82.14 2.42 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.473 2.116 . . . . 0.0 110.587 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' J' ' 30' ' ' THR . 0.9 OUTLIER -142.7 -95.66 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . 0.473 ' N ' ' HG3' ' J' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.04 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.663 HD13 HD11 ' L' ' 15' ' ' LEU . 47.9 mt -89.72 -24.36 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.67 -32.0 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -109.76 43.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.36 -0.838 . . . . 0.0 109.434 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' K' ' 9' ' ' SER . 13.4 tt0 -157.7 -36.38 0.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.529 -0.732 . . . . 0.0 109.141 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 4.2 m -101.44 -27.8 12.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 109.309 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 24.9 t -79.72 -27.29 40.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 0.0 109.253 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -92.96 -25.23 18.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.403 ' O ' ' O ' ' K' ' 5' ' ' GLN . 0.7 OUTLIER -159.58 140.96 12.85 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.27 -0.894 . . . . 0.0 109.605 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.68 99.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.611 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 23.2 m -49.85 146.39 4.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 0.0 109.666 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . 0.401 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -70.81 -175.97 1.22 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.152 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.89 -34.74 57.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -39.44 80.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . 0.47 ' O ' ' CZ ' ' K' ' 19' ' ' TYR . 68.6 mt-30 -66.8 -24.08 66.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.294 -0.879 . . . . 0.0 109.842 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . 0.401 HD12 ' O ' ' K' ' 12' ' ' SER . 16.7 mt -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 109.969 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -101.44 40.25 1.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . 0.555 ' OD1' ' CD2' ' K' ' 19' ' ' TYR . 19.4 p-10 -119.03 -19.32 8.51 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.283 -0.886 . . . . 0.0 109.592 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.555 ' CD2' ' OD1' ' K' ' 18' ' ' ASN . 0.1 OUTLIER -133.48 48.74 2.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.216 -0.928 . . . . 0.0 109.829 -179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 9.5 t -108.95 158.03 18.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.282 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.513 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.285 0.564 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.413 HG23 HG13 ' C' ' 10' ' ' ILE . 14.2 p -74.15 -7.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 109.71 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' L' ' 7' ' ' CYS . 8.5 m-20 -58.42 -37.7 75.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.272 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -49.86 -31.44 12.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.84 . . . . 0.0 109.881 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . 0.44 ' CE1' HD13 ' J' ' 17' ' ' LEU . 8.4 t60 -92.63 -29.11 16.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.15 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.45 HD22 ' CG ' ' D' ' 10' ' ' HIS . 14.9 mt -97.19 -68.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.471 ' N ' ' O ' ' L' ' 3' ' ' ASN . 24.9 t -46.59 -32.96 3.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.848 . . . . 0.0 109.517 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.33 -40.56 48.49 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -67.07 -12.78 60.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -1.145 . . . . 0.0 109.639 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.478 ' CG ' HD22 ' H' ' 6' ' ' LEU . 4.4 m-70 -86.77 -29.71 22.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.466 HD23 ' N ' ' L' ' 11' ' ' LEU . 6.1 mt -72.37 -49.96 30.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.591 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . . . . . . . . . 8.6 m -52.9 -38.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 109.921 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -36.18 83.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.039 -1.038 . . . . 0.0 109.811 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 20.32 12.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.663 HD11 HD13 ' K' ' 2' ' ' ILE . 1.1 mt -108.42 -53.19 2.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 16.5 p90 -69.04 -16.7 63.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.522 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 15.9 tp -82.06 -34.23 29.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.3 -0.875 . . . . 0.0 109.475 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.16 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -30.0 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.685 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.72 -138.61 17.06 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -53.53 -25.52 17.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -1.128 . . . . 0.0 109.612 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 137.0 58.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.65 -162.81 32.34 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.53 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 20.1 p90 -173.71 -172.25 0.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.458 -1.025 . . . . 0.0 109.065 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -144.63 153.4 41.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.055 -1.028 . . . . 0.0 109.361 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -133.82 121.94 22.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 88.8 m -141.23 103.94 6.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.603 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 82.04 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.485 2.123 . . . . 0.0 110.361 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' L' ' 30' ' ' THR . 0.8 OUTLIER -142.6 -95.52 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.868 . . . . 0.0 109.556 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' L' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.029 -1.045 . . . . 0.0 109.385 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.469 ' H3 ' ' CB ' ' B' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.408 ' H3 ' ' CB ' ' D' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.464 ' H3 ' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 32' ' ' IPH . . . . . 0.479 ' H3 ' ' CB ' ' H' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.482 ' H3 ' ' CB ' ' J' ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG23 HG23 ' A' ' 3' ' ' VAL . 14.1 tt -103.72 -29.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -1.139 . . . . 0.0 109.223 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 HG23 ' A' ' 2' ' ' ILE . 39.5 t -86.69 -12.36 10.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 109.589 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.94 34.4 1.24 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 6' ' ' CYS . 9.5 pt20 -171.23 -37.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.39 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 5' ' ' GLN . 60.6 m -86.44 -25.45 25.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.714 ' O ' HG11 ' F' ' 2' ' ' VAL . 41.9 t -79.22 -43.18 24.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.942 . . . . 0.0 109.408 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.1 t -80.07 -9.85 59.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -163.94 127.96 2.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.657 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 HG23 ' C6 ' ' B' ' 32' ' ' IPH . 3.4 mt -51.18 109.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 m -61.82 159.18 14.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.86 161.53 19.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.378 -0.826 . . . . 0.0 109.513 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.71 -32.05 65.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 109.535 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -72.93 -33.49 65.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.273 -0.892 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -74.58 -30.3 61.65 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.131 -0.981 . . . . 0.0 110.0 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -88.07 -10.16 51.06 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.117 -0.989 . . . . 0.0 109.876 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -88.29 -4.55 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.597 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' OD1' ' CD2' ' A' ' 19' ' ' TYR . 53.4 p30 -98.1 12.78 33.29 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CD2' ' OD1' ' A' ' 18' ' ' ASN . 37.5 m-85 -117.63 -15.82 10.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 23' ' ' GLY . 0.1 OUTLIER -74.9 156.97 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.051 -1.031 . . . . 0.0 109.436 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.544 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.599 ' O ' HG13 ' B' ' 2' ' ' VAL . 4.1 p -58.95 102.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.277 -0.889 . . . . 0.0 109.476 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' B' ' 2' ' ' VAL . 36.2 t30 175.54 -35.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.791 . . . . 0.0 109.014 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.42 -37.76 27.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.401 ' O ' ' OG ' ' B' ' 9' ' ' SER . 86.2 t60 -65.99 -27.92 68.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 0.0 109.281 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -95.72 -26.59 15.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.306 -0.871 . . . . 0.0 109.527 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 16.3 t -67.71 -36.01 79.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.784 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -75.45 -37.91 39.81 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 5' ' ' HIS . 0.9 OUTLIER -63.69 -17.19 62.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.235 -1.156 . . . . 0.0 109.365 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -88.36 -20.76 24.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.339 -0.851 . . . . 0.0 109.637 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 23.0 mt -97.18 9.1 43.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.908 . . . . 0.0 110.042 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.784 HG23 ' O ' ' B' ' 8' ' ' GLY . 1.9 t -102.79 -41.9 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.0 109.605 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.615 ' HA ' ' CE2' ' B' ' 16' ' ' TYR . 42.7 mt-10 -71.54 -35.8 70.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.47 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -89.11 11.55 18.22 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' B' ' 24' ' ' PHE . 0.6 OUTLIER -97.93 -57.75 2.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.847 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.615 ' CE2' ' HA ' ' B' ' 13' ' ' GLU . 6.7 p90 -64.11 -19.1 65.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.013 -1.054 . . . . 0.0 109.299 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 2.5 mt -73.94 -32.48 63.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.221 -0.924 . . . . 0.0 109.191 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 14' ' ' ALA . 59.9 t -68.65 -46.79 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.261 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -88.57 -76.86 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' B' ' 21' ' ' GLU . . . 104.15 -124.31 8.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 20' ' ' GLY . 0.0 OUTLIER -40.0 -52.46 2.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.518 -0.989 . . . . 0.0 110.137 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' B' ' 21' ' ' GLU . 0.6 OUTLIER -44.92 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 109.522 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.435 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 117.5 -172.65 14.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.665 ' CE2' HD13 ' B' ' 15' ' ' LEU . 2.2 p90 -171.68 175.27 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -1.166 . . . . 0.0 109.39 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -123.17 150.17 43.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.263 -0.898 . . . . 0.0 109.285 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -129.35 108.26 10.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 109.572 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 75.9 p -134.64 85.81 35.67 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.994 . . . . 0.0 109.292 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 92.05 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.51 2.14 . . . . 0.0 110.311 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -164.11 99.34 0.85 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.628 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.413 HG23 HG23 ' C' ' 3' ' ' VAL . 16.3 tt -102.73 -31.95 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.297 -1.12 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.413 HG23 HG23 ' C' ' 2' ' ' ILE . 43.0 t -84.33 -12.87 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.251 -0.906 . . . . 0.0 109.635 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.26 33.15 1.24 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.164 -0.96 . . . . 0.0 109.865 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -169.94 -36.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.764 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 55.8 m -87.13 -24.84 24.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.998 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 49.1 t -79.85 -39.8 29.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -82.58 -12.29 57.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.39 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -161.41 132.25 5.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.468 -0.77 . . . . 0.0 108.952 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.649 HG23 ' C6 ' ' D' ' 32' ' ' IPH . 3.3 mt -54.86 111.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 109.353 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -61.83 162.48 8.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 0.0 109.298 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.84 159.09 17.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' C' ' 17' ' ' GLU . 1.9 tt -54.13 -29.95 47.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.007 . . . . 0.0 109.617 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -74.94 -35.69 62.13 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.117 -0.99 . . . . 0.0 109.575 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -72.48 -29.68 63.86 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.5 -12.98 41.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.08 -1.012 . . . . 0.0 109.887 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' C' ' 13' ' ' LEU . 4.9 tt0 -83.84 -9.78 58.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.966 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 p30 -93.46 9.87 34.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.16 -0.962 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -113.89 -12.68 12.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.032 . . . . 0.0 109.855 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' D' ' 23' ' ' GLY . 0.1 OUTLIER -76.77 160.41 29.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.083 -1.01 . . . . 0.0 109.38 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.512 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.589 ' O ' HG13 ' D' ' 2' ' ' VAL . 3.4 p -56.45 99.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' D' ' 2' ' ' VAL . 39.6 t30 178.44 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.8 -37.2 24.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.402 ' O ' ' OG ' ' D' ' 9' ' ' SER . 86.4 t60 -67.42 -25.14 65.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.495 -0.753 . . . . 0.0 109.661 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mt -97.36 -29.23 13.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.111 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 35.3 t -65.15 -37.78 88.49 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.418 -0.801 . . . . 0.0 109.658 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.785 ' O ' HG23 ' D' ' 12' ' ' VAL . . . -74.22 -37.57 48.32 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' D' ' 5' ' ' HIS . 0.8 OUTLIER -63.06 -19.48 64.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -1.093 . . . . 0.0 109.366 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -86.54 -21.65 26.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 110.009 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' D' ' 7' ' ' CYS . 21.8 mt -95.8 7.5 46.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 110.035 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.785 HG23 ' O ' ' D' ' 8' ' ' GLY . 2.0 t -101.4 -44.48 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.032 -1.042 . . . . 0.0 109.429 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' D' ' 16' ' ' TYR . 51.7 mt-10 -66.55 -38.57 87.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.742 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -90.56 15.91 9.98 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.721 HD13 ' CE2' ' D' ' 24' ' ' PHE . 0.5 OUTLIER -99.23 -58.3 1.97 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.254 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' D' ' 13' ' ' GLU . 8.5 p90 -63.83 -19.03 64.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.208 -0.933 . . . . 0.0 109.407 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' D' ' 16' ' ' TYR . 2.6 mt -73.93 -31.59 63.13 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.353 -0.842 . . . . 0.0 109.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 14' ' ' ALA . 60.7 t -69.39 -44.86 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.301 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -91.39 -76.23 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 109.244 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' D' ' 21' ' ' GLU . . . 104.12 -124.41 8.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' D' ' 20' ' ' GLY . 0.0 OUTLIER -37.93 -55.96 1.17 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.813 -0.816 . . . . 0.0 110.13 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' D' ' 21' ' ' GLU . 0.4 OUTLIER -41.94 -76.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.765 . . . . 0.0 109.587 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' C' ' 20' ' ' CYS . . . 117.04 -170.59 13.48 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.721 ' CE2' HD13 ' D' ' 15' ' ' LEU . 2.5 p90 -173.72 175.25 2.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.355 -1.085 . . . . 0.0 109.178 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -123.93 151.19 43.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 109.366 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -129.25 107.95 9.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.412 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 18.8 p -134.19 84.95 40.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.16 -0.963 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.69 93.43 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.692 2.261 . . . . 0.0 110.072 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -164.29 100.1 0.83 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.611 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.404 HG23 HG23 ' E' ' 3' ' ' VAL . 17.1 tt -109.82 -30.71 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -1.179 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.404 HG23 HG23 ' E' ' 2' ' ' ILE . 37.2 t -85.75 -13.35 11.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.287 -0.883 . . . . 0.0 109.596 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -92.63 30.98 1.42 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.262 -0.898 . . . . 0.0 109.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -167.5 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.178 -0.951 . . . . 0.0 109.59 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -86.19 -26.55 25.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 44.6 t -78.08 -44.03 27.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.535 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 6.7 t -76.55 -13.77 60.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 11.3 m -162.24 132.43 4.73 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.162 -0.961 . . . . 0.0 109.505 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.515 HG23 ' C6 ' ' F' ' 32' ' ' IPH . 3.5 mt -52.5 110.63 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.085 -1.009 . . . . 0.0 109.597 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.6 m -61.85 159.93 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 109.404 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.98 160.47 18.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' E' ' 17' ' ' GLU . 2.5 tt -56.81 -29.62 62.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -0.98 . . . . 0.0 109.412 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -74.22 -33.45 63.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -75.2 -29.42 60.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -0.972 . . . . 0.0 109.76 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.0 -9.92 49.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' E' ' 13' ' ' LEU . 5.9 tt0 -87.92 -7.01 57.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' E' ' 18' ' ' ASN . 46.2 p30 -97.39 12.95 31.4 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -116.68 -13.82 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.09 157.84 29.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.103 -0.998 . . . . 0.0 109.618 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.542 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.205 0.526 . . . . 0.0 109.646 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 7' ' ' CYS . 4.6 p -58.89 101.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' F' ' 2' ' ' VAL . 40.5 t30 177.05 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.312 -0.868 . . . . 0.0 109.235 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.08 -35.37 25.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.292 -0.88 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . 0.433 ' O ' ' OG ' ' F' ' 9' ' ' SER . 86.4 t60 -68.23 -27.59 66.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 109.402 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.629 HD21 ' H5 ' ' B' ' 32' ' ' IPH . 5.7 mt -95.05 -28.5 15.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 34.6 t -65.9 -36.97 84.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.739 ' O ' HG23 ' F' ' 12' ' ' VAL . . . -75.1 -36.49 45.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' F' ' 5' ' ' HIS . 0.9 OUTLIER -66.15 -14.96 62.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.301 -1.117 . . . . 0.0 109.49 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -90.79 -19.44 23.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.169 -0.957 . . . . 0.0 109.283 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.474 ' O ' HD12 ' F' ' 15' ' ' LEU . 26.3 mt -97.29 8.59 44.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.36 -0.838 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.739 HG23 ' O ' ' F' ' 8' ' ' GLY . 1.7 t -102.45 -43.45 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.572 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.597 ' HA ' ' CE2' ' F' ' 16' ' ' TYR . 42.5 mt-10 -69.28 -37.5 77.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.411 ' HB2' HD11 ' L' ' 17' ' ' LEU . . . -89.82 16.64 7.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.283 -0.886 . . . . 0.0 109.605 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.632 HD13 ' CE2' ' F' ' 24' ' ' PHE . 0.5 OUTLIER -102.12 -56.25 2.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.186 -0.946 . . . . 0.0 109.519 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' F' ' 13' ' ' GLU . 6.2 p90 -65.44 -19.39 65.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.024 -1.047 . . . . 0.0 109.028 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' F' ' 16' ' ' TYR . 2.3 mt -74.18 -30.39 62.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.416 -0.802 . . . . 0.0 109.514 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.1 -44.3 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 108.964 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.79 -75.66 0.46 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.327 -0.858 . . . . 0.0 109.321 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' F' ' 21' ' ' GLU . . . 102.97 -123.0 7.69 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' F' ' 22' ' ' ARG . 0.0 OUTLIER -40.45 -56.07 2.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.455 -1.027 . . . . 0.0 109.921 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.453 ' C ' ' O ' ' F' ' 21' ' ' GLU . 0.3 OUTLIER -40.26 -74.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.417 -0.802 . . . . 0.0 109.756 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.03 -168.68 12.62 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.632 ' CE2' HD13 ' F' ' 15' ' ' LEU . 3.6 p90 -177.1 174.04 1.73 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.253 . . . . 0.0 109.946 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' F' ' 25' ' ' PHE . 39.1 p90 -122.56 147.45 46.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.753 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.49 109.39 12.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.06 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 61.1 p -135.47 84.28 34.87 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 109.609 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.4 92.57 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.614 2.209 . . . . 0.0 110.626 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -162.7 98.99 1.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.446 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' G' ' 3' ' ' VAL . 15.9 tt -103.84 -30.57 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -1.11 . . . . 0.0 109.175 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' G' ' 2' ' ' ILE . 39.9 t -86.21 -15.0 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.116 -0.99 . . . . 0.0 109.638 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -90.77 30.49 1.17 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.241 -0.912 . . . . 0.0 109.92 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -167.24 -36.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.053 -1.029 . . . . 0.0 109.567 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.19 -26.37 25.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 45.2 t -77.03 -47.0 21.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.111 -0.993 . . . . 0.0 109.289 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -75.65 -12.18 60.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.751 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -163.26 129.54 3.29 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.04 -1.037 . . . . 0.0 109.863 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.562 HG23 ' C6 ' ' H' ' 32' ' ' IPH . 3.3 mt -51.59 106.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.796 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 12.9 m -59.07 161.2 5.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.282 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.26 164.21 16.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.014 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' G' ' 17' ' ' GLU . 3.7 tt -60.1 -25.3 65.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.949 . . . . 0.0 109.873 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -79.34 -30.74 42.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -76.45 -30.49 57.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.44 -10.09 52.86 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.161 -0.962 . . . . 0.0 109.76 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' G' ' 13' ' ' LEU . 4.4 tt0 -88.21 -8.12 55.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.882 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' G' ' 18' ' ' ASN . 48.4 p30 -94.86 11.75 30.54 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -116.29 -16.61 10.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 158.98 32.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.165 -0.96 . . . . 0.0 109.328 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.293 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.572 ' O ' HG13 ' H' ' 2' ' ' VAL . 3.3 p -60.9 102.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.913 . . . . 0.0 109.219 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' H' ' 2' ' ' VAL . 35.8 t30 175.48 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.163 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -83.11 -36.54 24.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 0.0 109.14 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.95 -29.32 69.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 0.0 109.219 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mt -93.31 -29.64 15.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.398 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.435 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 25.1 t -65.05 -38.23 90.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.163 -0.961 . . . . 0.0 109.738 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.753 ' O ' HG23 ' H' ' 12' ' ' VAL . . . -74.04 -36.71 51.11 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.35 -16.39 64.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -1.137 . . . . 0.0 109.471 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -88.29 -20.5 25.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.259 -0.901 . . . . 0.0 109.306 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 24.7 mt -96.33 8.25 44.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.71 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.753 HG23 ' O ' ' H' ' 8' ' ' GLY . 1.9 t -102.27 -43.88 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.797 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.576 ' HA ' ' CE2' ' H' ' 16' ' ' TYR . 45.2 mt-10 -68.64 -36.66 78.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.439 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -89.94 12.67 16.77 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.672 HD13 ' CE2' ' H' ' 24' ' ' PHE . 0.5 OUTLIER -97.38 -59.24 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 109.73 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' HA ' ' H' ' 13' ' ' GLU . 7.6 p90 -61.96 -19.45 62.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.066 -1.021 . . . . 0.0 109.504 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' H' ' 16' ' ' TYR . 2.5 mt -74.45 -31.03 62.12 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.439 HG23 ' O ' ' H' ' 14' ' ' ALA . 60.3 t -69.39 -44.98 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.199 -0.938 . . . . 0.0 109.069 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.18 -75.48 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.58 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' H' ' 21' ' ' GLU . . . 104.42 -125.86 8.52 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' H' ' 22' ' ' ARG . 0.0 OUTLIER -39.66 -54.64 2.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.969 . . . . 0.0 110.126 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' H' ' 21' ' ' GLU . 0.4 OUTLIER -41.51 -72.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.883 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.85 -175.93 18.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.672 ' CE2' HD13 ' H' ' 15' ' ' LEU . 2.1 p90 -167.0 179.47 5.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -1.145 . . . . 0.0 109.28 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -126.37 146.89 49.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.576 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.36 112.9 16.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.948 . . . . 0.0 109.67 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -140.08 83.67 15.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.197 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.39 94.24 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.542 2.162 . . . . 0.0 110.111 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -164.83 100.54 0.78 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.857 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.452 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.436 HG23 HG23 ' I' ' 3' ' ' VAL . 16.8 tt -101.82 -29.5 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -1.061 . . . . 0.0 109.412 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.436 HG23 HG23 ' I' ' 2' ' ' ILE . 48.0 t -86.7 -13.8 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.217 -0.927 . . . . 0.0 109.835 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.39 31.75 1.12 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.139 -0.975 . . . . 0.0 109.728 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . 0.448 ' HG3' ' N ' ' I' ' 6' ' ' CYS . 9.5 pt20 -168.43 -41.04 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.148 -0.97 . . . . 0.0 109.599 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . 0.448 ' N ' ' HG3' ' I' ' 5' ' ' GLN . 57.8 m -82.0 -23.92 35.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.614 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.68 -45.08 17.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.348 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 4.8 t -77.44 -12.28 59.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.425 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.3 m -161.48 132.06 5.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.59 HG23 ' C6 ' ' J' ' 32' ' ' IPH . 3.4 mt -54.82 108.64 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.212 -0.93 . . . . 0.0 109.542 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 7.4 m -59.59 160.15 7.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.831 . . . . 0.0 109.831 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.56 158.56 20.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.456 -0.778 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' I' ' 17' ' ' GLU . 4.2 tt -55.37 -29.15 57.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.053 -1.029 . . . . 0.0 109.25 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -74.85 -34.66 62.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 109.791 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -73.24 -31.91 64.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.945 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 mt -86.36 -9.15 56.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.806 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' I' ' 13' ' ' LEU . 5.8 tt0 -89.71 -6.98 55.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.844 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . 0.41 ' C ' ' OD1' ' I' ' 18' ' ' ASN . 47.8 p30 -95.91 8.88 42.42 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.158 -0.964 . . . . 0.0 109.314 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.6 -12.03 12.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.65 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -77.33 157.98 30.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.59 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.573 ' O ' HG13 ' J' ' 2' ' ' VAL . 3.3 p -58.39 101.68 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.459 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' J' ' 2' ' ' VAL . 31.3 t30 175.63 -33.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.274 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -83.32 -37.84 22.88 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.253 -0.905 . . . . 0.0 109.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -67.71 -19.01 65.11 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.347 -0.846 . . . . 0.0 109.227 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -102.64 -29.23 11.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 109.08 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.481 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 14.4 t -67.39 -31.38 71.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.748 ' O ' HG23 ' J' ' 12' ' ' VAL . . . -77.67 -39.6 24.71 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 3.0 m -63.86 -16.34 61.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.348 -1.089 . . . . 0.0 109.767 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -88.79 -20.92 24.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.439 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' J' ' 7' ' ' CYS . 26.8 mt -95.58 7.99 44.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 0.0 109.618 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.748 HG23 ' O ' ' J' ' 8' ' ' GLY . 1.8 t -102.52 -44.6 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 0.0 109.447 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.598 ' HA ' ' CE2' ' J' ' 16' ' ' TYR . 49.1 mt-10 -67.65 -36.82 81.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.254 -0.904 . . . . 0.0 109.515 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.449 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -90.64 14.92 12.02 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.356 -0.84 . . . . 0.0 109.742 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.661 HD13 ' CE2' ' J' ' 24' ' ' PHE . 0.6 OUTLIER -99.91 -58.1 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.165 -0.96 . . . . 0.0 109.641 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' J' ' 13' ' ' GLU . 7.3 p90 -64.96 -18.28 65.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.346 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' J' ' 16' ' ' TYR . 2.2 mt -75.79 -31.06 59.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.31 -0.869 . . . . 0.0 108.892 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' J' ' 14' ' ' ALA . 62.9 t -73.76 -34.48 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 109.989 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.54 -58.93 1.79 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.128 -0.983 . . . . 0.0 110.092 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' J' ' 22' ' ' ARG . . . 74.74 -171.63 53.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' J' ' 20' ' ' GLY . 0.0 OUTLIER 16.91 -79.7 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 CA-C-N 117.756 0.778 . . . . 0.0 111.825 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' J' ' 20' ' ' GLY . 0.9 OUTLIER -30.59 -73.72 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.197 0.522 . . . . 0.0 110.39 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.01 -177.35 18.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.661 ' CE2' HD13 ' J' ' 15' ' ' LEU . 2.0 p90 -164.91 176.69 8.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.341 -1.094 . . . . 0.0 109.06 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' J' ' 25' ' ' PHE . 38.2 p90 -124.15 149.18 46.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.256 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -128.17 110.54 12.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p -136.82 85.82 22.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.512 -0.742 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.46 92.25 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.726 2.284 . . . . 0.0 110.462 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.61 99.31 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.286 -0.884 . . . . 0.0 109.41 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.447 HG23 HG23 ' K' ' 3' ' ' VAL . 13.9 tt -105.99 -28.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -1.162 . . . . 0.0 109.449 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.447 HG23 HG23 ' K' ' 2' ' ' ILE . 45.5 t -87.2 -15.11 9.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.251 -0.905 . . . . 0.0 109.213 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.3 32.53 0.93 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.386 -0.821 . . . . 0.0 110.075 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -169.58 -36.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 109.643 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' K' ' 9' ' ' SER . 40.1 m -87.32 -23.5 24.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.434 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 42.5 t -80.44 -43.59 20.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.244 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -79.21 -11.62 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' K' ' 6' ' ' CYS . 0.7 OUTLIER -163.52 128.01 2.89 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.224 -0.923 . . . . 0.0 109.674 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.463 HG23 ' C6 ' ' L' ' 32' ' ' IPH . 3.4 mt -50.6 107.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.707 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 16.8 m -59.88 163.3 4.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.068 -1.02 . . . . 0.0 109.207 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.06 162.17 15.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -0.986 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' K' ' 17' ' ' GLU . 1.8 tt -55.95 -30.11 61.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.87 . . . . 0.0 109.748 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -75.8 -32.97 60.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.975 . . . . 0.0 109.854 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -75.05 -28.19 60.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.953 . . . . 0.0 109.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 9.5 mt -89.95 -10.67 44.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.725 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' K' ' 13' ' ' LEU . 4.4 tt0 -87.72 -5.61 58.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -97.41 11.75 35.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.205 -0.935 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -115.86 -14.23 11.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.663 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.13 155.62 32.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 109.859 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.603 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.276 0.56 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.606 ' O ' HG13 ' L' ' 2' ' ' VAL . 3.3 p -59.84 100.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 109.12 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' L' ' 2' ' ' VAL . 36.5 t30 177.63 -35.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.213 -0.93 . . . . 0.0 109.241 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -81.31 -35.87 30.48 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.414 -0.804 . . . . 0.0 109.382 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -69.05 -23.12 64.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.383 -0.823 . . . . 0.0 109.461 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.21 -29.02 13.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 108.998 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.453 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 13.1 t -66.75 -36.22 81.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.481 -0.762 . . . . 0.0 109.209 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.75 ' O ' HG23 ' L' ' 12' ' ' VAL . . . -73.39 -39.12 51.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 26.7 m -64.98 -14.5 60.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -1.085 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -91.1 -19.18 23.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.464 ' O ' HD12 ' L' ' 15' ' ' LEU . 23.0 mt -98.47 10.74 40.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.75 HG23 ' O ' ' L' ' 8' ' ' GLY . 2.0 t -103.99 -44.26 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.599 ' HA ' ' CE2' ' L' ' 16' ' ' TYR . 45.4 mt-10 -69.29 -35.25 75.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.422 -0.799 . . . . 0.0 109.579 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.454 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -91.48 14.21 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' L' ' 24' ' ' PHE . 0.6 OUTLIER -99.63 -59.68 1.67 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' L' ' 13' ' ' GLU . 8.1 p90 -61.97 -21.77 65.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.06 -1.025 . . . . 0.0 109.117 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' L' ' 16' ' ' TYR . 2.2 mt -71.85 -31.83 66.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.225 -0.922 . . . . 0.0 109.447 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . 0.454 HG23 ' O ' ' L' ' 14' ' ' ALA . 58.8 t -70.13 -44.83 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.17 -77.67 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.216 -0.928 . . . . 0.0 109.194 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' L' ' 21' ' ' GLU . . . 105.73 -124.32 7.82 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' L' ' 22' ' ' ARG . 0.0 OUTLIER -39.96 -52.5 2.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.897 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' L' ' 21' ' ' GLU . 0.4 OUTLIER -44.43 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.333 -0.854 . . . . 0.0 109.357 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.77 -168.53 12.58 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.628 ' CE2' HD13 ' L' ' 15' ' ' LEU . 2.3 p90 -175.86 178.0 1.57 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.059 -1.259 . . . . 0.0 109.725 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 38.1 p90 -125.82 149.36 48.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.297 -0.877 . . . . 0.0 109.439 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -128.59 106.64 9.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.521 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -132.04 85.75 49.31 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.312 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.57 90.88 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 0.0 110.044 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -162.93 97.74 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.853 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.295 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.629 ' H5 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.649 ' C6 ' HG23 ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.515 ' C6 ' HG23 ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 32' ' ' IPH . . . . . 0.562 ' C6 ' HG23 ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.59 ' C6 ' HG23 ' I' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.463 ' C6 ' HG23 ' K' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 20.8 tt -100.91 -13.93 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -1.208 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.08 -53.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.715 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -88.67 18.28 4.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -120.41 -20.5 7.2 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.157 -0.964 . . . . 0.0 109.758 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.6 m -122.15 -24.0 5.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 t -86.11 -5.79 59.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 0.0 109.749 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -82.64 -21.52 35.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 10' ' ' ILE . 54.4 p -174.37 31.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.775 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.47 HG23 ' O1 ' ' B' ' 32' ' ' IPH . 2.4 mp 61.01 137.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.165 -0.959 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 m -94.79 -173.76 3.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.309 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.38 -175.89 2.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.177 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.79 -34.68 69.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.076 -1.015 . . . . 0.0 109.679 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 0.0 109.976 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.98 -43.11 99.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -68.89 -21.94 64.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.322 -0.861 . . . . 0.0 109.749 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.62 -38.9 90.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.103 -0.998 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.58 -30.69 63.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.886 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -99.07 56.11 1.03 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.521 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.1 t -154.81 121.9 5.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.334 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.553 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' B' ' 3' ' ' ASN . 38.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 2' ' ' VAL . 5.9 p -53.89 94.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.132 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' B' ' 1' ' ' PHE . 0.8 OUTLIER 175.84 -62.47 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.25 -0.906 . . . . 0.0 109.052 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.43 -30.89 68.92 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.253 -0.904 . . . . 0.0 109.096 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -70.26 -47.96 58.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.117 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.38 -23.1 62.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 108.945 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.76 -41.86 82.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.387 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' B' ' 11' ' ' LEU . . . -63.0 -27.44 70.41 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -67.51 -37.33 82.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -1.141 . . . . 0.0 109.277 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.527 ' CD2' HD13 ' F' ' 6' ' ' LEU . 65.6 m-70 -76.93 -17.02 59.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' B' ' 8' ' ' GLY . 87.7 mt -80.13 -55.46 4.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.512 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.436 HG22 ' O ' ' B' ' 8' ' ' GLY . 4.9 m -53.94 -31.54 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.684 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -68.58 -45.42 72.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.542 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.84 11.08 14.13 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.051 -1.03 . . . . 0.0 109.646 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.41 -57.71 2.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.191 -0.943 . . . . 0.0 109.558 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' B' ' 16' ' ' TYR . 9.8 p90 -64.8 -14.57 59.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.653 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.41 ' HG ' ' CE1' ' B' ' 16' ' ' TYR . 4.5 mt -80.55 -42.18 22.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.8 -39.07 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.283 -0.885 . . . . 0.0 109.46 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 72.1 m -80.12 -16.79 54.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.823 . . . . 0.0 109.732 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.44 -92.92 0.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -133.45 30.28 3.85 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.257 -1.143 . . . . 0.0 109.774 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -87.39 -40.97 13.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.573 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.19 149.21 18.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 21.3 p90 -150.85 -172.69 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -1.136 . . . . 0.0 109.365 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -135.13 152.34 51.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 109.649 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -134.26 105.53 6.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.409 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -141.01 115.14 7.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.513 -0.742 . . . . 0.0 109.462 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.09 78.88 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.386 2.057 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -132.95 160.81 36.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 109.717 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.517 -179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 21.1 tt -99.73 -15.06 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 t -69.02 -53.87 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.005 -1.059 . . . . 0.0 109.813 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.54 18.79 3.69 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -124.56 -10.99 7.36 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.91 . . . . 0.0 109.557 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.1 -23.51 3.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 13.2 t -92.11 -2.64 56.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.347 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -83.11 -23.7 32.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.317 -0.865 . . . . 0.0 109.318 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 52.6 p -174.06 31.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.479 HG23 ' O1 ' ' D' ' 32' ' ' IPH . 3.0 mt 60.79 148.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.963 . . . . 0.0 109.139 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . 0.616 ' SG ' HD21 ' C' ' 16' ' ' LEU . 0.1 OUTLIER -108.5 -175.6 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.097 -1.002 . . . . 0.0 109.571 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.12 -176.63 3.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.07 -30.69 65.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.596 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -78.07 -43.74 28.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.261 -0.899 . . . . 0.0 110.022 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -62.95 -41.21 99.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.855 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.616 HD21 ' SG ' ' C' ' 11' ' ' CYS . 39.9 mt -70.5 -23.38 62.65 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.67 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.23 -37.39 87.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.782 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.99 -31.36 66.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -98.32 58.67 1.3 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.142 -0.974 . . . . 0.0 109.46 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 53.4 t -158.88 120.37 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 109.849 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.344 179.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' D' ' 3' ' ' ASN . 37.7 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.265 0.555 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.676 ' O ' HG13 ' D' ' 2' ' ' VAL . 7.6 p -53.81 95.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 0.0 109.296 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' D' ' 1' ' ' PHE . 0.8 OUTLIER 176.17 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 108.995 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.08 -30.92 69.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.317 -0.864 . . . . 0.0 109.133 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -70.23 -47.35 61.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.39 -22.28 62.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 108.765 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -68.46 -43.84 76.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.44 -0.787 . . . . 0.0 109.537 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.608 ' HA2' HD12 ' D' ' 11' ' ' LEU . . . -60.73 -27.22 66.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 29.5 t -68.78 -36.38 78.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -1.12 . . . . 0.0 109.345 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -77.76 -14.63 59.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.49 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.608 HD12 ' HA2' ' D' ' 8' ' ' GLY . 82.2 mt -83.84 -54.42 4.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 109.626 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.478 HG22 ' O ' ' D' ' 8' ' ' GLY . 5.0 m -54.4 -32.96 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.06 -46.12 75.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.245 -0.909 . . . . 0.0 109.194 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.4 ' CB ' ' H5 ' ' D' ' 32' ' ' IPH . . . -86.79 14.29 7.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.868 . . . . 0.0 109.814 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.96 -55.08 2.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 13.9 p90 -66.7 -15.5 63.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.044 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' D' ' 17' ' ' LEU . 4.8 mt -79.02 -43.33 24.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.432 -0.793 . . . . 0.0 109.7 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 82.3 t -65.42 -41.4 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' D' ' 22' ' ' ARG . 81.0 m -77.26 -19.83 55.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.918 . . . . 0.0 109.534 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.14 -92.39 0.65 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -133.24 27.37 4.15 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.203 -1.175 . . . . 0.0 109.74 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' D' ' 19' ' ' CYS . 67.6 mtt-85 -84.25 -41.8 16.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.117 -0.99 . . . . 0.0 109.821 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.27 146.72 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -148.21 -172.86 4.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -1.192 . . . . 0.0 109.58 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -135.82 151.52 50.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.626 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -134.07 106.71 7.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.667 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.4 113.8 6.73 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.132 -0.98 . . . . 0.0 109.45 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.98 78.75 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.25 1.967 . . . . 0.0 110.165 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -132.62 162.64 30.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.78 -13.77 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -1.179 . . . . 0.0 109.524 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -70.16 -50.59 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.197 -0.939 . . . . 0.0 109.419 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -91.43 20.48 5.24 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.357 -0.839 . . . . 0.0 109.852 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -123.38 -17.78 6.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 96.2 m -125.1 -21.1 4.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.152 -0.967 . . . . 0.0 109.793 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.73 -4.39 57.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.0 109.182 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -83.95 -19.61 34.35 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 109.444 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 46.7 p -176.14 31.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.503 HG23 ' O1 ' ' F' ' 32' ' ' IPH . 2.6 mp 60.91 143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.21 -0.932 . . . . 0.0 109.324 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 m -100.95 -174.14 2.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.23 -176.99 3.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -32.74 65.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.243 -0.91 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -77.22 -44.95 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -61.32 -42.23 98.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.342 -0.848 . . . . 0.0 109.696 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 47.2 mt -69.77 -21.81 63.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.759 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.12 -35.47 79.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 109.735 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -59.97 -31.11 69.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.94 . . . . 0.0 109.592 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -99.23 60.14 1.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.193 -0.942 . . . . 0.0 109.219 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.99 120.88 2.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.38 -0.825 . . . . 0.0 109.278 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.545 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.652 ' O ' HG13 ' F' ' 2' ' ' VAL . 6.7 p -56.55 96.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 109.808 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 174.3 -60.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.181 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.17 -31.86 69.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.21 -0.932 . . . . 0.0 109.022 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -68.34 -50.1 55.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 108.924 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.527 HD13 ' CD2' ' B' ' 10' ' ' HIS . 16.8 mt -69.0 -22.99 64.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -66.64 -43.87 83.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 0.0 109.135 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' F' ' 11' ' ' LEU . . . -60.99 -28.97 69.66 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -66.15 -37.02 84.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -1.145 . . . . 0.0 109.363 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -78.17 -12.81 60.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.865 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' F' ' 8' ' ' GLY . 88.0 mt -85.17 -54.17 4.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.268 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.469 HG22 ' O ' ' F' ' 8' ' ' GLY . 3.7 m -54.75 -32.76 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -0.893 . . . . 0.0 109.252 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -67.25 -46.84 72.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.705 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.42 ' CB ' ' H5 ' ' F' ' 32' ' ' IPH . . . -86.39 11.27 12.74 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.174 -0.954 . . . . 0.0 109.858 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.9 -55.51 2.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 17.9 p90 -66.48 -16.66 64.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' F' ' 17' ' ' LEU . 4.8 mt -77.86 -39.89 41.92 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.268 -0.895 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.46 -40.45 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.895 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 -20.78 46.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.062 -1.024 . . . . 0.0 109.185 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.36 -89.44 0.81 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -136.72 33.99 2.68 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -91.0 -38.68 12.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.112 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.15 154.59 24.53 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -156.02 -173.53 4.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -1.141 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -135.07 154.95 51.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.996 . . . . 0.0 109.865 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -137.25 105.05 5.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 1.6 m -140.31 113.78 7.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.99 79.86 3.01 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.44 2.094 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -135.05 160.63 37.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.411 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.7 tt -101.14 -14.19 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 t -69.39 -53.11 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 109.272 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.97 22.18 2.83 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 110.052 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -124.84 -20.6 4.96 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.109 -0.994 . . . . 0.0 109.854 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 98.8 m -122.27 -22.29 5.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 109.604 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 t -89.54 -1.67 58.1 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.205 -0.934 . . . . 0.0 109.815 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -87.18 -19.3 28.63 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.106 -0.996 . . . . 0.0 109.164 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' G' ' 10' ' ' ILE . 27.5 p -176.05 31.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 109.4 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' G' ' 9' ' ' SER . 2.8 mt 61.86 143.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.893 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 5.5 m -99.26 -176.33 3.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.158 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.95 -174.87 2.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.34 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.94 -32.13 63.36 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.52 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -77.42 -44.79 27.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.009 . . . . 0.0 109.694 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -61.85 -41.86 98.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.29 -0.881 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 31.5 mt -70.31 -22.87 62.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.103 -0.998 . . . . 0.0 109.68 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.72 -37.46 87.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.948 . . . . 0.0 109.687 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -97.35 61.14 1.67 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.244 -0.91 . . . . 0.0 109.211 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.62 116.81 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 109.703 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 109.408 179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' H' ' 3' ' ' ASN . 34.1 m-85 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.625 ' O ' HG13 ' H' ' 2' ' ' VAL . 5.4 p -53.19 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -0.969 . . . . 0.0 109.476 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' H' ' 1' ' ' PHE . 0.9 OUTLIER 177.82 -62.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -0.905 . . . . 0.0 109.071 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -67.81 -32.49 73.08 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.294 -0.879 . . . . 0.0 109.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -68.12 -48.65 64.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.438 -0.789 . . . . 0.0 109.371 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.87 -23.95 63.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.348 -0.845 . . . . 0.0 108.846 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -44.17 83.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.645 -0.66 . . . . 0.0 109.274 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' H' ' 11' ' ' LEU . . . -61.53 -27.29 67.76 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 22.5 t -67.46 -38.09 83.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.345 -1.091 . . . . 0.0 109.205 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -76.22 -17.32 59.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.366 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.695 HD12 ' HA2' ' H' ' 8' ' ' GLY . 86.0 mt -80.17 -54.0 6.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.742 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.433 HG22 ' O ' ' H' ' 8' ' ' GLY . 5.5 m -56.68 -29.52 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.63 -44.19 71.14 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.224 -0.922 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' H5 ' ' H' ' 32' ' ' IPH . . . -88.9 10.72 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.62 -57.15 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -0.951 . . . . 0.0 109.759 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 12.8 p90 -64.56 -15.13 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.417 ' HG ' ' CE1' ' H' ' 16' ' ' TYR . 4.9 mt -79.8 -42.19 24.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.28 -40.35 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.534 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.33 -19.96 49.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.144 -0.973 . . . . 0.0 109.399 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.65 -93.24 0.63 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.66 29.84 4.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -87.07 -41.17 14.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.95 156.35 20.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.8 179.92 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -1.178 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -128.8 153.63 47.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 110.108 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.69 106.23 6.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.11 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 3.5 m -142.63 112.48 5.91 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.23 81.04 2.73 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.346 2.031 . . . . 0.0 110.377 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -135.39 161.14 36.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.381 -0.824 . . . . 0.0 109.14 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.074 -1.016 . . . . 0.0 109.502 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 20.2 tt -99.43 -13.45 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.175 -1.191 . . . . 0.0 109.834 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.77 -54.92 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.054 -1.029 . . . . 0.0 109.583 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -86.08 15.39 5.13 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.366 -0.834 . . . . 0.0 110.158 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -122.53 -10.1 8.42 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.044 -1.035 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -126.71 -27.0 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.906 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 14.5 t -90.12 -1.78 58.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.009 -1.057 . . . . 0.0 109.93 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 2.5 p -83.49 -18.23 39.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.098 -1.001 . . . . 0.0 109.453 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' I' ' 10' ' ' ILE . 40.0 p -178.55 31.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.523 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.476 HG23 ' O1 ' ' J' ' 32' ' ' IPH . 2.6 mt 60.83 147.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.242 -0.911 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' I' ' 16' ' ' LEU . 0.1 OUTLIER -107.46 -173.37 2.27 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.105 -0.997 . . . . 0.0 109.391 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.06 -175.14 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.771 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -33.8 66.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.267 -0.896 . . . . 0.0 109.484 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 -46.05 37.16 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.291 -0.881 . . . . 0.0 109.668 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -59.86 -45.02 93.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.761 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' I' ' 11' ' ' CYS . 29.7 mt -68.29 -20.1 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 110.076 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.5 -35.54 77.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.116 -0.99 . . . . 0.0 109.547 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -58.68 -32.61 69.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.288 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -97.48 62.68 1.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.361 -0.837 . . . . 0.0 109.199 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.66 119.74 1.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.206 -0.934 . . . . 0.0 109.501 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.68 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' J' ' 3' ' ' ASN . 40.1 m-85 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.661 ' O ' HG13 ' J' ' 2' ' ' VAL . 6.7 p -53.33 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 109.62 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' J' ' 1' ' ' PHE . 0.9 OUTLIER 178.41 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.836 . . . . 0.0 109.213 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -70.03 -31.19 68.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.308 -0.87 . . . . 0.0 109.036 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -68.32 -51.19 47.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.376 -0.827 . . . . 0.0 108.897 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 16.5 mt -67.01 -24.8 66.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.469 -0.769 . . . . 0.0 109.139 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 47.0 t -66.36 -43.74 85.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' J' ' 11' ' ' LEU . . . -60.42 -28.45 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 39.6 t -66.79 -38.59 86.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.596 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -76.05 -15.31 60.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.456 -0.777 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' J' ' 8' ' ' GLY . 96.5 mt -82.1 -55.86 4.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.415 HG22 ' O ' ' J' ' 8' ' ' GLY . 5.2 m -54.58 -31.09 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.285 -0.884 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -68.01 -46.2 71.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -0.827 . . . . 0.0 109.552 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.43 ' CB ' ' H5 ' ' J' ' 32' ' ' IPH . . . -88.02 13.74 10.46 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.275 -0.89 . . . . 0.0 109.622 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.0 -55.3 2.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 11.5 p90 -67.29 -14.84 63.29 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.26 -0.9 . . . . 0.0 109.239 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' J' ' 17' ' ' LEU . 4.2 mt -80.3 -37.97 31.65 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.371 -0.831 . . . . 0.0 109.632 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.6 -40.44 79.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.236 -0.915 . . . . 0.0 109.734 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -79.84 -18.74 50.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 109.145 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.41 -91.73 0.65 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -132.76 28.57 4.23 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.324 -1.104 . . . . 0.0 109.327 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -85.89 -42.67 13.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.27 -0.894 . . . . 0.0 109.597 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.2 155.06 14.78 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -159.79 177.3 10.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -1.152 . . . . 0.0 109.387 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -127.05 156.76 41.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.009 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -138.84 102.95 4.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.16 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 3.8 m -139.14 114.47 8.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 79.91 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.533 2.156 . . . . 0.0 110.431 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -133.7 162.22 32.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -0.903 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.979 . . . . 0.0 109.528 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -101.82 -15.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.237 -1.155 . . . . 0.0 109.434 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 t -68.19 -53.69 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -88.41 20.29 3.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 110.045 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -123.22 -19.1 6.09 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.074 -1.016 . . . . 0.0 109.777 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 95.1 m -123.19 -21.68 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.735 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -89.51 -4.51 57.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.165 -0.959 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 2.7 p -84.39 -18.21 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -0.997 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 51.8 p -177.36 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.586 HG23 ' O1 ' ' L' ' 32' ' ' IPH . 2.7 mt 62.09 141.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.368 -0.832 . . . . 0.0 109.905 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -98.45 -176.9 3.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 109.161 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . 0.481 ' O ' HD12 ' K' ' 16' ' ' LEU . 0.1 OUTLIER -112.4 -172.03 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.362 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -30.59 50.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.315 -0.865 . . . . 0.0 109.366 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -44.62 22.94 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 0.0 109.126 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -60.73 -44.59 96.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . 0.481 HD12 ' O ' ' K' ' 12' ' ' SER . 33.1 mt -68.46 -21.76 64.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.873 . . . . 0.0 110.033 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -66.05 -37.7 86.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.16 -0.962 . . . . 0.0 109.527 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -57.3 -31.34 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.935 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -98.37 55.77 1.13 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.056 -1.028 . . . . 0.0 109.661 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 52.0 t -155.36 120.83 4.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.037 -1.039 . . . . 0.0 109.41 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.961 -1.018 . . . . 0.0 109.539 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' L' ' 3' ' ' ASN . 41.3 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.668 ' O ' HG13 ' L' ' 2' ' ' VAL . 6.8 p -53.51 95.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 109.34 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' L' ' 1' ' ' PHE . 0.9 OUTLIER 175.15 -62.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -68.66 -34.06 75.05 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.235 -0.916 . . . . 0.0 108.826 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -65.83 -52.0 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.395 -0.816 . . . . 0.0 109.03 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 mt -66.53 -24.27 66.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 t -65.32 -45.24 85.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.455 -0.778 . . . . 0.0 109.452 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.665 ' HA2' HD12 ' L' ' 11' ' ' LEU . . . -60.18 -29.26 68.12 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -66.32 -36.71 83.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.161 -1.2 . . . . 0.0 109.397 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -77.36 -16.05 59.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.432 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.665 HD12 ' HA2' ' L' ' 8' ' ' GLY . 83.9 mt -82.1 -53.88 5.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.451 HG22 ' O ' ' L' ' 8' ' ' GLY . 5.3 m -56.2 -30.78 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 0.0 109.686 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -69.32 -43.16 74.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.474 ' CB ' ' H5 ' ' L' ' 32' ' ' IPH . . . -88.25 8.47 27.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.45 -57.67 2.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' L' ' 16' ' ' TYR . 11.3 p90 -64.24 -16.63 62.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.728 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' L' ' 17' ' ' LEU . 4.9 mt -78.05 -44.13 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.014 -1.054 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.3 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 109.843 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 75.7 m -79.59 -19.44 49.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 109.656 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.08 -92.56 0.65 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.71 31.4 3.36 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.283 -1.128 . . . . 0.0 109.57 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -87.67 -40.43 14.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.961 . . . . 0.0 109.596 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.24 148.16 15.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 22.3 p90 -151.97 -178.18 6.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -1.21 . . . . 0.0 109.465 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -129.86 158.13 40.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.749 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -141.42 102.09 4.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 0.0 109.528 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 6.3 m -138.4 114.44 8.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.243 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.67 79.82 3.11 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.355 2.037 . . . . 0.0 110.18 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -136.01 155.83 49.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.702 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.437 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . 0.47 ' O1 ' HG23 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.479 ' O1 ' HG23 ' C' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.503 ' O1 ' HG23 ' E' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 32' ' ' IPH . . . . . 0.434 ' O1 ' HG23 ' G' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 32' ' ' IPH . . . . . 0.476 ' O1 ' HG23 ' I' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.586 ' O1 ' HG23 ' K' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.0 tt -77.47 -18.99 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.41 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 28' ' ' PRO . 11.3 t -79.7 -22.59 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -108.67 48.13 0.87 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.1 -1.0 . . . . 0.0 109.864 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -173.0 -38.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.329 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.6 m -104.94 -29.82 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.564 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 53.6 t -66.99 -27.15 67.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -93.5 2.69 56.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.087 -1.008 . . . . 0.0 109.86 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.58 140.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.234 -0.916 . . . . 0.0 109.558 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 HD11 HG23 ' F' ' 2' ' ' VAL . 5.0 mt -61.32 116.73 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 109.423 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.9 m -75.59 -179.36 4.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.57 174.66 6.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.238 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -38.19 85.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.505 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -43.02 94.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.685 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -44.09 97.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.195 -0.941 . . . . 0.0 109.641 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 16' ' ' LEU . 78.1 mt -66.79 -21.11 66.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.217 -0.927 . . . . 0.0 109.6 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.44 -23.73 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -70.38 -8.52 51.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.669 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -115.46 24.1 11.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.482 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.0 137.72 51.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.862 . . . . 0.0 109.125 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.557 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' I' ' 9' ' ' SER . 6.3 p90 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.081 0.467 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.93 145.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -177.84 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.426 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.06 -29.47 49.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.255 -0.903 . . . . 0.0 109.348 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -71.19 -40.4 71.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.284 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' J' ' 10' ' ' HIS . 7.3 mt -83.14 -25.11 32.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.516 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 13.5 t -74.4 -26.15 59.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 0.0 110.093 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.59 -31.57 29.81 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 75.7 p -80.86 -14.73 57.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.583 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.14 -17.82 48.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 12' ' ' VAL . 13.9 mt -92.5 -49.45 6.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.478 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' B' ' 11' ' ' LEU . 3.9 m -43.65 -43.81 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.65 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -64.41 -44.32 91.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.526 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.19 19.85 4.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 109.568 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mt -106.73 -56.95 2.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.014 -1.054 . . . . 0.0 109.715 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -62.86 -21.74 66.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.306 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -42.79 67.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.598 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.63 -49.78 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 109.254 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -31.82 65.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.58 -110.64 3.46 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -124.68 28.47 6.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.333 -1.098 . . . . 0.0 109.274 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -87.86 -55.6 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.635 ' HA3' HG22 ' D' ' 27' ' ' THR . . . 134.51 158.47 8.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -162.55 163.53 27.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -1.117 . . . . 0.0 109.359 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -126.49 144.21 50.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -126.67 96.48 4.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.89 . . . . 0.0 109.644 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.42 108.14 13.4 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' B' ' 29' ' ' LYS . 35.0 Cg_endo -77.16 -173.07 1.63 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.158 1.906 . . . . 0.0 109.434 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' B' ' 28' ' ' PRO . 0.0 OUTLIER 78.44 151.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.6 -20.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' D' ' 28' ' ' PRO . 12.6 t -78.47 -21.58 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -110.13 46.58 1.02 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.181 -0.949 . . . . 0.0 109.633 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -171.81 -35.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.614 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 76.3 m -107.94 -26.56 10.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.318 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -70.98 -24.8 62.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.514 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 70.9 p -95.03 2.49 55.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.718 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.63 138.88 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.343 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.533 HD11 HG23 ' L' ' 2' ' ' VAL . 4.2 mt -59.03 115.84 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 m -73.94 179.44 4.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.056 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.25 179.31 4.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.555 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -36.88 73.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -43.37 85.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 0.0 109.379 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.41 -43.0 99.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.475 -0.766 . . . . 0.0 109.7 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' C' ' 16' ' ' LEU . 80.8 mt -69.26 -19.62 63.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.538 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -74.36 -23.86 59.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.674 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -70.84 -8.06 49.91 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.772 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -114.46 22.18 13.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.17 138.05 51.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.046 -1.033 . . . . 0.0 109.742 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.344 179.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 12.2 p90 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.247 0.546 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -81.43 144.19 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.329 -0.857 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -173.64 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -75.88 -30.13 58.73 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.333 -0.854 . . . . 0.0 109.759 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -73.71 -36.19 65.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -0.912 . . . . 0.0 109.765 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.59 -23.12 25.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.0 109.17 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 9.2 t -77.33 -24.97 50.71 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.27 -31.75 30.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 52.7 p -81.16 -14.38 57.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -1.114 . . . . 0.0 109.606 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -81.15 -18.78 45.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -0.91 . . . . 0.0 109.641 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' D' ' 12' ' ' VAL . 10.3 mt -91.42 -49.03 6.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' D' ' 11' ' ' LEU . 5.1 m -44.48 -42.57 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 109.591 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -65.27 -43.32 91.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 109.367 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.07 12.84 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.384 -0.823 . . . . 0.0 109.701 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' D' ' 15' ' ' LEU . 1.7 mt -102.05 -56.87 2.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 109.571 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 16' ' ' TYR . 16.5 p90 -63.4 -19.98 65.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.062 -1.024 . . . . 0.0 109.173 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 17' ' ' LEU . 0.1 OUTLIER -72.15 -46.13 57.69 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.272 -0.892 . . . . 0.0 109.248 179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.12 -53.95 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.306 -0.871 . . . . 0.0 109.114 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.89 39.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.1 -113.47 3.66 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -123.66 32.23 5.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.316 -1.108 . . . . 0.0 109.746 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -91.05 -53.72 4.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.43 154.72 7.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' D' ' 24' ' ' PHE . 7.0 p90 -158.46 167.1 30.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -1.131 . . . . 0.0 109.24 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -128.88 152.68 48.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.097 -1.002 . . . . 0.0 109.591 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -135.78 104.05 5.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.635 HG22 ' HA3' ' B' ' 23' ' ' GLY . 0.0 OUTLIER -135.59 101.46 10.83 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 109.567 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' C' ' 3' ' ' VAL . 36.3 Cg_endo -79.65 105.74 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.765 2.31 . . . . 0.0 111.495 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' D' ' 28' ' ' PRO . 0.1 OUTLIER 159.78 147.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.264 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.68 -18.22 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -1.158 . . . . 0.0 109.21 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' E' ' 7' ' ' CYS . 13.5 t -80.07 -23.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -107.88 48.81 0.83 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.246 -0.909 . . . . 0.0 109.843 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -174.82 -36.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -108.92 -22.41 12.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.119 -0.988 . . . . 0.0 109.179 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' E' ' 3' ' ' VAL . 53.9 t -73.88 -24.87 59.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 108.928 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 64.8 p -94.71 1.56 55.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.391 -0.818 . . . . 0.0 109.515 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.24 139.28 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 109.668 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.25 116.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 109.722 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 43.2 m -75.37 -178.17 3.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.17 -0.956 . . . . 0.0 109.295 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.14 174.75 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.562 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -37.16 84.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.929 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.06 -44.97 82.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.986 -1.071 . . . . 0.0 109.326 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -58.24 -46.57 85.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.876 . . . . 0.0 109.656 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.1 mt -65.04 -20.49 66.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -74.45 -24.58 59.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.005 . . . . 0.0 109.297 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -69.17 -7.33 35.4 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -116.42 24.23 11.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.188 -0.945 . . . . 0.0 109.683 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.85 138.48 52.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.669 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.447 HG23 HD11 ' A' ' 10' ' ' ILE . 7.4 p -68.36 142.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.441 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -174.19 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -78.02 -27.25 48.82 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.615 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -73.88 -39.74 63.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 109.305 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.47 -25.09 31.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.281 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.4 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 8.6 t -74.87 -24.32 58.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.416 -0.803 . . . . 0.0 109.642 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.95 -32.34 26.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . 0.406 ' HA ' HG22 ' F' ' 12' ' ' VAL . 80.6 p -82.33 -11.72 58.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.3 -16.3 46.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.204 -0.935 . . . . 0.0 109.318 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' F' ' 7' ' ' CYS . 11.6 mt -94.55 -49.14 5.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.252 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' F' ' 9' ' ' SER . 6.5 m -44.53 -41.55 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 109.547 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -66.92 -43.61 82.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.997 -1.064 . . . . 0.0 109.42 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.15 15.78 9.66 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' F' ' 15' ' ' LEU . 1.4 mt -102.69 -57.9 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.644 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' F' ' 16' ' ' TYR . 18.6 p90 -61.17 -21.76 64.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.177 -0.952 . . . . 0.0 109.509 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' F' ' 17' ' ' LEU . 0.1 OUTLIER -70.26 -47.4 61.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.286 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.75 -51.95 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -26.93 52.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.0 109.543 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.19 -113.41 3.64 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -122.94 27.51 7.65 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -1.176 . . . . 0.0 109.675 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -84.88 -55.32 4.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.9 147.82 6.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' F' ' 24' ' ' PHE . 6.0 p90 -150.19 169.82 20.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.372 -1.076 . . . . 0.0 109.421 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.116 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -127.17 102.66 7.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 0.0 109.236 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 106.89 7.9 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.352 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' F' ' 29' ' ' LYS . 33.2 Cg_endo -75.4 -173.73 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.051 1.834 . . . . 0.0 109.51 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' F' ' 28' ' ' PRO . 0.0 OUTLIER 79.4 155.65 0.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.808 . . . . 0.0 110.244 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.42 -19.41 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.131 -1.217 . . . . 0.0 108.78 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' H' ' 28' ' ' PRO . 11.9 t -78.72 -24.99 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 109.521 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -106.93 48.64 0.83 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.276 -0.89 . . . . 0.0 109.869 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -173.78 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.579 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 79.2 m -108.34 -26.87 10.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -20.45 62.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.13 -0.981 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 62.6 p -98.52 0.99 46.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.072 -1.018 . . . . 0.0 109.495 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.6 140.2 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.2 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 4.7 mt -61.05 116.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.896 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 53.9 m -74.88 179.05 5.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.832 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.44 173.3 7.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -34.1 77.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.258 -0.902 . . . . 0.0 109.906 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -44.39 75.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.101 -0.999 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -60.7 -43.46 97.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.345 -0.847 . . . . 0.0 109.836 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.19 -21.88 65.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -72.7 -25.05 61.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.26 -0.9 . . . . 0.0 109.498 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.16 -11.66 59.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.349 -0.844 . . . . 0.0 109.558 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -112.38 22.52 14.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.104 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.6 138.52 50.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.146 -0.972 . . . . 0.0 109.338 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.697 -179.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' K' ' 9' ' ' SER . 5.9 p90 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.65 146.13 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.307 -0.87 . . . . 0.0 109.646 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -177.28 -38.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 0.0 109.069 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -76.07 -29.45 57.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.504 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -72.86 -36.79 67.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.342 -0.849 . . . . 0.0 109.598 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' L' ' 10' ' ' HIS . 7.5 mt -87.46 -21.69 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.514 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 36.5 t -77.61 -23.86 49.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.259 -0.9 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.72 -30.91 25.42 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . 0.4 ' HA ' HG22 ' H' ' 12' ' ' VAL . 25.2 p -82.0 -13.96 56.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.554 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -81.36 -18.06 46.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.144 -0.972 . . . . 0.0 109.221 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 11.5 mt -92.17 -48.94 6.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.668 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' H' ' 11' ' ' LEU . 3.5 m -44.17 -43.01 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 109.452 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -64.85 -45.48 85.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.63 15.28 8.35 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.373 -0.829 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -103.02 -58.3 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 0.0 109.811 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' H' ' 16' ' ' TYR . 18.0 p90 -61.79 -19.8 62.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.074 -1.016 . . . . 0.0 109.327 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' H' ' 17' ' ' LEU . 0.1 OUTLIER -72.42 -45.62 58.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.241 -0.912 . . . . 0.0 109.282 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.71 -52.04 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -28.37 55.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 0.0 109.402 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.5 -113.69 3.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -122.47 31.28 6.18 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.266 -1.138 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -89.81 -51.12 5.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.59 159.51 9.86 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' H' ' 24' ' ' PHE . 6.3 p90 -164.0 164.63 23.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.753 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -127.1 153.19 46.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.84 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -134.99 106.14 6.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.5 100.78 10.12 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.165 -0.959 . . . . 0.0 109.527 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' G' ' 3' ' ' VAL . 37.2 Cg_endo -79.6 103.08 1.55 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.833 2.356 . . . . 0.0 111.437 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' H' ' 28' ' ' PRO . 0.1 OUTLIER 161.72 149.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.511 -0.743 . . . . 0.0 109.277 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.399 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . . . . . . . . . 15.1 tt -75.11 -18.47 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -1.151 . . . . 0.0 109.734 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 t -81.82 -21.18 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.66 50.62 0.78 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.0 109.233 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -176.02 -38.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.395 -0.816 . . . . 0.0 109.188 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -104.84 -30.37 9.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.58 -23.53 65.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.394 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -95.39 -0.67 52.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 1' ' ' PHE . 3.3 p -176.46 140.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.982 . . . . 0.0 109.698 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mt -60.58 114.54 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.193 -0.942 . . . . 0.0 109.523 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -74.18 178.33 5.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.68 173.75 7.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.912 . . . . 0.0 109.537 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -37.63 85.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.785 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.78 -42.48 90.74 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.098 -1.001 . . . . 0.0 109.79 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.11 -44.97 95.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.13 -18.78 65.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.08 -1.012 . . . . 0.0 109.925 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.0 -22.93 55.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.341 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.51 -6.05 37.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.678 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.31 21.72 12.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.203 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.84 137.55 51.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.501 -0.75 . . . . 0.0 109.234 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.42 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.15 145.68 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.614 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -175.96 -39.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -75.86 -29.35 58.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -73.04 -35.16 66.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.43 -21.13 23.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.412 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 30.4 t -78.16 -22.7 48.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.42 -34.06 15.12 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 86.2 p -79.46 -13.73 59.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -1.192 . . . . 0.0 109.307 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' B' ' 6' ' ' LEU . 1.6 m-70 -82.11 -15.37 53.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.251 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' J' ' 12' ' ' VAL . 16.0 mt -95.08 -48.95 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.341 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' J' ' 11' ' ' LEU . 5.8 m -43.97 -42.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.182 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' J' ' 12' ' ' VAL . 12.0 tt0 -65.69 -43.7 88.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.292 -0.88 . . . . 0.0 109.668 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.42 14.99 11.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' J' ' 15' ' ' LEU . 1.6 mt -101.68 -59.1 1.76 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.63 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' J' ' 16' ' ' TYR . 14.4 p90 -59.84 -23.3 63.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.252 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -47.1 64.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.444 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.23 -51.51 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.887 . . . . 0.0 109.534 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -27.37 57.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.396 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.19 -111.9 3.37 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.99 26.82 7.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.21 -1.171 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -85.54 -52.16 6.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.24 156.05 8.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' J' ' 24' ' ' PHE . 7.2 p90 -160.26 164.46 32.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -126.77 143.7 51.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.557 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -125.87 97.84 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.135 -0.978 . . . . 0.0 109.577 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.76 108.42 11.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' J' ' 29' ' ' LYS . 34.5 Cg_endo -76.96 -173.04 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.254 1.969 . . . . 0.0 110.079 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' J' ' 28' ' ' PRO . 0.0 OUTLIER 77.96 154.34 0.15 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.609 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.35 -17.59 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.117 -1.225 . . . . 0.0 109.715 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' K' ' 7' ' ' CYS . 11.8 t -81.04 -21.51 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.999 -1.063 . . . . 0.0 109.257 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -109.65 48.97 0.85 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.276 -0.89 . . . . 0.0 109.711 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -174.29 -39.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.289 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 75.3 m -105.23 -23.61 12.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 109.511 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.431 ' HB3' ' O ' ' K' ' 3' ' ' VAL . 49.6 t -72.62 -25.72 61.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 67.1 p -94.71 1.99 55.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.589 ' HB3' ' CZ ' ' H' ' 1' ' ' PHE . 0.3 OUTLIER -179.07 139.87 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -0.924 . . . . 0.0 109.691 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 mt -60.4 114.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.876 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 54.8 m -73.31 -175.7 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.41 176.78 5.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -37.78 80.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.01 . . . . 0.0 109.241 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.66 -43.51 89.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -60.61 -46.1 91.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.16 -0.962 . . . . 0.0 109.351 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' K' ' 16' ' ' LEU . 68.9 mt -64.96 -22.38 66.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.404 -0.81 . . . . 0.0 109.708 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.58 -23.08 59.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.999 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.02 -7.46 46.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.062 -1.024 . . . . 0.0 109.76 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.41 23.7 12.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.967 . . . . 0.0 109.365 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.28 134.62 54.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 0.0 109.548 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.533 HG23 HD11 ' C' ' 10' ' ' ILE . 7.3 p -66.81 145.11 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -175.98 -38.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.269 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -77.23 -27.58 53.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.282 -0.886 . . . . 0.0 109.526 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -74.14 -37.5 64.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -86.79 -23.15 25.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.267 -0.896 . . . . 0.0 109.349 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.417 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 7.3 t -76.79 -22.4 53.74 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.357 -0.839 . . . . 0.0 109.059 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.82 -32.13 22.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 29.1 p -82.54 -14.32 55.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.307 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.552 ' CD2' HD13 ' H' ' 6' ' ' LEU . 1.9 m-70 -80.8 -17.2 51.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.844 . . . . 0.0 109.649 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' L' ' 12' ' ' VAL . 12.1 mt -92.95 -50.25 5.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.425 HG23 ' N ' ' L' ' 13' ' ' GLU . 11.3 m -43.39 -42.41 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.405 -0.81 . . . . 0.0 109.709 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.425 ' N ' HG23 ' L' ' 12' ' ' VAL . 11.2 tt0 -66.17 -43.32 87.24 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.238 -0.914 . . . . 0.0 109.494 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.08 15.22 10.56 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' L' ' 15' ' ' LEU . 1.8 mt -102.72 -58.95 1.79 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' L' ' 16' ' ' TYR . 19.8 p90 -59.8 -22.69 62.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.4 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' L' ' 17' ' ' LEU . 0.1 OUTLIER -70.2 -47.6 60.79 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.9 . . . . 0.0 109.499 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.75 -50.63 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.855 . . . . 0.0 109.541 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -27.85 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.923 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.34 -113.9 3.74 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -122.56 28.95 7.11 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.307 -1.114 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -87.48 -53.46 4.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.347 -0.845 . . . . 0.0 109.694 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.74 158.14 8.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' L' ' 24' ' ' PHE . 7.1 p90 -162.53 163.75 27.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -1.123 . . . . 0.0 109.468 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -126.76 143.29 51.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 109.313 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -125.28 94.45 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 108.65 17.39 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.476 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' L' ' 29' ' ' LYS . 34.3 Cg_endo -77.02 -173.01 1.6 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.165 1.91 . . . . 0.0 109.646 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' L' ' 28' ' ' PRO . 0.0 OUTLIER 77.94 155.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.669 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 31' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 33' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 32' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 tt -92.77 -18.77 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.542 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.97 -47.04 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.271 -0.893 . . . . 0.0 109.726 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.6 58.97 5.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.382 -0.824 . . . . 0.0 109.557 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.257 -0.902 . . . . 0.0 109.424 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -54.91 2.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -47.11 -32.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.5 -90.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 109.617 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.93 136.32 38.79 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.569 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -58.64 130.96 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.174 -0.954 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' O ' HG22 ' A' ' 10' ' ' ILE . 91.4 m -75.06 -177.67 3.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 -177.14 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -73.04 -18.16 61.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.161 -0.962 . . . . 0.0 109.774 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -80.11 -45.0 18.97 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.136 -0.977 . . . . 0.0 109.471 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.12 -51.01 16.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.927 . . . . 0.0 110.022 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.2 mt -54.83 -21.53 11.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.761 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -64.68 -45.74 85.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.092 -1.005 . . . . 0.0 109.465 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -53.79 -40.24 66.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -89.74 59.92 4.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.49 128.93 6.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.965 . . . . 0.0 109.635 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.403 HG22 ' HG ' ' B' ' 6' ' ' LEU . 6.3 p -169.11 135.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.515 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -70.86 -32.42 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.296 -0.878 . . . . 0.0 109.401 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -69.37 -49.28 56.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.853 . . . . 0.0 109.158 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.403 ' HG ' HG22 ' B' ' 2' ' ' VAL . 14.6 mt -69.23 -26.05 64.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.196 -0.94 . . . . 0.0 108.958 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.479 ' O ' ' HG ' ' B' ' 11' ' ' LEU . 46.8 t -72.7 -30.23 64.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.538 -0.726 . . . . 0.0 109.673 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.81 -30.63 63.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.62 10.5 20.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 0.0 109.742 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -110.54 -16.27 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.583 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' B' ' 7' ' ' CYS . 3.5 mt -98.34 -30.06 12.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.254 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 16.9 m -54.13 -36.07 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.861 . . . . 0.0 109.081 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' B' ' 14' ' ' ALA . 25.6 pt-20 -78.37 -37.53 43.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 109.387 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.505 ' N ' ' HG3' ' B' ' 13' ' ' GLU . . . -74.87 -7.51 53.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.32 -0.862 . . . . 0.0 109.797 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' B' ' 15' ' ' LEU . 6.9 mt -99.07 -43.07 6.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.51 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.495 ' OH ' ' CD1' ' D' ' 26' ' ' TYR . 0.1 OUTLIER -53.03 -30.27 34.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.344 -0.848 . . . . 0.0 109.483 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.86 -61.29 1.93 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.754 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.22 -64.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.118 -0.989 . . . . 0.0 109.59 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -37.61 66.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.16 -134.11 13.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.64 39.52 0.92 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -1.203 . . . . 0.0 109.306 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 -34.89 9.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 0.0 109.773 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 161.46 35.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -162.85 164.75 25.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.47 -1.017 . . . . 0.0 108.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' B' ' 25' ' ' PHE . 32.6 p90 -123.17 147.99 46.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.136 -0.978 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -130.07 116.24 18.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.265 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 3.2 m -142.92 101.92 5.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 29' ' ' LYS . 34.9 Cg_endo -77.18 -53.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.748 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' B' ' 28' ' ' PRO . 2.7 tttt 41.47 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.528 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.088 -1.007 . . . . 0.0 109.596 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.786 -1.325 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . . . . . . . . . 19.8 tt -94.08 -16.99 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -1.203 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.21 -45.68 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.036 -1.04 . . . . 0.0 109.273 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' C' ' 5' ' ' GLN . 0.6 OUTLIER -86.38 62.81 7.64 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.297 -0.877 . . . . 0.0 109.474 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' C' ' 4' ' ' GLU . 32.0 tt0 175.46 -35.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 0.0 109.405 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 -54.21 3.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 12.1 t -45.99 -32.67 2.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.491 -0.755 . . . . 0.0 109.57 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 1.4 p -90.7 -93.99 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 137.61 46.62 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.114 -0.991 . . . . 0.0 109.556 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.566 HD12 ' N ' ' C' ' 10' ' ' ILE . 2.8 mp -60.31 133.23 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 109.348 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.89 -175.36 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 109.929 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.23 -175.76 3.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.436 -0.79 . . . . 0.0 109.26 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 tp -74.38 -19.08 60.56 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 109.513 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -79.94 -45.59 18.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.693 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -73.25 -51.7 16.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.777 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -53.39 -28.9 31.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.447 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.69 -47.21 82.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.805 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -53.01 -39.97 63.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.66 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.06 64.75 4.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.223 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.13 126.47 3.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.293 -0.879 . . . . 0.0 109.414 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.517 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.31 0.576 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.412 HG22 ' HG ' ' D' ' 6' ' ' LEU . 6.1 p -172.26 136.23 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -168.9 -39.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 109.295 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 109.055 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -69.94 -52.64 22.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.316 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.412 ' HG ' HG22 ' D' ' 2' ' ' VAL . 12.2 mt -67.45 -26.24 66.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 0.0 108.708 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' D' ' 11' ' ' LEU . 4.7 t -73.82 -26.0 60.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.594 -0.691 . . . . 0.0 109.622 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.78 -30.49 55.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.49 9.57 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -1.027 . . . . 0.0 109.306 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -18.02 14.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.229 -0.919 . . . . 0.0 109.838 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.41 ' CD2' ' C2 ' ' D' ' 32' ' ' IPH . 3.6 mt -97.86 -29.03 13.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 109.59 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . . . . . . . . . 24.2 m -54.99 -36.45 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 109.804 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' D' ' 14' ' ' ALA . 25.0 pt-20 -77.65 -36.68 51.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.145 -0.972 . . . . 0.0 109.215 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' D' ' 13' ' ' GLU . . . -75.0 -9.11 58.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 109.773 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' D' ' 15' ' ' LEU . 6.7 mt -97.91 -43.85 6.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 109.585 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -26.54 14.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.451 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.724 HD11 ' HB1' ' J' ' 14' ' ' ALA . 3.0 mm? -79.19 -61.32 2.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 109.659 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 96.8 t -46.51 -61.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.552 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -37.39 75.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.8 -134.49 14.58 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.89 39.14 0.83 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.204 -1.174 . . . . 0.0 109.48 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -33.47 9.5 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.28 174.09 38.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -176.01 166.8 3.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.133 . . . . 0.0 109.232 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . 0.431 ' O ' ' CD1' ' D' ' 25' ' ' PHE . 32.1 p90 -127.49 146.38 50.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.722 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.495 ' CD1' ' OH ' ' B' ' 16' ' ' TYR . 3.1 t80 -128.94 116.53 19.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.386 -0.821 . . . . 0.0 109.394 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -141.21 103.67 6.1 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' D' ' 29' ' ' LYS . 36.3 Cg_endo -77.81 -53.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.404 2.069 . . . . 0.0 110.417 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' D' ' 28' ' ' PRO . 2.6 tttt 40.75 -159.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.496 -0.752 . . . . 0.0 109.525 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.166 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.31 -18.1 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.262 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.95 -47.81 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.283 -0.886 . . . . 0.0 109.354 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' E' ' 5' ' ' GLN . 1.0 OUTLIER -85.3 60.7 6.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 109.707 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' E' ' 4' ' ' GLU . 32.6 tt0 177.18 -34.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.126 -0.984 . . . . 0.0 109.279 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -54.66 2.98 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.46 -0.775 . . . . 0.0 109.632 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -47.81 -32.13 5.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -88.07 -93.13 0.1 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.2 -0.938 . . . . 0.0 109.378 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.25 136.54 42.69 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 109.36 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.589 ' N ' HD12 ' E' ' 10' ' ' ILE . 2.6 mp -59.89 130.45 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 109.408 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . 0.442 ' O ' HG22 ' E' ' 10' ' ' ILE . 96.4 m -73.76 -173.75 1.59 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.208 -0.932 . . . . 0.0 109.402 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.22 -175.61 3.92 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -72.78 -20.68 61.13 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.124 -0.985 . . . . 0.0 109.647 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.85 -46.26 21.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.93 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -73.24 -49.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 110.115 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 80.1 mt -55.94 -23.58 32.77 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.94 -41.74 97.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.948 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -57.38 -40.23 77.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.323 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -91.7 64.41 4.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.27 127.79 3.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.269 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.985 . . . . 0.0 109.587 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' F' ' 6' ' ' LEU . 7.3 p -173.12 133.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -165.57 -40.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -72.16 -33.84 68.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.504 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -68.08 -47.59 67.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.41 ' HG ' HG22 ' F' ' 2' ' ' VAL . 14.7 mt -70.89 -26.34 63.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 108.916 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG ' ' F' ' 11' ' ' LEU . 49.7 t -73.39 -27.33 61.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.466 -0.771 . . . . 0.0 109.819 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.35 60.84 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.54 14.11 15.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -1.091 . . . . 0.0 109.511 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -112.08 -19.08 12.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.272 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.461 ' CD2' ' C2 ' ' F' ' 32' ' ' IPH . 3.2 mt -96.05 -31.19 13.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.309 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.441 HG23 ' N ' ' F' ' 13' ' ' GLU . 15.9 m -51.98 -40.48 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 109.087 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' F' ' 14' ' ' ALA . 25.4 pt-20 -74.77 -37.82 62.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.512 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' F' ' 13' ' ' GLU . . . -73.78 -8.18 55.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' F' ' 15' ' ' LEU . 7.2 mt -99.82 -43.99 6.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -28.5 17.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' F' ' 17' ' ' LEU . 2.9 mm? -77.18 -61.04 2.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.242 -0.911 . . . . 0.0 109.786 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 94.6 t -47.74 -62.45 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.207 -0.933 . . . . 0.0 109.675 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.82 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.607 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.98 -136.21 17.08 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.45 37.58 0.74 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.173 -1.193 . . . . 0.0 109.633 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.54 -32.1 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.1 175.07 40.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -177.01 168.98 2.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -1.194 . . . . 0.0 109.728 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . 0.437 ' O ' ' CD1' ' F' ' 25' ' ' PHE . 32.8 p90 -130.05 146.26 51.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 109.879 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . 0.547 ' CD1' ' OH ' ' H' ' 16' ' ' TYR . 4.0 t80 -128.59 117.21 20.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.073 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -141.79 102.33 5.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.037 -1.04 . . . . 0.0 109.558 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' F' ' 29' ' ' LYS . 33.1 Cg_endo -76.7 -56.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.516 2.144 . . . . 0.0 110.495 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' F' ' 28' ' ' PRO . 2.2 tttt 44.54 -156.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.245 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.871 -1.061 . . . . 0.0 109.4 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . . . . . . . . . 18.1 tt -93.01 -18.6 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 108.946 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.19 -47.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 61.6 6.94 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.342 -0.849 . . . . 0.0 110.005 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 176.86 -31.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.329 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' G' ' 7' ' ' CYS . 0.1 OUTLIER -102.76 -54.0 2.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.829 . . . . 0.0 109.811 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' G' ' 6' ' ' CYS . 0.7 OUTLIER -46.93 -29.81 2.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 108.976 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -91.43 -94.64 0.13 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.307 -0.871 . . . . 0.0 109.226 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.42 137.04 44.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.16 -0.962 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.619 ' H ' HD12 ' G' ' 10' ' ' ILE . 3.1 mp -61.39 126.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.939 . . . . 0.0 109.761 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . 0.416 ' O ' HG22 ' G' ' 10' ' ' ILE . 99.4 m -69.22 -173.24 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.341 -0.85 . . . . 0.0 109.384 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.48 -175.25 3.82 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.0 -20.32 60.37 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.139 -0.976 . . . . 0.0 109.689 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -77.95 -44.57 26.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.0 -53.07 10.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.768 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 83.6 mt -52.56 -24.61 8.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -62.23 -47.38 84.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -0.973 . . . . 0.0 109.463 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -52.18 -39.98 60.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.615 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -91.08 65.18 5.5 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.916 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 30.4 t -164.28 131.32 3.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.466 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.351 0.596 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.408 HG22 ' HG ' ' H' ' 6' ' ' LEU . 7.4 p -172.26 135.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.241 -0.912 . . . . 0.0 109.365 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -167.89 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.313 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -72.02 -31.96 66.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.43 -0.794 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -69.58 -49.11 57.21 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.0 109.127 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.408 ' HG ' HG22 ' H' ' 2' ' ' VAL . 11.8 mt -69.71 -26.27 64.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.894 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' H' ' 11' ' ' LEU . 41.0 t -71.87 -30.45 65.43 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.48 -0.762 . . . . 0.0 109.398 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.68 -31.58 62.52 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.8 13.23 13.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.205 -1.173 . . . . 0.0 109.645 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -17.91 12.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' H' ' 7' ' ' CYS . 4.6 mt -96.21 -35.5 11.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.445 HG23 ' N ' ' H' ' 13' ' ' GLU . 20.9 m -48.16 -39.73 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.432 -0.793 . . . . 0.0 109.646 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' H' ' 14' ' ' ALA . 24.8 pt-20 -76.41 -35.54 58.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' H' ' 13' ' ' GLU . . . -75.17 -9.21 58.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.89 -46.18 6.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.725 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.547 ' OH ' ' CD1' ' F' ' 26' ' ' TYR . 0.1 OUTLIER -50.1 -29.68 9.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.49 -61.46 1.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.576 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.49 -65.8 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.891 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 16.0 m -49.47 -51.25 37.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.011 -1.056 . . . . 0.0 109.443 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' H' ' 22' ' ' ARG . . . 68.86 107.82 0.03 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.064 -1.065 . . . . 0.0 110.57 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER 34.6 30.0 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.75 -0.853 . . . . 0.0 111.272 179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' H' ' 20' ' ' GLY . 0.0 OUTLIER -106.61 -27.23 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.957 -1.089 . . . . 0.0 108.338 179.143 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.91 159.25 33.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -164.25 167.46 19.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -1.056 . . . . 0.0 109.125 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -127.95 147.22 50.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.103 -0.998 . . . . 0.0 109.539 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -131.18 115.57 16.53 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.28 -0.887 . . . . 0.0 109.427 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 2.0 m -140.57 102.66 6.52 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.481 -0.762 . . . . 0.0 109.317 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' H' ' 29' ' ' LYS . 34.0 Cg_endo -77.05 -53.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.42 2.08 . . . . 0.0 110.259 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' H' ' 28' ' ' PRO . 2.8 tttt 40.58 -158.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.622 -0.674 . . . . 0.0 109.357 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.404 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' I' ' 6' ' ' CYS . 17.7 tt -95.28 -18.42 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.43 -1.041 . . . . 0.0 109.374 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.18 -48.65 42.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' I' ' 5' ' ' GLN . 0.9 OUTLIER -85.1 62.33 7.44 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.367 -0.833 . . . . 0.0 109.694 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' I' ' 4' ' ' GLU . 30.4 tt0 174.14 -30.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.84 . . . . 0.0 109.431 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' I' ' 2' ' ' ILE . 0.1 OUTLIER -101.79 -54.96 2.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.0 109.479 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.77 -30.2 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.99 -95.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.652 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.18 133.57 46.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.016 -1.052 . . . . 0.0 109.488 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.594 ' H ' HD12 ' I' ' 10' ' ' ILE . 2.7 mp -55.83 134.26 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 108.73 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . 0.408 ' O ' HG22 ' I' ' 10' ' ' ILE . 91.7 m -78.02 -177.12 4.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.108 -0.995 . . . . 0.0 109.796 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.72 -179.88 5.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.327 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tp -70.69 -21.56 62.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -77.01 -45.9 25.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.065 -1.022 . . . . 0.0 109.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -72.58 -51.55 19.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.785 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.2 mt -53.16 -25.19 12.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.796 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.86 -48.56 81.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.082 -1.011 . . . . 0.0 109.271 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -51.12 -41.51 60.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.4 -0.813 . . . . 0.0 109.889 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.23 59.26 3.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.94 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -156.9 129.22 7.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.452 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' J' ' 6' ' ' LEU . 5.8 p -171.22 135.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.32 -0.863 . . . . 0.0 109.344 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -167.98 -40.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 0.0 109.331 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -72.49 -32.5 66.24 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.235 -0.916 . . . . 0.0 109.253 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.09 -53.2 27.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 109.292 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' J' ' 2' ' ' VAL . 10.1 mt -66.11 -27.48 68.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 108.685 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.416 ' O ' ' HG ' ' J' ' 11' ' ' LEU . 47.9 t -70.53 -35.1 72.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.509 -0.744 . . . . 0.0 109.462 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.4 -28.46 72.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 2.4 m -91.7 13.81 17.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -1.136 . . . . 0.0 109.738 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.21 -18.07 12.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.336 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' C2 ' ' J' ' 31' ' ' IPH . 4.8 mt -96.29 -32.09 12.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.44 HG23 ' N ' ' J' ' 13' ' ' GLU . 21.3 m -51.64 -39.55 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.245 -0.91 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.501 ' HG3' ' N ' ' J' ' 14' ' ' ALA . 25.2 pt-20 -76.09 -35.56 59.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.353 -0.842 . . . . 0.0 109.456 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.724 ' HB1' HD11 ' D' ' 17' ' ' LEU . . . -75.05 -9.84 58.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.299 -0.876 . . . . 0.0 109.643 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -97.92 -44.43 6.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -27.62 14.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 109.669 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -77.78 -61.2 2.07 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.397 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 97.5 t -47.09 -64.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 -37.7 66.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.66 -136.2 17.9 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.6 39.46 0.84 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.178 -1.19 . . . . 0.0 109.385 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 -36.06 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.08 171.74 33.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -174.09 167.74 4.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -1.185 . . . . 0.0 109.632 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -127.27 154.96 44.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.306 -0.871 . . . . 0.0 109.989 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -138.83 119.81 14.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.343 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 1.3 m -142.68 96.98 6.05 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 0.0 109.502 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' J' ' 29' ' ' LYS . 37.5 Cg_endo -81.56 24.4 0.7 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.842 2.361 . . . . 0.0 111.538 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' J' ' 28' ' ' PRO . 2.7 tttt -45.63 173.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 109.99 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . 0.444 ' OXT' ' O ' ' J' ' 29' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.53 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . . . . . . . . . 18.5 tt -93.26 -17.74 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -1.217 . . . . 0.0 109.839 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 19.7 t -74.53 -46.46 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.485 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' K' ' 5' ' ' GLN . 0.9 OUTLIER -86.09 61.45 6.84 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.241 -0.912 . . . . 0.0 109.492 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' K' ' 4' ' ' GLU . 30.7 tt0 175.39 -31.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.89 -54.67 2.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.42 -30.69 5.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.463 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.22 -91.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.98 134.15 40.25 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.179 -0.951 . . . . 0.0 109.433 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.622 HD12 ' H ' ' K' ' 10' ' ' ILE . 2.8 mp -56.52 131.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.883 . . . . 0.0 109.311 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . 0.428 ' O ' HG22 ' K' ' 10' ' ' ILE . 92.0 m -75.63 -174.48 2.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.333 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.26 -176.14 4.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.327 -0.858 . . . . 0.0 108.803 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -71.99 -23.15 61.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.09 -1.007 . . . . 0.0 109.643 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.23 -44.92 43.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.834 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -74.92 -49.84 18.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.23 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 68.5 mt -55.59 -24.95 35.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.748 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.78 -41.07 99.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.9 . . . . 0.0 109.687 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -57.83 -37.85 74.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.212 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 64.96 3.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.113 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 13.7 t -161.55 127.05 3.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.47 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.324 0.583 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.417 HG22 ' HG ' ' L' ' 6' ' ' LEU . 7.2 p -171.16 135.4 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.34 -0.85 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -168.17 -42.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.327 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.89 -32.79 69.86 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.263 -0.898 . . . . 0.0 109.261 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -67.43 -53.87 25.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' L' ' 2' ' ' VAL . 13.1 mt -66.33 -26.59 67.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' L' ' 11' ' ' LEU . 43.8 t -72.67 -29.58 63.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.311 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.2 -29.99 63.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.38 13.55 15.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -1.106 . . . . 0.0 109.504 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -113.12 -14.66 12.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.351 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' L' ' 7' ' ' CYS . 5.1 mt -99.37 -32.38 11.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.123 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.431 HG23 ' N ' ' L' ' 13' ' ' GLU . 16.3 m -51.95 -40.2 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' L' ' 14' ' ' ALA . 25.4 pt-20 -73.85 -38.29 64.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.316 -0.865 . . . . 0.0 109.351 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' L' ' 13' ' ' GLU . . . -74.38 -9.28 58.44 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.229 -0.919 . . . . 0.0 109.914 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' L' ' 15' ' ' LEU . 6.4 mt -97.57 -44.38 6.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 109.545 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.77 -29.7 19.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.762 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' L' ' 17' ' ' LEU . 2.7 mm? -75.77 -60.73 2.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -48.06 -59.5 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.596 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 22.7 m -60.45 -36.57 78.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.966 . . . . 0.0 109.76 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.65 -134.59 15.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.32 37.48 0.78 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.192 -1.181 . . . . 0.0 109.696 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -34.2 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 109.355 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.62 170.87 39.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -171.05 167.32 7.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -1.136 . . . . 0.0 109.186 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . 0.4 ' CD1' ' C ' ' L' ' 25' ' ' PHE . 32.9 p90 -127.51 149.07 50.3 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 0.0 109.407 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -133.25 117.68 17.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.276 -0.89 . . . . 0.0 109.305 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 4.5 m -142.68 103.68 5.37 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 109.275 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' L' ' 29' ' ' LYS . 35.5 Cg_endo -77.52 -54.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.469 2.113 . . . . 0.0 110.363 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' L' ' 28' ' ' PRO . 2.8 tttt 43.34 -153.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.329 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' IPH . . . . . 0.41 ' C2 ' ' CD2' ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 32' ' ' IPH . . . . . 0.461 ' C2 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 32' ' ' IPH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' J' J ' 31' ' ' IPH . . . . . 0.43 ' H5 ' HD11 ' D' ' 17' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 32' ' ' IPH . . . . . 0.4 ' C2 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 31' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_